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Abstract 
 Protein-RNA interactions and protein folding are critical subjects in biochemistry, 
because of their significance during the formation of active complexes and signaling pathways. 
Regardless of the substantial amount of studies in the fields of protein-RNA interactions and 
protein folding, little is known about the stability and kinetics of these in the cell. This doctoral 
dissertation aims to advance the understanding of protein-RNA interactions and protein folding 
inside cells through comparative in vitro studies, utilizing U1A-SL2 RNA complex and 
PGK/VlsE proteins as model systems, respectively. For the protein-RNA studies, dynamics 
experiments of one positive charged mutant of the spliceosomal U1A protein, the golden model 
for the RNA Recognition Motif (RRM), reveled a conformational transition for the protein 
only. Also, U1A-SL2 RNA dissociation kinetics studies with U1A positive charged mutants 
supported the previously proposed two-step dissociation pathway and demonstrated the 
importance of positive charge residues.  The U1A-SL2 was also investigated in macromolecular 
crowded buffers were its binding affinity increased. It was also studied inside mammalian cells 
were it localized in the nucleus and its binding affinity decreased.  For the protein folding 
studies, the extracellular VlsE antigen was found to be destabilized inside mammalian cells 
opposed to the intracellular PGK enzyme.  
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Part I 
RNA Binding Proteins Dynamics 
 
Introduction 
 RNA is a dynamic molecule required for life. RNA molecules are critical for DNA 
expression, protein regulation, and other important cellular processes.1-4 In order to be involved 
in all of these cellular processes, RNA molecules have evolved extremely dynamic structures such 
as internal loops, hairpin loops and bulges.5,6 In living cells RNA is always in close interaction 
with RNA binding proteins (RBPs) to regulate cellular machines such as the ribosome and the 
spliceosome.7,8 In most cases, RBPs bind to RNA molecules as soon as they are transcribed and 
control the spatial, temporal and functional dynamics of RNAs.9 Because RBPs are highly 
involved in RNA splicing in the brain, most of the RBP-related diseases are neurodegenerative 
disorders.9  
 Functional units known as ribonucleoprotein (RNPs) are formed when several RBPs 
interact with RNA. RBPs are extremely dynamic, because they associate and dissociate at 
different steps of the post-transcriptional processes.7 These dynamics depend on the specificity of 
binging in the RNA-RBPs complex, which is related to the RNA biding domain (RBD) within 
the RNP complex. RBDs diversity allow RNA-protein complexes to have protein-protein 
interactions and catalytic activity.10-13 Protein-protein interactions through RBDs can modulate 
the recognition of the RNA.11-13 Thus, the specificity of a RBP for a specific RNA molecule can 
change upon binding to another protein. For example, during spliceosome assembly the U2AF65 
protein interaction with the pre-mRNA is strengthened by the interaction with the SF1 protein. 
The catalytic activity of RBPs can also be regulated by protein-protein and protein-RNA 
interactions. Therefore, the RBPs have evolved to perform a variety of functions and specifically 
recognize their cognate RNA from the whole pool of RNA in the cell.14  
 Up to now, 40 different types of RBDs have been identified.15 From all of these RBDs, 
the RNA recognition motif (RRM) is the most common RBD.11-13,16,17 RRMs are found in 
eukaryotes, prokaryotes and viruses.13 Because of its significance, the RRM has been he golden 
model for RNA-protein studies. Biochemical characterizations have demonstrated that the 
RRM is a simple but dynamic domain capable of binding RNA, DNA and other proteins.10,12,13 
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The first structural studies of the RRM revealed that the canonical RRM has antiparallel β-
sheets flanked by two α-helices with β1α1β2β3αβ4 topology (Figure 1).18,19  
 
 
Figure 1. Schematic of β-sheet in the RRM domain: a) RNP1 and RNP2 and b) consensus sequence with the 
RNPs residues highlighted. 
 
 This domain is also approximately 90 amino acids and uses a combination of van der 
Waals interactions, salt bridges, stacking interactions and hydrogen bonds to bind RNA. The 
RNA is primarily recognized by the β-sheet surface. In β3 and β1, the consensus sequences 
RNP1 and RNP2 are found, respectively. Residues 3 and 5 of RNP1 and residue 2 of RNP2 are 
aromatic. These two consensus sequences enable π-π stacking interactions, which are important 
for the binding affinity.18,19 Most RRMs bind RNA with nanomolar affinity. The N- and the C-
terminal regions dramatically enhance this affinity because they increase the network of 
interactions. The C-terminal is also responsible of differentiating between RNA and DNA by 
interacting with the RNA’s sugar 2’OH group.13  
 Two or more RRM can bind to longer RNA molecules expanding the versatility of RNPs 
units.10,13 The linker connecting two domains is crucial for affinity and specificity.13 The 
flexibility and the length of the linker can influence the affinity for RNA.  Non-canonical RRM 
domains mediate the protein-protein interactions.13  
 The majority of the studies on the RRM domain have been done with the U1A small 
nucleoprotein polypeptide (U1A).20  The U1A protein is found in the U1 small nuclear 
ribonucleoprotein particle (U1 snRNP), which is one of the RNA-protein complexes in the 
spliceosome (Figure 2).21 Although, the function of the U1A protein during splicing is unclear, 
recent studies have proposed that U1A might be involved in the communication between U1 
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snRNP and U2 snRNP. For this, U1A binds to Rsd1 protein that binds to PrP5. Then, PrP5 
interacts with SF3b of U2 snRNP2.22 
 
 
Figure 2. The spliceosome and U1A protein: a) representation of spliceosome with pre-mRNA intron, exons 
and four snRNPs (U1, U2, U4, U5, and U6) and b) U1A proposed interaction network during pre-
spliceosome assembly with U1snRNP-U2snRNP communication during pre-spliceosome assembly.  
 
The U1A binds to stem loop 2 (SL2) RNA of U1 snRNP and it has two RRM domains. The 
N-terminal domain shown in Figure 3 is sufficient for high binding affinity to SL2 RNA.19,23 
U1A can also self-regulate its own pre-mRNA. To do this, two full-length units of U1A protein 
bind to the upstream region of the polyadenylation signal (poly-A) of the 3’-untraslated region 
(3’-UTR) of it own pre-mRNA, which inhibit the cleavage of the poly-A inhibiting U1A 
protein expression.24 U1A’s binding site in the 3’-UTR is referred to as the polyadenylation 
inhibition element (PIE) RNA, which has an asymmetric internal loop known as box 1 and box 
2.25-28 
 
Figure 3. U1A protein: a) Crystal structure of U1A-SL2 RNA and b) Sequences of SL2 RNA.  
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 The work presented in this part was performed utilizing the U1A protein and SL2 RNA 
model system. In the first chapter, fast temperature jump (T-Jump) kinetic data with molecular 
dynamic (MD) simulations revealed the intermolecular dynamics of the U1A protein. The 
second chapter presents the effect of the removal of positively charge mutants on the two-step 
dissociation pathway of the U1A-SL2 RNA complex. Finally, the third chapter has the first 
kinetics studies of this complex in a crowded environment and in living cells.  
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Chapter 1 
Native Conformational Dynamics of the Spliceosomal U1A Protein§ 
The work in this chapter would not have been possible without Dr. Zhaleh Ghaemi, who collaborated 
equally with me during this project.  
 
1.1 Introduction 
 Complexes involving protein and RNA molecules are crucial for the maintenance of 
important structures and machineries in the cell, such as the ribosome and the spliceosome.1-3 
Recent studies have shown that mutated RNA binding proteins (RBPs) are over-expressed in 
cancer cells, and that the majority of RBP-related diseases are genetic disorders.4 The most 
abundant RBP domain in eukaryotes is the RNA recognition motif (RRM).1 The RRM fold is 
comprised of an antiparallel β-sheet surface faced by two α-helices with the sequence 
β1α1β2β3α2β4. The RRM has two conserved hydrophobic sequences RNP1 (in strand β3) and 
RNP2 (in strand β1), which include two or three aromatic amino acids that form stacking 
interactions with RNA bases.1,5 The remaining amino acid sequence can vary substantially.  
  The U1A protein (N-terminal domain shown in Figure 4) is an important model system 
for RRM dynamics.6,7 U1A is a component of the U1 small nuclear ribonucleoprotein (U1 
snRNP), which assembles with other snRNPs and various other proteins onto pre-mRNA to 
form the spliceosome. The spliceosome then removes introns from the pre mRNA to make 
mRNA.8 U1A has two RRMs, but only the N-terminal RRM has high binding affinity to the 
stem loop 2 (SL2) RNA of the U1 snRNA.9,10  
 We study the N-terminal domain of U1A here, with the goal of understanding protein-
only dynamics (no RNA bound), because the energy landscape of the protein alone may already 
encode dynamics of the RNA-protein complex. In particular, aromatic stacking in the binding 
site is important for RNA-protein binding and may be affected by long-range electrostatic 
interactions with basic residues such as lysine. Such electrostatic interactions are important for 
the overall protein-RNA binding affinity, but they may also play a role in the specificity of the 
complex.11,12 It is interesting to note that the net charge of the SL2-binding N-terminal RRM of 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
§ This chapter is partially reproduced from Irisbel Guzman, Zhaleh Ghaemi, Anne Baranger, Zaida Luthey-
Schulten and Martin Gruebele, Journal of Physical Chemistry B, 119(9):3651-61 DOI: 10.1021/jp511760m. 
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U1A protein is +7, whereas the charge of the C-terminal domain is 0.13 This difference may 
contribute to the fact that the C-terminal RRM does not bind RNA, while the N-terminal 
RRM binds to SL2 RNA with a sub-nanomolar dissociation constant (Kd) in vitro. 14   
 By inserting a tryptophan probe into U1A near the active site (Phe56Trp mutant), we 
previously reported kinetics experiments that suggested a two-step pathway for the dissociation 
of the U1A- SL2 RNA complex.15 The first step is a fast step of ~30 µs, assigned to a tight-loose 
transition of the U1A-SL2 RNA complex. The second step is a much slower step of ~200 ms 
assigned to the complete dissociation of the complex. During association, helix C has to swing 
open to accommodate RNA upon binding (Figure 4).16 
 
Figure 4.  A) U1A protein. Residue Lys22 colored in red, the fluorescence probe Trp56 in turquoise. Helix C 
(in purple, extends from residues 90-98) U1A protein. B) The U1A protein in complex with SL2 RNA (in 
gray): helix C assumes an open conformation in the complex to make the short-range interaction sites 
accessible to the RNA. C) The sequence of U1A protein used in both experiments and simulations, Lys22 is 
colored in red. 
 
Could a microsecond transition, associated with helix C motion or other protein motions, also 
occur in the U1A protein by itself? Such a transition would indicate that protein U1A in its 
native state can already visit conformational sub-states that are important for its RNA binding 
function. Such sub-states would be a prerequisite for conformational selection of U1A by the 
SL2 RNA.  
 To answer this question, we study two U1A mutants, both with the active site fluorescent 
probe Trp56. To probe the effect of a positively charged residue on protein dynamics, Lys22 was 
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mutated to glutamine (Figures 1A). Why Lys22 among many positive residues?16 Loop 1 and 
Loop 3 have positive charges (e.g. Lys20, Lys22, Lys50). Loop 3 protrudes into the SL2 RNA 
binding site, therefore mutation in this loop could have a significant short-range effect on the 
complex stability. Thus, we chose Lys22 in Loop 1 because it still lies within 4.5 Å of the nearest 
RNA phosphates, whereas the other positively charged residues are even further away. Also, 
Lys22 is known from past work to contribute to complex stability between U1A and its cognate 
RNA partner.17-19 We induced relaxation kinetics of the Phe56Trp pseudo wild type and its 
Lys22Gln mutant by temperature jumps. We found that the Lys22Gln mutant showed a ~20 ms 
relaxation phase detected by Trp56 fluorescence, whereas the pseudo wild type did not. This 
could be because the double mutant undergoes conformational dynamics not present in the 
pseudo wild type, or the dynamics may be present in both proteins, but the fluorescence probe is 
more sensitive in the double mutant.  
 The 20 ms phase is tantalizingly close to the tight-loose U1A-RNA transition observed 
previously, but the T-jump experiment provides no structural insight. Therefore we utilize 
molecular dynamics (MD) simulation to elucidate the local and global structural rearrangements 
that influence tryptophan fluorescence. The simulations explain how Trp56 can probe local 
structural rearrangement in the active site of the Lys22Gln mutant, but not in the pseudo wild 
type. Several microseconds of full-atom MD simulations in explicit solvent also show that helix 
C motion is a good candidate for the larger scale structural rearrangements that can influence the 
local environment around the Trp56 probe. Based on the simulations, we propose a three state 
model for helix C dynamics in U1A (closed/semi-closed/open), and we assign the T-jump phase 
to the equilibrium between closed/open and semi-closed states. These results illustrate nicely that 
proteins can visit conformational sub-states on the native side of the folding barrier, and that 
these motions can be related to functional motions. Such interconversion among multiple native 
sub-states have now been observed in several cases,20,21 including single molecule studies.22-24 
 
1.2 Materials and methods 
 
1.2.1 Selection of position for mutation 
 In the experiments reported here, we used a 102-amino acid N-terminal U1A fragment 
that comprises the N-terminal RRM of U1A. The N-terminal RRM of U1A is sufficient for 
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high affinity binding to the SL2 RNA,17,25 and its Phe56Trp mutant still binds RNA strongly 
and has been successfully used to monitor the dissociation of the U1A-SL2 complex.12,26 To 
analyze the role of positively charged residues on protein dynamics in the absence of RNA, the 
Lys22 residue that participates in electrostatic interactions with RNA, but does not directly 
hydrogen bond to RNA, was chosen for mutation.19 The residue was mutated to glutamine to 
conserve the relative size of the residue while eliminating the positive charge.  
 
1.2.2 Protein expression and purification  
 The expression vector for the N-terminal domain of U1A was obtained from Nagai.16 All 
mutants were generated by site-directed mutagenesis and confirmed by sequencing. The 
expression vectors contained a sequence coding for a hexaHis tag at the N-terminus of the 
protein to facilitate purification. Expression vectors for the mutant U1A proteins were 
transformed into Escherichia coli strain BL21DE3 (pLysS) competent cells. The cells were grown 
in LB medium, and protein expression was induced with 1 mM IPTG at OD600=0.60. The 
cultures were grown for 5–6 h after induction. The cells were pelleted, resuspended in 10 mL of 
lysis buffer (50 mM NaH2PO4, 300 mM NaCl, 20 mM imidazole, pH 7.6) and lysed by 
ultrasonication. The lysate was centrifuged at 10,000 rpm, the supernatant was loaded on a 1 mL 
Ni-NTA column, and the protein was eluted with elution buffer (50 mM NaH2PO4, 300 mM 
NaCl, 250 mM imidazole, pH 7.6). Eluted protein was dialyzed against storage buffer (10 mM 
potassium phosphate, 50 mM KCl) and concentrated by amicon filter MWCO 3,000. The 
concentration of each protein was determined using a bicinchoninic acid (BCA) assay 
(ThermoScientific). The histidine tag of all U1A mutants was removed by thrombin cleavage. 
The molecular weights of the purified proteins were confirmed by low-resolution electrospray 
ionization mass spectrometry and the purities of the proteins were assessed by SDS-PAGE.  
 
1.2.3 Circular dichroism (CD)  
 Thermal stability of U1A mutants were measured in a J-715 spectrpolarimeter equipped 
with a Peltier temperature control (Jasco Inc.) at 25, 35, and 45 °C. A quartz cuvette (Starna 
Cells Inc.) with 200 mm path length was used to acquire CD spectra of 10 µM samples (10 mM 
cacodylic acid, 50 mM NaCl, pH 7.4) from 200−250 nm. Each CD spectrum in Figure 3 is an 
average of 50 spectra at 200 nm/min scan speed.  
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1.2.4 Laser-induced temperature jump  
 Microsecond relaxation kinetics of the two U1A mutants was measured with a home-
built temperature jump apparatus described elsewhere.15 All experiments were carried out in 
binding buffer (10 mM potassium phosphate, 200 mM KCl, pH 7.4). The SL2 RNA was heat-
shocked before complexation to ensure correct secondary structure conformation and decrease 
the Kd to its optimal (lowest) value. 
Laser temperature jumps of 8-10 °C were achieved using a Surelite III Q-switched 
Nd:YAG laser (Continuum Inc.) Raman-shifted to 1.9 ìm by passing the beam through a 1 m 
long tube with hydrogen gas pressurized to 300 psi. The beam was then passed through a 50% 
beam splitter to allow the sample to be excited from two sides providing more uniform heating. 
The pre-jump equilibrium temperature was set using an automated temperature controller, 
model Lake Shore 330 (Lake Shore Cryotronics Inc.). The sample cell was made of fused silica 
tubing 3530S-100 (VitroCom) fused shut on one side. The fluorescence excitation path length 
was 0.3 mm. The sample was excited every 12.5 nanoseconds with a 80 MHz pulsed Ti:sapphire 
laser (KMLabs Inc.). The Ti:sapphire laser wavelength was 860 nm, which was frequency tripled 
to 287 nm. The train of tryptophan fluorescence decays was then guided from the sample by an 
optical light-guide (Oriel Corp.), passed through a B370 band-pass filter (Hoya Corp.) and 
collected by a photomultiplier R7400U-03 (Hamamatsu Corp.). The fluorescence decays were 
digitized every 100 ps for a total of 500 ms by a DPO7254 oscilloscope (Tektronix Inc.) with 2.5 
GHz bandwidth. Each trace contained many tryptophan fluorescence decays (one every 12.5 ns), 
whose varying lifetime after the temperature jump tracks the protein conformational dynamics. 
 
1.2.5 T-jump fluorescence lifetime decays analysis  
 Relaxation kinetics data were analyzed using MATLAB (Mathworks Inc.). Time traces 
were first binned into groups of 100 tryptophan fluorescence decays, which corresponds to 1.25 
ms per bin. We analyzed the data by fitting each averaged fluorescence decay f as a linear 
combination of two fluorescence decay profiles, f =a1(t)  +a2(t) , where  is the fluorescence 
profile before the temperature jump, and  represents the equilibrated fluorescence profile after 
the temperature jump. The parameter c1 = a1/(a1+a2) tracks the progression of the fluorescence 
decay profile (i.e. change in tryptophan lifetime) from before the temperature jump (χ1=1), to 
€ 
f1
€ 
f2
€ 
f1
€ 
f2
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when equilibrium has been reached again after the jump (χ1=0). The kinetics c1(t) were then 
fitted to a single exponential function starting at t=0 where the jump occurred. 
 
1.2.6 Construction of the computational model systems 
 The structure of the U1A protein was determined by X-ray crystallography (residues 3-
92)16 and NMR spectroscopy (residues 2-117).27 To simulate the protein sequence used in the 
experiments (residues 1-102), we constructed the model protein system from the NMR 
structure. We used multiseq28 to align the NMR models and model 43 for U1A was chosen, 
which has the minimum root mean square deviation (RMSD) from the rest of the structures. 
Residue Met1 was added by xLEaP29 tool of Amber program30, and the Phe56Trp or 
Lys22Gln/Phe56Trp mutants were constructed by psfgen in NAMD2 software.31 
The first solvation layers were added with the Solvate32 program, and the Solvate plugin 
of VMD33 was used to solvate the rest of the box with TIP3P water molecules.34 After 
neutralizing the system by addition of Cl- and K+ ions using the Ionize software35, 0.21 M KCl 
was added to the water box to reproduce the experimental condition. Therefore, the simulation 
system contained 28471 and 28282 atoms for Phe56Trp and Lys22Gln/Phe56Trp mutants, 
respectively. CHARMM2736 force field was used and the determination of the protonation 
states was done with PropKa37. A stepwise minimization and equilibration were performed as 
suggested by Eargle et al.38 with NPT equilibration of 5 ns. Production runs used periodic 
boundary condition in NPT ensemble using a Nosé-Hoover thermostat39 with a coupling 
constant of 1 ps, and the pressure was controlled with Parrinello-Rahman barostat40 with a time 
constant of coupling of 1 ps. Hydrogen bonds were constrained to their equilibrium values by 
LINCS41, Lennard-Jones interactions were cut off at a distance of 1.2 nm and the time step was 
1 fs. Long-range electrostatics was computed by particle-mesh Ewald algorithm.42 All 
simulations were performed with Gromacs 4.5 package.43  
 
1.2.7 Molecular dynamics simulations 
 We simulated the T-jump experiments of U1A protein with Phe56Trp and 
Lys22Gln/Phe56Trp mutants. A total of 500 ns of simulation, with five independent replicas 
was performed for both mutants. To simulate the T-jump experiments after performing 20 ns of 
simulation at 25 °C, the system temperature was raised to 35 °C in a stepwise manner in the 
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course of 500 ps. During the production runs, at 25 °C and 35 °C, we observed the 
conformational changes of the protein upon increasing the temperature. Root mean squared 
deviations (RMSDs) of the backbone from the equilibrated structure were plotted for residues 8 
to 98 versus time. Based on them, the last 40 ns of each simulation were used for the analysis 
(Figure 5). 
 
Figure 5. RMSD of the backbone atoms of residues 8 to 98 of Phe56Trp and Lys22Gln/ Phe56Trp mutant 
trajectories at 25 °C with respect to the equilibrated structures. 
 
 
1.3 Results 
 
1.3.1 The Lys22Gln mutation does not affect the overall secondary structure of U1A  
 To probe whether the overall secondary structure of the proteins changes upon varying 
the temperature, we evaluated the average secondary structure of the U1A pseudo wild type and 
double mutant using circular dichroism (CD) spectroscopy. The equilibrium CD spectrum of 
each U1A mutant was measured at 25 °C and 45 °C to span the full range of the temperature 
jump experiments (from 25-35 and 35-45 °C). The CD spectra for the double mutant were 
similar to the Phe56Trp pseudo wild type at each temperature and overlapped almost perfectly 
between the two temperatures (Figure 6), indicating that neither the substitution of Lys to Gln 
nor the temperature jump introduces a large perturbation of the secondary structure of the 
protein up to 45 °C. 
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Figure 6. Circular dichroism studies were used to verify if the secondary structure change after temperature: A) 
data for Phe45Trp at 25 °C and 45 °C, and B) data for Lys22Gln/Phe45Trp at 25 °C and 45 °C. 
 
1.3.2 Temperature jumps of the Lys22Gln mutant reveal microsecond protein structural 
relaxation 
 Tryptophan fluorescence has an intrinsic temperature-dependence for the fluorescence 
quantum yield and lifetime.44,45 Tryptophan fluorescence also senses solvent exposure (via 
emission wavelength red shift) and quenching by certain nearby side chains (via intensity and 
lifetime reduction following Dexter quenching).46-48 We detected Dexter quenching by 
measuring the change of Trp fluorescence lifetime.  
 To induce protein relaxation kinetics, we repeated 10 °C T-jumps with both mutants at 
two temperatures at least 100 times in 3 independent sets of experiments. Our pseudo wild type 
Phe56Trp shows only an “instant” (<20 ns) intrinsic response after a 25 °C to 35 °C temperature 
jump, without clearly resolvable ms kinetics (Figure 7). The same temperature jump of the 
Lys22Gln/Phe56Trp mutant reveals a fast kinetic phase of t1 ~ 21±1 µs (Figure 7). The 
amplitude of this phase is negative; indicating increased quenching of the Trp residue as a result 
of structural relaxation of the protein upon T-jump.  
 The resolvable kinetic phase has a similar amplitude and relaxation time when the T-
jump was performed from 25 °C and from 35 °C, but is missing in the Phe56Trp mutant 
altogether (Figure 7). Thus the structural relaxation sensed by Trp56 follows the same trend over 
a 20 °C range of temperatures in the Lys22Gln mutant, but is not detectable in the pseudo wild 
type. The main questions raised by these T-jump results are: why does only Lys22Gln/Phe56Trp 
show this relaxation phase? What causes increased Trp quenching at higher temperature? What 
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conformational changes of U1A are responsible for the µs relaxation? To answer these questions, 
we performed a series of MD simulations and analyzed both local motions at the active site, and 
slower global motions. 
 
Figure 7. T-jump results for the pseudo wild type (Phe56Trp) in red and Lys22Gln/Phe56Trp U1A in blue: 
A) from 25 °C and B) from 35 °C. The data has been logarithmically binned. 
 
1.3.3 MD simulations reveal local conformational changes occurring in Lys22Gln/Phe56Trp 
but not in Phe56Trp upon T-jump  
 To understand the local factors influencing Trp fluorescence, we performed a total of 500 
ns of MD simulations on each of the native U1A mutants (Phe56Trp and 
Lys22Gln/Phe56Trp), at 25 °C and 35 °C. Since the T-jump experiments monitor the 
quenching of fluorescence decays from the Trp56, we focused our analysis on the amino acids 
that can quench this signal by Dexter energy transfer.46 We selected amino acids with the center 
of mass of their side chains positioned up to 0.8 nm away from the center of mass of the side 
chain of Trp56 as candidates for changes in Trp fluorescence quenching. 0.8 nm is a very 
conservative cutoff for Dexter transfer.49 In Table 1 and Figure 8 all the possible amino acids 
with their average side chain distances from the Trp56 are presented.  
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Figure 8. Amino acids that their side chains can quench Trp 56 fluorescence are represented in licorice and 
Trp 56 is colored in blue. 
 
Table 1. The average and standard deviation of the distance of the center of mass of the side chains of the 
amino acid residues shown in figure S3, to the center of mass of the side chain of Trp 56 for both mutants in 
the U1A protein. 
 
 
Residue and sequence 
number 
Distance to Trp 56 phenol- 
K22Q/F56W (nm) 
Distance to Trp 56 
phenol- F56W (nm) 
Asp 42 0.98 ± 0.06 1.24 ± 0.06 
Gln 54 0.91 ± 0.04 0.63 ± 0.04 
Gln 85 1.07 ± 0.09 1.03 ± 0.12 
Asp 90 0.95 ± 0.03 0.93 ± 0.07 
Asp 92 1.24 ± 0.04 1.19 ± 0.1 
Lys 88 1.14 ± 0.04 1.11 ± 0.08 
Lys 96 1.27 ± 0.08 1.00 ± 0.16 
Lys 50 2.08 ± 0.15 1.82 ± 0.11 
Lys 27 1.25 ± 0.11 1.34 ± 0.11 
Lys 98 1.14 ± 0.1 1.6 ± 0.12 
His 10 1.07 ± 0.12 1.58 ± 0.03 
Asn 15 0.98 ± 0.05 0.80 ± 0.04 
Asn 16 1.55 ± 0.04 1.37 ± 0.04 
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 Among them Tyr13, Gln54, and Lys96 satisfied the cutoff criterion and showed 
temperature-dependent interactions for at least one of the two mutants. For the Phe56Trp 
mutant, as shown in Figure 9A, the distribution of the distance of the center of mass of the side 
chain of Trp56 to the center of mass of the side chains of Tyr13 and Gln54 at low (25 °C) and 
high (35 °C) temperature did not change significantly. In addition, the side chain of Lys96, 
already outside at the 0.8 nm limit of the quenching range, moved even further away at the 
higher temperature. These results agree with the T-jump of Phe56Trp mutant, in which no clear 
kinetic phase is observed.  
 For the Lys22Gln/Phe56Trp mutant, the Tyr13-Trp56 distance has a bimodal 
distribution at 25 °C. The small population at larger distances shifts towards smaller distances 
after the T-jump, as shown in Figure 9A (upper panel). An even better candidate for quenching, 
Figure 9A also shows that the population of Gln54-Trp56 distances shifts substantially towards 
smaller distances at higher temperature. Finally, the Lys96 residue shifts from completely outside 
the quenching range (as for the pseudo wild type) to well within quenching range. All of these 
changes in the environment of Trp56 of the Lys22Gln/Phe56Trp mutant are consistent with the 
increased quenching of the observed kinetic phase during the T-jump experiment. Trp56 and the 
three most probable quenching residues are shown within the protein in Figure 9B.  
 To correlate side chain distance changes with conformation of the Lys22Gln/Phe56Trp 
mutant, we further analyzed the MD trajectories. In Figure 9C, the protein conformational 
changes corresponding to the populations with shorter or longer distance of the Tyr13 and 
Gln54 residues to Trp56 are colored in orange (shorter) and cyan (longer).  The changes in the 
environment of Trp56 are associated with a small shift in helix C orientation. Movement of helix 
C increases the available space for Trp56 in the double mutant, and allowed the tryptophan to 
sample conformations at larger distance with respect to Tyr13 and Gln54. Thus changes in helix 
C position are a reasonable candidate for a larger structural rearrangement that can be sensed by 
the Trp56 fluorescence at the active site, and we pursued helix C dynamics in further 
simulations. 
 18 
 
Figure 9. U1A protein analysis: A) The normalized probability of the center of mass distance (CoM) of the 
Tyr13-Trp56 (upper panel) and Gln54-Trp56 (middle panel) and Lys96-Trp56 (lower panel) for Phe56Trp 
and Lys22Gln/Phe56Trp mutants. B) The position of the residues that could quench the fluorescence of 
Trp56 inside the protein. C) The change of the protein conformation corresponding to a smaller (colored in 
orange) and larger distances (colored in cyan) of Tyr13 and Gln54 to Trp56. 
 
1.3.4 MD simulations yield a candidate for global conformational change 
 The Trp56 conformational changes discussed above occur on a nanosecond time scale. 
Thus they can serve only as a reporter for a slower activated conformational change, but by 
themselves they cannot explain the ~20 µs experimentally observed time scale measured in Figure 
7. Rather, a slower and therefore most likely larger-scale structural rearrangement of U1A would 
have to shift the rapid Trp-Tyr/Gln/Lys conformational equilibrium on a microsecond time 
scale. 
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Figure 10. A) Different helix C conformations: the initial position of helix C in the simulation starting open is 
colored in red. Orange shows the semi-closed conformation, which is the final helix C conformation after 120 
ns of simulation starting from an open helix. Purple is a snapshot of the helix from the simulation starting with 
closed helix, which does not escape from that state in 500 ns. B) The overlay of the semi-closed and closed 
conformations together with the position of Asp92 in helix C; the blue dot shows the approximate position of 
Trp56, and the arrow symbolizes the distance measured in panels C+D C) The change of the center of mass 
distance of Asp92-Trp56 during the open to semi-closed transition at 35 °C. C) The center of mass distance 
of Asp92-Trp56 remains outside the quenching range in the closed trajectory at 35 °C. 
 
 As shown by our MD simulation, a small helix C motion controls the Trp56 accessible 
conformational space. Thus the question arises: can helix C, which moves to an open 
conformation when RNA binds, undergo slower conformational switching in isolated U1A 
protein? The open conformation has been seen by X-ray crystallography and structural NMR of 
the protein bound to SL2 RNA,17,27 and also in an unbound state.16,27 In addition, recent MD 
simulations already showed that helix C can sample open and closed conformations in free wild-
type protein.50 The second question is: if helix C does move, can it explain increased quenching 
of Trp56 upon T-jump for the Ly22Gln/Phe56Trp mutant only? 
 To investigate these questions, we began with a 120 ns MD simulation at 25 °C, starting 
in the open conformation of the Lys22Gln/Phe56Trp mutant. This time is still much shorter 
than the experimental observation, but dynamics in MD simulations are expected to be 
accelerated,51,52 and we will address the question of time scales for helix C motion quantitatively 
 20 
in the next subsection. After 55 ns of simulation, helix C moves down and assumes a 
conformation that we called semi-closed (Figure 10A). As shown in Figure 10A, the semi-closed 
conformation differs from the closed conformation by a twist of the helix C. The semi-closed 
state of helix C reveals a new candidate for Trp56 quenching, not previously observed in the 
simulations of the closed native state: residue Asp92 (Figure 10B). This known Trp quencher46 
shifts from outside the quenching range in the open to around 0.5 nm in the semi-closed state 
(Figure 10C). 
 The majority of simulations starting from the closed state remained closed, showing that 
the closed to “semi closed” transition is potentially slower. Figure 10D shows that Asp92 is not 
able to quench Trp56 in the closed state, which is why Asp92 was not a candidate for quenching 
in the closed simulations discussed in the previous sub-section. Finally, three simulations of the 
pseudo wild type, starting from the open state, revealed no conformational transitions, and no 
Asp92-Trp56 quenching (Figure 11). 
 
Figure 11. The normalized probability of the center of mass (CoM) distance of Asp92 to Trp56 of pseudo wild 
type shows that this residue cannot effectively quench Trp56. 
 
 Thus the MD simulations can explain the experimental data by the following scenario: at 
low temperature, the closed state is most populated. Upon experimental T-jump from 25-35 °C 
and 35-45 °C, the closed state is destabilized and the semi-closed state becomes increasingly 
populated. This reaction takes 20 ms, either because of an activation barrier, or because of high 
protein- or solvent-mediated friction. Trp56 is quenched more in the semi-closed state 
populated at higher temperature, as observed experimentally. The transition from semi-closed to 
open is not monitored by the experiment on our 500 ms time scale, either because the fully open 
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state is too unstable, or because the semi-closed to open transition (which would unquench Trp) 
is too slow. Likewise, any direct closed-open transition cannot be monitored by Asp92 
quenching (average distance always > 0.8 nm), although it may be monitored by some of the 
quenchers discussed earlier. 
 
1.3.5 Simulation reveals two pathways from closed to open states  
 Given the tentative scenario in the previous sub-section, we sampled open, semi-closed 
and closed states more extensively for both Ly22Gln/Phe56Trp and Phe56Trp mutants. In 
Table 2 all simulations, totaling 3.2 ms the for Ly22Gln/Phe56Trp mutant a 1.75 ms for the 
Phe56Trp pseudo wild type, are listed.  
 
Table 2. All simulations performed to examine different states for Ly22Gln/Phe56Trp and Phe56Trp 
mutants. 
 
 
Initial state Total time in ns 
(Number of trajectories) 
Temperature 
(°C) 
Transition  
(Number of events) 
Ly22Gln/Phe56Trp 
Open  495 (4) 25 Open à Semi-closed (1) 
Open  375 (3) 35 0 
Closed  800 (8) 25 Closed à Open (1) 
Closed  500 (5) 35 0 
Semi-closed  680 (6) 25 Semi-closed à Closed (2) 
Semi-closed  400 (4) 35 Semi-closed à Closed (1) 
Phe56Trp 
Open  375 (3) 25 0 
Open  375 (3) 35 0 
Closed  500 (5) 25 0 
Closed  500 (5) 35 0 
 
 In these simulations, the semi-closed state was distinguished from the closed state based 
on two order parameters: 1) the center of mass distance of the Asp92 to Trp56 and 2) the 
number of contacts of Ile 94 and the side chains of hydrophobic residues mostly on the β-sheet, 
namely residues Trp56, Leu58, Met51, Leu41 and Leu44 (see Figure 12 for a structural 
definition of the order parameters).  
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Figure 12. Amino acids used to define two order parameters for differentiating the “semi-closed” from the 
“closed” state: 1) the center of mass distance of the Asp92 to Trp56, drawn as a yellow line and 2) the 
coordination number of Ile 94 and the side chains of hydrophobic residues mostly on the β-sheet, namely 
residues Trp56, Leu58, Met51, Leu41 and Leu44. 
 
 
 First of all, comparison of the Asp92-Trp56 center of mass distance in the various states 
at 35°C confirms that even with more statistical sampling, Asp92 is an effective quencher of the 
Trp56 fluorescence signal only in the semi-closed state, but not in the open or closed states 
(Figure 13).  
 
Figure 13. Normalized probability of the center of mass distance of Asp92-Trp56 resulted from 35 °C 
trajectories show that semi-closed state can effectively quench the signal of Trp56, but the closed state cannot. 
 
 Extensive MD sampling of different states reveals several transitions among different 
states in the Ly22Gln/Phe56Trp mutant. Listed in the last column of Table 2, we directly 
observed three different transitions: at 25 °C, from open to semi-closed (1 event); from semi-
closed to closed (2 events) and from closed to a complete open state (1 event); and at 35°C, from 
semi-closed to closed (1 event). No transitions were observed from closed to “semi-closed,” or 
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from open directly to closed. These transitions suggest two-pathways connecting the closed to 
semi-closed state, depicted in Figure 14: one pathway passes through the open state and an 
alternative one directly connects the semi-closed to the closed state. The unobserved and 
potentially slower transitions are shown as gray arrows in Figure 14. 
 
 
Figure 14.  The two-pathway model proposed based on the observed transitions in the MD simulations that 
are listed in Table 2.  The unobserved transitions are marked with gray arrows. 
 
 We estimated the relaxation time from simulations and compared it with the observed 
time from T-jump experiment. The rate equations according to the proposed scheme in Figure 
11 are: 
 
d[C]
dt = k−1[O]+ k−3[Sc]− k1[C]− k3[C]
d[O]
dt = k1[C]+ k−2[Sc]− k−1[O]− k2[O]
d[Sc]
dt = k3[C]+ k2[O]− k−2[Sc]− k−3[Sc]
 [1] 
which can be organized in a matrix form as:  
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The transition rates (k1, k-1, …) were estimated based on the Bayesian inference approach 
suggested by Ensign and Pande,1 that we briefly describe here. For a two-state model the 
probability density of transition rate, k is given by Bayes’ rule: 
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p(k |D, I ) = p(D | k, I )p(k | I )p(D | I )  
where p(D|k,I) is the probability of generating data D given the rate k and simulation 
background I and  p(k|I) is the prior probability which represents the state of  knowledge about k 
before the data is taken. We can write the probability of observing a transition at time t given 
rate k and starting from a configuration X in a trajectory as: ptransition (t | k,X, I )dt = k exp(−kt)dt . 
Therefore, if no transition has occurred we get pnot (t | k,X, I ) = 1− dt0
t
∫ 'exp(−kt ') = exp(−kt) . 
Hence, for a set of simulation data, D, consists of N trajectories, if n of them made the transition 
at time {tf} and N-n of them do not make the transition in the simulation time {ti}, the 
probability of observing the set of simulation data D is:
p(D | k,X, I ) = k exp(−kt f )
i=1
n
∏ exp(−kti )
j=1
N−n
∏ = kn exp(−kΘ)  where Θ  is the total relevant trajectory 
time. If we consider a uniform prior probability, we get the normalized probability density of rate 
k as: p(k |D, I ) = Θ
n+1
n! k
n exp(−kΘ)with the expectation value and variance in equation 3.  
                k = n +1
Θ
,σ k =
n +1
Θ2
          [3] 
We used equation [3] to estimate the rates described in Figure 7. The results together with the 
simulation times at 25 °C were reported in Table 3. 
 
Table 3. The transition events occurred between different states and their assigned rates based on a Bayesian 
inference approach.  
 
Transition Time (ns) <k> × 106 (1/s) σk × 106 (1/s) 
Open àSemi-closed 455 4.4   3.1 
Open à Closed 495 2 2 
Semi-closed àClosed 555 5.4 3.1 
Semi-closedà Open 686 1.5 1.5 
Closed à Semi-closed 800 1.25 1.25 
Closed à Open 795 2.5 1.8 
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The rate constants, obtained using a Bayesian inference approach suggested by Ensign and 
Pande,53 are summarized in Table 3. By putting the values of the rates we got the rate matrix 
(from equation [2]) for which we calculated the eigenvalues (the non-trivial eigenvalues are 
λ± = −8.525± i1.73476 ) and eigenvectors. Based on those we obtained the following solution for 
the concentration of Sc(t): 
 [Sc(t)]= 0.25− 0.25e−8.525t cos(1.734t)− 0.51e−8.525t sin(1.734t)  [4] 
From equation [4] the half-life for the semi-closed state concentration (the time for which the 
concentration is half of its maximum value) is estimated to be = 0.26 ms using the average 
rates and = 1.7 ms using rates slower by one standard deviation of the Bayesian model. Both 
relaxation times have been multiplied by a factor of 2.15 to account for the faster diffusion 
coefficient of TIP3P water in MD simulations with respect to experiments.54,55  
  Even the slower computed relaxation time is at least a factor of 8.5≈ (ln2.21 ms)/1.7 ms 
faster than the experimental relaxation time of ~ 21 ms. If the difference is due to a higher 
activation barrier for helix motion in the experiment, it corresponds to a free energy error of at 
least kBTln(8.5)≈5.3 kJ/mole in the simulations.  
 If the experimentally observed relaxation is indeed due to helix motion, one possibility is 
that the MD simulation underestimates the cooperativity of water dynamics required for the 
semi-closed to closed transition, overestimating its rate. Thus we considered the effect of the 
water molecules around the fluorescence probe in the binding site. We calculated the number of 
water molecules in contact with Trp56 using 
   ,  
where G1  and G2 are groups of atoms of the side chain of Trp56 and water molecules and r0 = 0.2 
nm. As shown in Figure 15, there are smaller numbers of water molecules in contact with Trp56 
in closed state with respect to the semi-closed state. This indicates that the transition between 
these two states correlates with the change of the number of water molecules in a confined space 
τ obs
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around Trp56. Hence the difference of the diffusion coefficients of water in the simulation and 
experiment could play a role in the relaxation time. 
 
Figure 15.  Number of water molecules in contact with the side chain atoms of Trp56 in the two closed and 
semi-closed state. 
 
 
1.4 Discussion 
An important factor in protein-RNA interaction is the extent to which a RBP alone can sample 
conformations relevant for protein-RNA dynamics. In the case of U1A, helix-C undergoes a 
large closed to open transition when RNA binds. If the RNA does not induce a fit in the 
protein, but instead binds when the protein samples the right conformation, the protein could 
sample the required conformational space even when the RNA is not present. Thus, this 
conformational change could be the rate-limiting step for the protein-RNA recognition process. 
Closely related to conformational selection is the idea of multiple binding modes. Proteins and 
small molecules often bind in more than one specific arrangement. RNA and protein are both 
complex large molecules, thus they are more likely to have multiple arrangements corresponding 
to a local free energy minimum: the protein can offer several similar conformations for the RNA 
to select, perhaps with different side chain-base interactions. 
 We recently detected evidence for two binding arrangements of U1A with SL2 RNA by 
observing a ca. 30 ms relaxation of protein-RNA complex when temperature is jumped from 25 
to 35 °C.15 But, could U1A by itself undergo rearrangements on such a slow, activated time scale? 
For the pseudo wild type Phe56Trp, the answer from Figure 4 appears to be ‘no’. We did not 
detect any clear relaxation on a > 1 ms time scale by monitoring the Trp56 fluorescence lifetime 
of the Phe56Trp mutant. The reason could be that U1A does not undergo any slow relaxation, 
or that the relaxation cannot be detected by tryptophan fluorescence lifetime, which is most 
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sensitive to short range quenching by a select group of amino acid side chains.49 Our simulations 
show that the latter may well be the case: Trp56 is out of range of quenchers. 
 RNA-binding proteins are quite sensitive to long-range electrostatics, often having a 
significant positive charge to create high affinity for the negatively charged nucleic acid. 
Therefore, we hypothesized that such long-range interactions could also have an effect on the 
kinetics of the protein by itself. Indeed, the Lys22Gln/Phe56Trp mutant does show a ~20 ms 
relaxation signal upon T-jump, on a time scale similar to the protein-RNA rearrangement 
reported previously.15 Unlike the Phe56Trp mutant, the mutant with a positive charge removed 
(Lys22Gln/Phe56Trp) gives the tryptophan multiple opportunities to report on conformational 
fluctuations of the protein.  
 The conformational fluctuation that gives rise to the 20 ms relaxation in Figure 4 is not 
likely to be a complete open-closed interconversion of helix C because the simulations in Figure 
5 did not show a significant increase of the quenching by residues of the helix and the TDS 
linker (namely Lys88, Asp90, Asp92, Lys96 and Lys98). Therefore, our candidate for the 
conformational fluctuation is a closed to semi-closed equilibrium of helix C. We did not observe 
the closed to semi-closed transition in 800 ns (8 replicas) of simulation starting from the closed 
state, so it could be slow. The reverse transition, as well as closed to semi-closed via the open 
state is supported by our MD simulations. Helix C movement involves a transition between two 
compact states, likely to involve breaking and making of contacts that could motivate the long 
time scale associated with the reaction. This idea is further supported by the analysis of our MD 
trajectories. In Figure 16, we show the higher number of contacts of Ile94 (and thus higher 
friction) during the simulations in closed state with respect to the semi-closed state. We also 
characterized changes in the hydrogen bonding networks: the side chains of Lys88-Asp90 
hydrogen bond present in the closed state is broken in the semi-closed state; instead Lys88-Glu5 
side chains and two weaker hydrogen bonds between the side chains of Val102-Lys23 and 
Val102-Lys96 are formed in the semi-closed state.  
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Figure 16.  Comparison of the contacts number of Ile94 and the side chains of hydrophobic residues mostly on 
the β-sheet, namely residues Trp56, Leu58, Met51, Leu41 and Leu44: in semi-closed state Ile94 makes almost 
no contact.  
 
 Finally, Figure 17 illustrates the hypothesis for the double mutant, which is consistent 
with the experimental data and MD simulation results. Based on our MD results there are two 
pathways from closed to the semi-closed state: one is a direct transition and the other one passes 
through the open state. The presence of both these pathways show that even the relatively simple 
process of helix conformational fluctuation in native U1A without any RNA bound can have a 
fairly complex free energy landscape. 
 In summary, an important question in RNA-protein binding is whether the protein can 
already sample conformations relevant for its binding function even without any RNA, so the 
protein is “pre-programmed” with the right conformations. We combined experiments and MD 
simulation to show that this indeed is the case for protein U1A. Our work also points out that 
fluorescence is not always a universal probe of such dynamics, and care must be taken to make 
sure that fluorescent probes can detect it. 
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Figure 17. A simple 3D energy landscape to explain the experimental data and MD simulation results for the 
open (O) in red, semi-closed (SC) in yellow, and closed (C) in blue states. For the coordinate q1, we propose 
that the open state (of U1A is less stable than the semi-closed state, and rapidly converts to it. The semi-closed 
and closed states interconvert more slowly (20 ms), and quench Trp56 differently: the closed state less than the 
semi-closed state. At higher temperature, the semi-closed state becomes more stable than the closed state, and 
so the rapidly sampled Trp conformational distribution adjusts to favor more quenching upon T-jump. For 
coordinate q2, we propose a one-step transition from open to “Close” interconversion with one barrier. 
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Chapter 2 
Effects of Electrostatic Interactions on U1A-SL2 RNA Complex Kinetics 
 
2.1 Introduction  
 In eukaryotes, RNA is typically bound to RNA binding proteins (RBPs). During 
maturation of pre-mRNA transcripts many RBP-RNA interactions are important for 5’-end 
capping, 3’-end polyadenylation, splicing, transport, nuclear export and intra-cellular localization 
of mRNA.1 In addition to regulatory processes, RBP-RNA interactions are crucial for the 
maintenance of important structures and machinery in the cell, such as the ribosome and 
spliceosome.1-3 To enable RBPs to have this wide range of function, a variety of RNA binding 
domains (RBDs) have evolved that dynamically recognize diverse RNA architectures and 
sequences.4 The most abundant RBD in eukaryotes is the RNA recognition motif (RRM).2  
 The RRM structure is comprised of an antiparallel β-sheet surface faced by two α-
helices, with the sequence β1α1β2β3α2β4. The RRM has two conserved hydrophobic sequences 
RNP1 (β3) and RNP2 (β1), which include two or three aromatic amino acids that form stacking 
interactions with RNA bases, and remaining primary sequence can vary.2,5 The U1A protein is 
often used as a model to study RRM dynamics due to its extensive cellular and biochemical 
characterization.6,7 U1A is a component of the U1 small nuclear ribonucleoprotein (U1 snRNP), 
which assembles with other snRNPs, pre-mRNA and various other proteins to form the 
spliceosome.8 U1A has two RRMs, but only the N-terminal RRM is sufficient for high binding 
affinity to the stem loop 2 (SL2) RNA of the U1 snRNA shown in Figures 18a and 18b.9,10  
 The important roles of RBPs and their wide range of interactions with RNA, proteins, 
and DNA have motivated the study of the origins of RBP-RNA recognition. In order to identify 
the interactions that are important for RBP-RNA recognition, information from detailed 
kinetics studies of RBP-RNA complexes is needed. In particular, electrostatic interactions 
mediated by basic residues in RNA binding proteins are important for the protein-RNA 
encounter complex. Thus, these interactions play roles in the binding affinity and specificity of 
the complex.11 It is also interesting to note that the net charge of N-terminal RRM of U1A 
protein is +7 while that of C-terminal RRM is 0.12 Many of the positively charged residues are 
missing in the C-terminal RRM, or are replaced by negatively charged or neutral residues. 
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Figure 18. A) Structure of the U1A-SL2 complex: Lys20 is shown in yellow, Lys22 in green, Lys23 in blue 
and Lys50 in red. B) Sequence of SL2 RNA. Nucleotides that are directly recognized by the protein are shown 
in red. C) Sequence of the N-terminal RRM of the U1A protein.  
 
This difference may contribute to the fact that the C-terminal RRM does not bind RNA, while 
the N-terminal RRM binds to SL2 RNA with a sub-nanomolar dissociation constant (Kd).13 
Interactions between large positive patches of RBPs and the negative surface of RNA play an 
important role in the non-specific attraction of the two macromolecules.  
We previously reported kinetics data that support a two-step pathway for the dissociation 
of the U1A- SL2 RNA complex.14 In this pathway, the first step is a fast step of ~100 µs that is 
assigned to the loosening of the U1A-SL2 RNA complex, and the second step is a slow step of 
~200 ms that is assigned to the actual dissociation of the complex. Because of the interesting role 
of electrostatic forces during RBPs-RNA complex formation and stability, we now investigate 
the effects of these forces on the proposed two-step pathway. To probe the contributions of 
positively charged residues to complex stability and dissociation, four positively charged amino 
acids (Lys20, Lys22, Lys23 and Lys50) in U1A that have close interactions with SL2 RNA, but 
do not form hydrogen bonds with the RNA, were mutated to glutamine (Figures 18a and 18b). 
 Previous surface plasmon resonance (SPR) kinetics studies showed that Lys20 plays a 
role during initial complex association, while Lys22 and Lys23 increase complex stability.15-17 In 
these studies, a two-step association pathway was proposed, in which there is electrostatic 
 36 
attraction during initial association and stacking interactions during complex formation. 
Therefore, studying the roles of these positively charged amino acids in kinetic studies could 
contribute to our understanding of the proposed kinetic pathway for U1A-SL2 RNA complex 
dissociation. 
Utilizing fast fluorescence methods and tryptophan as probe, we found that the Lys 
20Gln, Lys23Gln, and Lys50Gln mutants do not report the first step during dissociation. 
Lys22Gln reports the first dissociation step, but speeds up the relaxation time. This agrees with 
prior data on U1A protein-only dynamics, where Lys22Gln is an active probe of fast dynamics, 
but the pseudo-wild type, although it also shows such dynamics in MD simulations, is silent in 
time-resolved fluorescence. Thus Lys22Gln/Phe56/Trp has the unique capability of serving as a 
global reporter of both U1A dynamics and U1A-RNA dynamics. The four positively charged 
mutants speed up the second (protein RNA dissociation) step. φ value analysis demonstrated that 
each positively charged mutant has a distinct effect on the transition state free energy. We also 
report the activation and equilibrium free energies for each reaction step during U1A-SL2 RNA 
complex dissociation obtained from a global fitting.  
 
2.2 Materials and methods 
 
2.2.1 Proteins expression and purification 
 The expression vector for the N-terminal domain of U1A was obtained from Nagai.18 All 
mutants were generated by site-directed mutagenesis and confirmed by sequencing. The 
expression vectors contained a sequence coding for a hexaHis tag at the N-terminus of the 
protein to facilitate purification. Expression vectors for the mutant U1A proteins were 
transformed into Escherichia coli strain BL21DE3 (pLysS) competent cells. The cells were grown 
in LB medium, and protein expression was induced with 1 mM IPTG at OD600=0.60. The 
cultures were grown for 5–6 h after induction. The cells were pelleted, resuspended in 10 mL of 
lysis buffer (50 mM NaH2PO4, 300 mM NaCl, 20 mM imidazole, pH 7.6) and lysed by 
ultrasonication. The lysate was centrifuged at 10,000 rpm, the supernatant was loaded on a 1 mL 
Ni-NTA column, and the protein was eluted with elution buffer (50 mM NaH2PO4, 300 mM 
NaCl, 250 mM imidazole, pH 7.6). Eluted protein was dialyzed against storage buffer (10 mM 
potassium phosphate, 50 mM KCl) and concentrated by amicon filter MWCO 3,000. The 
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concentration of each protein was determined using a BCA assay (Pierce). The histidine tag of 
all U1A mutants was removed by Thrombin cleavage. The molecular weights of the purified 
proteins were confirmed by low-resolution electrospray ionization mass spectrometry and the 
purities of the proteins were assessed by SDS-PAGE.  
 
2.2.2 Electrophoretic mobility shift assay (EMSA)  
 Different concentrations of U1A protein were incubated with 50 pM [γ-32P] ATP-
labeled RNA for 30 minutes at room temperature in a buffer containing 10 mM potassium 
phosphate (pH 7.4) and 1M KCl. Electrophoreses were carried out at 25 °C for 40 minutes at 
350 V with 0.5X TBE as running buffer. The native gels, 8% acrylamide (42:1 = acrylamide : 
biacrylamide, 15 cm x 40 cm x 1.5 mm), were pre-run at 350 V for 30 minutes before loading 10 
µl of reaction mixture per well. The temperature of the gel was maintained at 25 °C by a 
circulating water bath. Gels were visualized on a Molecular Dynamics Storm phosphorimager. 
Fraction RNA bound versus protein concentration was plotted and curves were fitted to the 
equation: Fraction bound = 1/(1+Kd/[P]T) using KaleidaGraph (Synergy Software, PA). All 
binding measurements were performed with a greater than 10-fold excess of protein over RNA 
in each binding reaction used to determine the Kd so that [P] would be approximately equal to 
[P]Total. 
 
2.2.3 Circular dichroism (CD)  
 Thermal stability of U1A mutants were measured in a J-715 spectrpolarimeter equipped 
with a Peltier temperature control (Jasco Inc.) at 25, 35, and 45 °C. A quartz cuvette (Starna 
Cells Inc.) with 200 mm path length was used to acquire CD spectra of 10 µM samples (10 mM 
cacodylic acid, 50 mM NaCl, pH 7.4) from 200−250 nm. Each CD spectrum in Supplementary 
Figure 4 is an average of 50 spectra at 200 nm/min scan speed. Laser-induced temperature jump: 
Relaxation kinetics of the U1A mutants and the equilibrated complexes with SL2 RNA in 
binding buffer (10 mM potassium phosphate, 200 mM KCl, pH 7.4) were measured with a 
home-built temperature jump (T-jump) apparatus described elsewhere.14 The SL2 RNA was 
heat-shocked before complexation to ensure correct secondary structure conformation and 
decrease significantly the dissociation constant (Kd). Only 20 µM of U1A-SL2 RNA complex 
was utilized to avoid aggregation.  
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Laser temperature jumps of 8-10 °C were achieved using a Surelite III Q-switched 
Nd:YAG laser (Continuum Inc.) Raman-shifted to 1.9 µm by passing the beam through a 1 m 
long tube with hydrogen gas pressurized to 300 psi. The beam was then passed through a 50 % 
beam splitter to allow the sample to be excited from two sides providing more uniform heating. 
The pre-jump equilibrium temperature was set using an automated temperature controller, 
model Lake Shore 330 (Lake Shore Cryotronics Inc.). The sample cell was made of fused silica 
tubing 3530S-100 (VitroCom) fused shut on one side. The fluorescence excitation path length 
was 0.3 mm. The sample was excited with a 80 MHz pulsed Ti:sapphire laser (KMLabs Inc.). 
The Ti:sapphire laser wavelength was 860 nm, which was frequency tripled with a third 
harmonic generator (CSK Optronics Inc.) to 287 nm. Tryptophan fluorescence was then guided 
from the sample by an optical light-guide (Oriel Corp.), passed through a B370 band-pass filter 
(Hoya Corp.) and collected by a photomultiplier R7400U-03 (Hamamatsu Corp.). The signal 
was then recorded and digitized every 100 ps by an oscilloscope DPO7254 (Tektronix Inc.) with 
2.5 GHz bandwidth. The length of the time traces was 500 µs and each trace contained many 
tryptophan fluorescence decays every 12.5 ns (80 MHz). The temperature jump was set to occur 
153.75 ìs after the oscilloscope was triggered to start data collection to provide a pre-jump 
baseline. The fluorescence decay peak signal was usually 10-40 mV. The fluorescence lifetime 
decay analysis has been previously reported.19 
 
2.2.4 Stopped flow experiments 
 U1A-SL2 dissociation kinetics were monitored using fast mixing measurements 
performed using a SX-20 stopped flow spectrometer (Applied Photophysics). The tryptophan 
was excited at 280 nm and fluorescence emission was monitored through a 350 nm interference 
filter (Applied Photophysics) with a 2 mm entrance and exit slit width. The Trp56 fluorescence 
intensity was monitored between 320-450 nm. The fast mixing time is approximately 3 ms 
giving a dead time of ∼1 ms. Fluorescence scans were collected in 10 s data files with 1000 data 
points. During dissociation studies a syringe with 1 µM U1A–RNA complex solution in binding 
buffer (10 mM potassium phosphate, 200 mM KCl, pH 7.4) was fast mixed with phosphate 
buffer (10 mM potassium phosphate, 1.8 M KCl, pH 7.4) from another syringe. Upon mixing 
the protein-RNA complex solution with the buffer in a 1:1 ratio, the final concentration of the 
 39 
U1A–RNA complex was 0.5 µM. A final concentration of 1 M KCl was required to obtain an 
optimal dissociation fluorescence signal. For each sample, at least seven individual scans were 
averaged to give one data set. Three independent averages were use for data analysis. 
 
2.3 Results 
 
2.3.1 Determination of optimal dissociation conditions  
 To determine the optimal conditions for the  stopped flow and T-jumps studies, we 
measured the dissociation constant (Kd) for each of the U1A mutants using electrophoretic 
mobility shift assays (EMSA, Table 4). We determined the Kd at 25 °C and 35 °C because these 
are the starting temperatures used in T-jumps experiments. At 25 °C and 200 mM KCl, all of 
the Lys to Gln mutations decreased the binding affinity compared to the Phe56Trp mutant.   
The mutation of Lys22 and Lys50 each decreased the binding affinity more than 14-fold.  
Lys20Gln and Lys23Gln had a less significant effect on the binding affinity, only a ~3-fold and 
~6-fold decrease, respectively.  The same trend was previously observed by another lab.15  At 35 
°C the dissociation constants of Phe56Trp mutant decreased ~5-fold, and the other mutants also 
showed decreased binding affinity at higher temperature.   
 
Table 4. Kd values of mutant U1A proteins.  
 
 
 We also wanted to characterize the Kd at 45 °C, because this was close to the final 
temperature obtained during the ~10 °C T-jumps experiments from 35 °C. But, it was not 
possible to measure using EMSA because of the limited number of shifted bands visible under 
these conditions.  
Protein  Kd (M) in 200 mM KCl  
25 °C  
Kd (M) in 200 mM KCl  
35 °C  
Kd (M)  in 1 M KCl 
25 °C  
F56W 2.21 (± 0.09) × 10-8 1.2 (± 0.3) × 10-7 1.1 (± 0.2) × 10-7 
K20Q/F56W 7.4 (± 0.5) × 10-8 5 (± 1) × 10-7 2.4 (± 0.2) × 10-7 
K22Q/F56W 3.28 (± 0.06) × 10-7 1.2 (± 0.2) × 10-6 4.3 (± 0.2) × 10-7 
K23Q/F56W 1.32 (± 0.04) × 10-7 3.7 (± 0.2) × 10-7 3.53 (± 0.03) × 10-7 
K50Q/F56W 3.92 (± 0.05) × 10-7 2.2 (± 0.5) × 10-6 5.8 (± 0.8) × 10-7 
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 In the stopped-flow setup, two solutions are rapidly mixed together.  For complex 
dissociation, one syringe is filled with the protein-RNA complex, and the other is filled with 
buffer.  Therefore, the binding affinity of the complex has to be weak enough to dissociate with 
two-fold dilution, or we can use a high concentration of salt in the buffer syringe to drive 
dissociation.  Based on the binding affinity of U1A (Phe56Trp), we decided to jump the salt 
concentration from 0.2 to 1 M KCl for dissociation.  The increase of salt concentration 
decreased the binding affinity from 22 (±1) nM to 110 (±20) nM, sufficient for dissociation 
(Table 4).  
 
2.3.2 Mutations do not affect the general secondary structure 
 To probe whether the secondary structure of the proteins changes upon varying the 
temperature, we evaluated the structures of the U1A mutants using circular dichroism (CD) 
spectroscopy. The CD spectrum of each mutant U1A mutant was measured at 25 °C and 45 °C 
because T-jump experiments were performed up to 45 °C shown in Figure 19. The buffer 
condition was the same used during T-jump experiments. 
 
Figure 19. Circular dichroism of U1A positively charged mutants: a) K20Q/F56W, b) K22Q/F56W, c) 
K23Q/F56W, and d) K50Q/F56W. 
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The CD spectra for all of the mutants were similar to the Phe56Trp control protein at each 
temperature and overlapped almost perfectly between the two temperatures indicating that 
neither the substitution of Lys for Gln nor the temperature jump introduces a large perturbation 
of the secondary structure of the protein up to 45 °C. 
 
2.3.3 Only Lys22Gln/Phe56Trp showed the first dissociation step 
 The earliest step of RNA-protein complex dissociation was monitored using laser-
induced T-jump experiments. Our probe signal was the Trp fluorescence decay lifetime change c, 
normalized from 1 (pre-jump) to 0 (post jump). The protein-RNA complex solution in a 200 
mM KCl buffer was perturbed by temperature jumps from 25 °C to 35 °C and from 35 °C to 45 
°C (See Methods and ref. 14 for more details of data analysis). A single phase with a relaxation 
time of ≈38 ms was observed for the Phe56Trp U1A-SL2 RNA complex under our 
experimental conditions (Figure 20).  
 
Figure 20. T-jumps of F56W-SL2 RNA complex in 200 mM KCl buffer: from 25 °C in blue and from 35 °C 
in red. The data was logarithmically binned. 
 
 The Lys22Gln/Phe56Trp mutation slightly speed up the relaxation time (Figure 21a and 
21b). The fast phase did not significantly change with temperature between 35 °C and 45 °C, 
which is consistent with the same transition from a tightly bound to a loosely bound U1A-SL2 
RNA complex observed for Phe56Trp here and by Anunciado et al.14  
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Figure 21. T-jump of K22Q/F56W mutant in 200 mM KCl buffer: a) K22Q/F56W-SL2 RNA complex from 
25 °C to 35 °C, and b) K22Q/F56W -SL2-RNA complex from 35 °C to 45 °C. The data was logarithmically 
binned.  
 
 
We did not observe the fast phase with the Lys20Gln/Phe56Trp, Lys23Gln/Phe56Trp and 
Lys50Gln/Phe56Trp mutants (Figure 22). Therefore, these mutations are not capable of 
reporting the first step during dissociation kinetics of the U1A-SL2 RNA complex.  
 
Figure 22. T-jumps experiments of U1A mutants-SL2 RNA complexes at 25 °C in blue and 35 °C in red: A) 
K20Q/F56W, B) K23Q/F56W, and C) K50Q/F56W.  
 
2.3.4 Removal of positive charge residues speed up the second dissociation step  
 To measure the complete dissociation kinetics of the complexes formed between the 
mutant proteins and SL2 RNA, stopped flow experiments were performed. A solution of the 
U1A-SL2 RNA complex was mixed with a buffered solution containing no U1A or SL2 RNA 
to change the KCl concentration from an initial concentration of 200 mM KCl to a final 
concentration of 1 M KCl and the concentration of the U1A-SL2 RNA complex was reduced by 
a factor of 2 upon mixing. Under these conditions, the dissociation rate should dominate the 
 43 
relaxation process, so the observed rate is close to the dissociation rate. A single phase was 
observed upon fast mixing for the dissociation of the complexes formed with 
Lys20Gln/Phe56Trp, Lys22Gln/Phe56Trp, Lys23Gln/Phe56Trp and Lys50Gln/Phe56Trp 
mutants shown in Figure 23. 
 
Figure 23. Stopped flow experiments of U1A mutants-SL2 RNA complexes at 25 °C: A) K20Q/F56W, B) 
K22Q/F56W, C) K23Q/F56W, and D) K50Q/ F56W. 
 
 Interestingly, the dissociation rate of the Lys22Gln/Phe56Trp-SL2 complex was faster 
than the other mutants with lower binding affinity, and the Phe56Trp-SL2 complex (Figure 24).  
 
Figure 24. Stopped flow experiments of F56W-SL2 RNA complex: A) at 25 °C and B) at 35 °C  
 
The fluorescence amplitude increased almost to the protein-only baseline for all of the positively 
charged mutants, indicating nearly full dissociation of the complex. These observations are also 
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consistent with the unimolecular complex dissociation rate dominating the bimolecular 
association kinetics. As shown in Figure 25, the dissociation time τ2 increases 10 fold upon 
heating by 10 °C. This is the temperature dependence expected from full complex dissociation. 
 
Figure 25. Stopped flow experiments of U1A mutants-SL2 RNA complexes at 35 °C: a) K20Q/F56W, b) 
K22Q/F56W, c) K23Q/F56W, and d) K50Q/ F56W.  
 
For all the positively charged U1A mutants, the data could be fit by a single exponential function 
and τ was not concentration-dependent (Figure 26). 
 
 
Figure 26. Stopped flow experiments of 0.5 U1A mutants-SL2 RNA complexes at 25 °C in blue and 35 °C in 
red to verify concentration dependency.  
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The stopped flow results are summarized in Table 5. 
 
Table 5. The average dissociation relaxation time τ2 calculated from the stopped flow experiments with an 
initial concentration of 1 µM U1A mutant-SL2 RNA complex in 200 mM KCl. 
 
 
 
 
 
 
 
2.3.5 Global fit of the data  
 To probe our hypothesis of a two-step dissociation pathway ( ), 
we performed global fits of the kinetic and thermodynamic data for the U1A mutants. We used a 
similar approach to that previously reported by Anunciado et al.14 We simultaneously fitted the 
temperature jump, stopped flow and EMSA binding data at all temperatures measured (see 
Methods). The global fit yielded the activation and equilibrium free energies for each reaction 
step during dissociation, as well as linear free energy dependences on temperature and salt 
concentration, modeled by the linear free energy relationship in eq. 1. 
   (1)  
For the first step of dissociation ( ) we obtained DG0 = 5.29 ± 0.05 kJ/mole and 
DGT = -0.61 ± 0.01 kJ/mole. The calculated shows that the tightly bound complex is 
destabilized by temperature faster than the loosely bound complex. For the second step (
), we obtained DG0 = 9.97 ± 0.05 kJ/mole, DGT = -0.07 ± 0.01 kJ/mole, and 
DGKCl = -23.1 ± 0.01 kJ/mole. Thus, complete dissociation is favored at higher temperatures and 
higher salt concentrations. The activation energies were fitted to eq. 2: 
 . (2) 
The prefactor was fixed to km=(0.01 h(T))-1 ms-1, using a normal Kramers viscosity dependence 
for both reactions.20 The activation energies are  = 8.76 ± 0.01 kJ/mole and 
= 34.2 kJ/mole for the second step. No temperature dependence of the activation 
€ 
PRtight →PRloose →P + R
€ 
ΔG = ΔG0 + ΔGT (T −T0) + ΔGKCl[KCl]
€ 
PRtight →PRloose
€ 
ΔGT
€ 
PRloose →P + R
kAB = k0e
−ΔGAB
† /RT
ΔGtight→loose†
ΔGloose→dissociated†
Protein  τ  (s) in 200 mM KCl  25 °C  τ  (s) in 200 mM KCl 35 °C  
F56W 2.0 ± 0.1 0.22 ± 0.03 
K20Q/F56W 1.30  ± 0.03 0.14 ± 0.02 
K22Q/F56W 0.87 ± 0.02 0.09 ± 0.03 
K23Q/F56W 1.85 ± 0.04 0.20 ± 0.04 
K50Q/F56W 1.20 ± 0.02 0.13 ± 0.03 
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free energy was fitted because only two temperatures were measured. The actual barriers may be 
correspondingly higher if the diffusion prefactor is faster; if both reactions have a similar 
prefactor (as assumed here), complete dissociation has a significantly higher activation barrier 
than tight-loose interchange.  
 
2.4 Discussion  
 In this report, we corroborated our proposed two-step dissociation pathway presented in 
Figure 27. Although we observed the same dissociation pathway, our relaxation phases for each 
of the steps are different than in Anunciado et al paper, because we utilized different 
experimental conditions required for a newer version of the stopped-flow instrument.  
 
Figure 27. Kinetic scheme for the dissociation of the U1A-SL2 complex at 25 °C: The first step is a fast step 
of ~30 µs that is assigned to the loosening of the U1A-SL2 RNA complex, and the second step is a slow step 
of ~2 s that is assigned to the actual dissociation of the complex. Trp 56 is highlighted in green.  
 
 In the T-jump experiments, the fast interconversion between the tight and loose complexes 
disappeared when Lys20, Lys23 and Lys50 were replaced by glutamines, demonstrating that the 
removal of either one of these lysines affect the reporting of this step by the tryptophan probe. 
Despite the possibility of these mutants to inhibit the formation of the tightly bound complex, 
this is unlikely because Lys22Gln/Phe56Trp mutant, with a low binding affinity, also reported 
this transition. Thus, an important aspect from this data is that the proposed tightly bound 
complex state is not related to the tightness of the complex. But, instead its appearance is 
correlated to the tryptophan environment in the mutant. The removal of the positive charged 
residues (Lys 20, Lys 23 and Lys 50) could have prompted a change in the global dynamics 
(unpublished work of Dr. Zhaleh Ghaemi) of the protein, possibly affecting the local reporting 
properties of the tryptophan in position 56. In contrast to Lys22Gln/Phe56Trp and Phe56Trp, 
the correlated motion of the amino acids Lys 20, Lys 23, and Lys50 mutants is affected upon 
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binding to the SL2 RNA (Figure 28). Therefore, besides the interactions with A6 of SL2 RNA, 
the correlated motion of residues within the protein is also responsible for the reporting 
mechanism of the tryptophan during dissociation.  
 
Figure 28.  Net correlation changes of u1A protein mutants upon binding to RNA: After subtracting the correlation 
values of each protein amino acid before and after the binding to RNA, the difference of the populations of the 
residues which gained correlation and lost correlation were calculated (y axis). Mutants with a negative net effect 
count gain correlation upon binding and mutants with a positive net effect gain lost correlation upon binding 
(unpublished work of Dr. Zhaleh Ghaemi).  
  
 Another interesting aspect of this data is the fact that Lys22Gln/Phe56Trp mutant was 
also able to show the first dissociation step. Previously, this mutant reported dynamics of the 
protein only as well.19 Thus, the reporting capabilities of Lys22Gln/Phe56Trp, especially on the 
helix C, and the data presented in this report demonstrated that this mutant could be a global 
reporter for U1A fast kinetics studies.  
 For the second dissociation step, stopped flow data showed a speed up upon mutation. 
For Lys 20, Lys 22 and Lys 23 mutants a similar trend had been observed before for the 
dissociation kinetics utilizing SPR measurements.17 From our studies and previously reported 
ones, the dissociation kinetics trend is not fully correlated with the binding affinities. To 
understand this, we performed a φ value analysis (Figure 29 and Table 6) to study the effect of 
the mutations on the transition state. For this analysis, Phe56Trp was used as our wild type 
control. 
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Figure 29. Schematic of the free energy landscape for the second step of U1A-SL2 RNA complex dissociation: 
Free energies were obtained from the Kd and φ value analysis for the complex and transition state, respectively. 
The positively charged mutants are colored with different green intensities, and the size of dashed lines 
represents the differences in ΔΔΔG.  
 
 The most negative change of free energy (ΔΔΔG) between the transition state and the 
complex state changes of free energies was observed for Lys22Gln/Phe56Trp, which was the 
mutant with faster dissociation. The Lys23Gln/Phe56Trp had the least negative ΔΔΔG that 
relates to its slower dissociation kinetics. This analysis showed us that these positively charged 
residues are important for the stability of the transition state. Moreover, although 
Lys50Gln/Phe56Trp mutant has the largest complex destabilization, it is not the faster to 
dissociate probably because its transition state still has 82 % of complex contacts.  
Table 6. Parameters from φ value analysis  
 
 
 
Also, the dissociation kinetics could be the result of the electrostatic signaling from the binding 
region, which in includes loop 3, to the helix C. The movement of the helix C is a necessary 
conformational change for RNA binding, which is control by the linker region. Shortest paths to 
 
Protein  
 
ΔΔG M-WT 
(kJ/mole) 
 
ΔΔG# M-WT   
(kJ/mole) 
ΔΔΔG  
(ΔΔG# M-WT -ΔΔG M-WT)    
(kJ/mole) 
 
φ# 
K20Q/F56W 3.0  1.9 -1.1  0.64 
K22Q/F56W 6.7  4.6 -2.1 (faster) 0.70 
K23Q/F56W 4.4  4.2 -0.2 (slower) 0.95 
K50Q/F56W 7.1  5.9 -1.2 0.82 
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account for the signaling pathways between the loop3, where Lys 50 is found, and linker 
(residues 88 to 91) have been calculated (unpublished work of Dr. Zhaleh Ghaemi). Upon 
mutations, both the residues and the number of residues these pathways pass change. The overall 
trend is towards longer pathways and thus less efficient signaling, which corresponds with the 
order of observed stopped flow experiments. 
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Chapter 3 
Cellular and macromolecular crowding studies of the spliceosomal U1A-SL2 RNA complex 
 
3.1 Introduction 
 For decades the role of RNA molecules as an ancestral biomolecule have been extensively 
discussed. Most of these discussions are based on what we know about RNA and its versatility to 
encode genetic information and perform catalytic functions.1-5 Although evolution has not 
significantly changed the main composition of RNA molecules, a class of protein has evolved 
together with the RNA to make possible several processes in cells. These proteins are known as 
RNA binding proteins (RBPs) and are capable of regulating RNA through dynamic 
interactions.6,7 Cellular biology studies have shown that RBPs are main players during 
transcription, pre-mRNA splicing, RNA localization, and translation.8,9  
 Because of the importance of RBPs in several cellular processes, extensive biochemical 
and biophysical studies have been done to elucidate their binding mechanism. In vitro studies 
have revealed that most RBPs bind to RNA with high binding specificity and affinity.10-17 These 
studies have also shed light on the binding mechanism of some RBPs and the effect of different 
buffer conditions on the formation of an effective RBP-RNA complex.15,18-20 Despite all the 
studies, there is no study that unravels the effect of the cellular environment in the kinetics of 
protein and RNA interactions.  
 The intracellular environment is crowded and has many biomolecules with different sizes, 
charges and localization. Therefore, the conditions inside living cells can modulate biomolecules 
interactions differently. For example, in living cells there is more than 300 mg/mL of 
macromolecules, which reduces the available volume for other molecules.21,22 This phenomenon 
is known as the macromolecular crowding effect and it causes an increase in the effective 
concentration of molecules in the cell. This effect has been shown to change the in vitro stability 
and conformation of free RNAs23,24 and proteins22,25-28, and to alter protein-protein 
interactions29,30. Now, it is the time to study how protein-RNA interactions could be affected by 
the macromolecular crowding effect.   
 In this manuscript, we report the first fast kinetics studies of a RNA-protein complex in a 
crowded and cellular environment. For this kinetics studies, we used the U1A-Stem Loop 2 
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(SL2) RNA complex (Figure 30) because it is a well-studied model system. The U1A protein is 
part of the U1 small ribonuclear protein (U1 snRNP), which is a unit of the spliceosome.31,32 
 
Figure 30. Structure of U1A protein in dark blue with highlighted β-strands in light blue and SL2 RNA in 
gold.  
 
The U1A protein has two RNA recognition motifs (RRM), but the N-terminus motif alone is 
sufficient for high binding affinity. The RRM domain is the most abundant RNA binding 
domain (RBD). Utilizing fast relaxation imagining (FReI), our studies showed that the U1A-
SL2 RNA complex is stabilized in macromolecular crowded buffers following a classical excluded 
volume model. In the cellular environment the U1A-SL2 RNA complex is localized inside the 
nucleus, probably through a RNA-mediated mechanism. Moreover, the complex binding affinity 
is reduced inside cells relative to aqueous buffer stability, which could be the result of competitive 
interactions by other RNAs/RBPs or electrostatic interactions/stickiness inside cells.  
 
3.2 Materials and methods  
 
3.2.1 Proteins engineering and purification 
  The expression vector for the N-terminal domain of U1A was obtained from Nagai.33 
The expression vector contained a sequence coding for a hexa-His tag at the N-terminus of the 
protein to facilitate purification. A cysteine is necessary to attach a fluorescent dye through a 
malemide reaction. Site-directed mutagenesis was use to obtain U1A protein with the isoleucine 
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94 to cysteine (Ile94Cys) mutation. We selected this position for mutation because of its distance 
is close to the end of the stem of SL2 RNA. Also the Phe56Trp mutation was incorporated in 
this construct to perform further comparative studies. The Ile94Cys/Phe56Trp mutant was 
confirmed by sequencing.  
 This expression vector was transformed into the Escherichia coli strain BL21-DE3 
(pLysS) competent cells. The cells were grown in LB medium at 37 °C, and protein expression 
was induced with 1 mM IPTG at OD600=0.60. The cultures were grown overnight after 
induction at 20 °C. The cells were centrifuged, and the pellet was resuspended in 10 mL of lysis 
buffer (50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole, Complete Mini Protease Inhibitor 
cocktail (Roche), pH 8) and lysed by ultrasonication. Then, the lysate was centrifuged at 10,000 
rpm and the supernatant was sterilized through a 0. 22 µm filter. The filtered solution was 
loaded into a 1 mL Ni-NTA column of an FLPC-AKTA, and the protein was eluted with 
elution buffer (50 mM NaH2PO4, 300 mM NaCl, 500 mM imidazole, pH 8). Eluted protein 
was dialyzed against storage buffer (10 mM potassium phosphate, 50 mM KCl, pH 7) and 
concentrated by amicon filter MWCO 3,000. The histidine tag was removed by Thrombin 
cleavage. The molecular weight of the purified protein was confirmed by low-resolution 
electrospray ionization mass spectrometry, and the purity of the protein was assessed by SDS-
PAGE.  
 
3.2.2 Malemide reaction and purification  
 The reaction buffer (10 mM potassium phosphate, 50 mM KCl, pH 7) was degassed 
using a sonicator and house vacuum for 2 hours. In a Have round-bottom flask with a stirrer the 
Ile94Cys/Phe56Trp mutant was added, then the Tris(2-carboxyethyl)phosphine (TCEP) and 
finally the degased buffer. The reduction proceeded for 2 hours at room temperature and under 
nitrogen. After 2 hours, the 10-fold excess of Alexa-488-c5-maleimide was quickly added. The 
round-bottom flask was covered with aluminum foil, and the reaction proceeded overnight at 
room temperature and under nitrogen. The next day a MWCO 3,000 centrifugal filter was used 
to remove excess dye. The molecular weight of the dye-labeled protein was confirmed by low-
resolution electrospray ionization mass spectrometry, and the labeling efficiency was assessed by 
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UV spectrometry (> 95% yield). SL2-RNA-Alexa-594 was bought from Integrated DNA 
Technology (IDT). 
 
3.2.3 Cell culture, microinjection and sample preparation  
 U2OS cells were cultured in petri dishes with coverslips with DMEM serum medium 
supplemented with 1% penicillin-streptomycin (PS) and 10% fetal bovine serum (FBS).  After 
the culture reached 50-60% confluency, cultured media was removed and 3 mL of Opti-MEM 
reduced serum medium (Gibco) was added. Cells were microinjected with the double dye-
labeled U1A-SL2 RNA complex utilizing an Eppendorf FemtoJet® microinjector.  After 
microinjection an imaging chamber was prepared between the coverslip and a standard 2.5×7.5 
cm microscope slide, separated by a 120 µm spacer (Grace BioLabs) with Opti-MEM reduced 
serum medium supplemented with 30 % FBS.  
 For in aqueous buffer measurements, the same coverslip, slides and spacers were used, but 
instead a 3 µM solution of double labeled U1A-SL2 RNA complex in 10 mM potassium 
phosphate was transferred into the imaging chamber. Micrometer-sized dye beads on the 
coverslip ensured that the objective focus was at the surface of the slide just as for cells, to avoid 
any temperature gradient across the chamber. For Ficoll buffer experiments the procedure was 
the same as for buffer experiments, but different solutions (0 to 150 mg/ml) of Ficoll-70 were 
used in the phosphate buffer system. 
 
3.2.4 Fluorescence relaxation imaging (FREI)  
 The FReI instrument has been previously explained in detail.34 To collect the equilibrium 
data, donor and acceptor fluorescence were acquired for 4 s from room temperature to around 35 
°C to avoid protein unfolding. A 4-6 °C temperature jump was applied by a 2200 nm infrared 
diode laser. The red acceptor and green donor images were projected onto a CCD camera.  The 
initial acceptor intensity was scaled by a factor a so that D-aA at the beginning of the jump was 
equal to 0 and then D-aA (scaled D-A) was plotted against time. Relaxation towards the new 
equilibrium at higher temperature was recorded for 6 s.  
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3.2.5 Spectral bleed-through, crosstalk and temperature dependency controls  
  The corrections for bleed-through and crosstalk were done following Gordon et al 
quantitative analysis.35  
Table 7.   List of parameters used for spectral correction of fluorescent dyes 
Parameter Filter and fluorophore Measurement 
Dd Donor filter with donor only present Green channel with 470 nm LED 
Fd FRET filter with donor only present Red channel with 470 nm LED 
Ad Acceptor filter with donor only present Red channel with 590 nm LED 
Da Donor filter with acceptor only Green channel with 470 nm LED 
Fa FRET filter with acceptor only Red channel with 470 nm LED 
Aa Acceptor filter with acceptor only Red channel with 590 nm LED 
Df Donor filter with acceptor and donor Green channel with 470 nm LED 
Ff FRET filter with acceptor and donor Red channel with 470 nm LED 
Af Acceptor filter with acceptor and donor Red channel with 590 nm LED 
5 
 
To obtain the pure red signal (𝐴𝑓𝑎) from the acceptor that would has been if the donor was not 
present and therefore no FRET occurred equation 1 was used: 
     𝐴𝑓𝑎 = !"! !"!" !"!! !"!" !!!"      (1) 
Then, the red signal (𝐹𝑅𝐸𝑇1) from FRET experiments can be corrected for bleed-through and 
crosstalk with equation 2:  
   𝐹𝑅𝐸𝑇1 = !"! !"!" !"!!"# !"!" ! !"!" !"!"!! !"!" !"!"    (2) 
Utilizing 𝐹𝑅𝐸𝑇1 in equation 3, we can obtain the pure green signal (𝐷𝑓𝑑) from the donor that 
would has been if no acceptor was present and therefore no FRET occurred:  
   𝐷𝑓𝑑 = 𝐷𝑓 − 𝐹𝑅𝐸𝑇 1 − !"!" − 𝐴𝑓𝑎 !"!"    (3) 
To characterize temperature dependency control experiments were performed for the free dyes 
(Alexa448 and Alexa594) and conjugated contracts (U1A-Alexa488 and SL2-Alexa594). These 
controls were performed at the FREI instrument and corroborated in the Cary Eclipse 
Fluorescence Spectrophotometer (Agilent Technologies) from 20-50 °C.  
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3.2.6 Calibration to obtain inside cell concentrations  
 The approximate size (z-distance, depth) of the U2OS cells was determined to obtain an 
estimate of the concentration of protein and RNA inside cell. For this, the cells were labeled 
with Calcein Dye for 30 minutes at 37 °C and imaged in a LSM 700 (Zeiss) confocal laser 
scanning microscope utilizing Z-stacks. Then, utilizing the size obtained from the analysis 
performed with Imaris-8 (Bitplane) software a calibration experiment with different 
concentrations of dye labeled protein and RNA versus fluorescence intensity was performed. 
Three independent experiments were taken for the calibration and they were done at the FREI 
microscope setup. 
 
3.3 Results 
 
3.3.1 Spectral bleed-through and crosstalk of Alexa488 and Alexa594 
 For our studies, we selected Alexa488 and Alexa594 as our FRET pair, because their 
spectral properties were appropriate for our FREI microscope setup and SL2 RNA can be 
ordered with Alexa594 malemide linked to it. Because it was the first time that we use these 
fluorescent dyes, we decided to characterize their spectral bleed-through and crosstalk. All of the 
ratios required for equations 1 to 3 are reasonable values for a FRET pair, but the Fa/Aa ratio 
that related to the direct excitation of the red dye by the blue (470 nm) LED. Although this ratio 
is around 26%, for our experiment this value is tolerable. 
 
Table 8. Calculated values of parameters used for spectral correction of fluorescent dyes 
Parameter Measurement Calculated 
Df Green channel under 470 nm LED illumination  * 
Ff Red channel under 470 nm LED illumination * 
Af Red channel under 590 nm LED illumination * 
Fd/Dd Green channel to red channel bleed-through 0.082 ± 0.001 
Ad/Fd Direct excitation of green dye by 590 nm LED ~0 
Da/Aa Red channel to green channel bleed-through 0.0198  ±  0.0003 
Fa/Aa Direct excitation of red dye by 470 nm LED 0.263  ± 0.001 
Da/Fa Crosstalk of red dye at 470 nm 0.0816  ± 0.0001 
 
*Value change between each experiment 
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3.3.2 Temperature characterization of Alexa488 and Alexa594  
 Because we wanted to perform temperature relaxation experiments, we characterized the 
temperature dependence of these Alexa dyes (Figure 31).  This characterization was done from 
20 °C to 50 °C, because that is the temperature range for our studies. For Alexa488 an increase 
of 9 % (Figure 31a) in intensity was observed and for Alexa594 a decrease of 5 % (Figure 31b) 
was observed. Although the temperature dependences of these dyes follow the same trend as the 
protein-RNA dissociation (green intensity increase and red intensity decrease), the change of 
intensities during dissociation are significantly larger (Figure 31c). 
 
Figure 31. Temperature characterization of Alexa dyes: A) free U1A protein labeled with Alexa488, B) free 
SL2 RNA labeled with Alexa594, and C) complexed U1A protein-Alexa488 and SL2 RNA-Alexa594. 
 
3.3.3 U1A-SL2 RNA complex affinity is enhanced under macromolecular crowding conditions 
  Before performing kinetic experiments inside cells, we evaluate the effect of a crowded 
environment on the U1A-SL2 RNA complex in vitro. For this, we dilute the fluorescently 
labeled U1A-SL2 RNA complex in several buffered-solution with different concentrations of 
Ficoll-70 (an inert macromolecular crowder). FREI experiments were done for each Ficoll-70 
buffered solution (0-150 mg/mL) from room temperature to ~40 °C (Figure 32a). The bleed-
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through/crosstalk was corrected using Equations 1 to 3 and the parameters in Table 2. The 
FREI experiments were globally fitted with 𝑈1𝐴 − 𝑆𝐿2 ⇌ 𝑈1𝐴 + 𝑆𝐿2 model and !"!!!!"!!" =𝑘!""[𝑈1𝐴]   − 𝑘!"[𝑆𝐿2]!  master kinetic equation in which     𝑘!" = !!""!! , 𝐾! = 𝑒(∆!!") , and ∆𝐺 = 𝐺1  (𝑇 − 𝑇!). Thus, from the FREI traces thermodynamic and kinetic parameters were 
extracted.  
 
 
Figure 32. FREI experiments: A) example of a complete experiment in aqueous buffer (no Ficoll-70) of 3 µM 
of 1:1: U1A-SL2 RNA complex, and B) effect of increasing concentration of Ficoll-70 on the association rate 
(kon) at 20 °C. 
 
3.3.4 SL2 RNA and the U1A-SL2 RNA complex are highly localized in the nucleus 
 Before studying the dynamics of the U1A-SL2 RNA complex inside the cells, we 
decided to microinject each fluorescently labeled component (free U1A and free SL2 RNA) into 
U2OS cell as controls. We microinjected 15 cells with each free component (30 total).  After 40 
to 60 minutes, nuclear and cytoplasmic microinjection of free U1A mostly diffused through the 
whole cell as shown in Figure 33a. In contrast, after cytoplasmic microinjection of the free SL2 
RNA (Figure 33b) almost complete localization in the nucleus was observed after a similar 
amount of time. Also, when the cell were microinjected into the nucleus with SL2 RNA, it 
stayed inside the nucleus (not shown). Similarly, the cells microinjected with U1A-SL2 RNA 
complex showed almost complete nuclear localization (Figure 33c).   
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Figure 33. Images of U2OS cells microinjected with: A) with free U1A, B) free SL2 RNA, and C) U1A-SL2 
RNA complex.  
 
3.3.5 U1A-SL2 RNA binding affinity decreases inside cells  
 An approximation for the concentration of free U1A and SL2 RNA inside cells is needed 
to characterize the dynamics of the U1A-SL2 RNA complex inside cells, because it is a 
bimolecular process. The average depth (z-distance, depth) of U2OS cells was determined to be 
10 ± 2 µm with confocal microscopy. The calibration curves in Figure 6 were obtained for the 
dye labeled U1A-Alexa488 and SL2-Alexa594 in an imaging chamber with 10 ± 2 µm.  
 The calibration curve that was utilized to calculate the concentration of both U1A-
Alexa488 and SL2-Alexa594 inside cells was the curve for SL2-Alexa594 (red curve in Figure 
34), because the fluorescence intensity of only SL2-Alexa594 can be obtained from direct 
excitation with the amber LED, even in complex with U1A-Alexa488. Also, the same 
concentration of the SL2 RNA was assumed for U1A-Alexa488, because a 1:1 solution was 
injected inside cells. The U1A-Alexa488 intensity in cells is altered by complex formation due to 
FRET, so it is not used to calculate concentration. The calibration curve was obtained as a 
reference.  
 
Figure 34. Calibration curves to measure an approximate concentration of U1A and SL2 RNA inside cells  
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After microinjecting the U2OS cells, FREI experiments were performed (Figure 35). After 
increasing the temperature to ~28 °C for each in-cell experiment kinetics were no longer 
observed. The signal to noise ratio inside cells was smaller than for in vitro experiments, so it is 
possible that kinetics at higher temperature were hidden by the experimental noise.   
 
Figure 35.  Sample data for in cell FREI experiment 
Interestingly, the U1A-SL2 RNA complex stability decreased by ~30 folds inside cells as shown 
in Table 9. This destabilization was reflected in a decrease in the association rate (kon), and not 
relative change in the dissociation kinetics.  
 
Table 9. Comparison of in vitro and in cell  
Sample Kd (M) at 20 °C  kon (M-1 s-1) at 20 °C 
In vitro (0 Ficoll-70) 7.5 (± 1) x 10 -8 5.3 (± 1) x 10 6 
In cell* 2.4 (± 4) x 10 -6 5.7 (± 1) x 10 5 
 
*Average of 3 in cell independent experiments 
3.4 Discussion 
 The U1A protein and SL2 RNA have been used as a model system to study the dynamics 
of the RRM domain for more than two decades. Many aspects of the RRM-RNA recognition 
process have been understood utilizing this model, for example association36-38 and dissociation39 
pathways were proposed and characterized utilizing surface plasmon resonance (SPR), laser-
induced temperature jump and stopped flow. Furthermore, the importance of electrostatic 
interactions in both pathways37 and the role of amino acid community networks upon binding 
have been characterized.40-44 Therefore, the U1A-SL2 RNA system is a good model to transfer 
the current in vitro knowledge of protein-RNA interactions into the cell. To accomplish this, we 
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performed in vitro experiments with Ficoll-70 (a macromolecular crowder) and inside U2OS 
cells. 
 Our in vitro studies on the U1A-SL2 RNA showed that its binding affinity is enhanced 
under macromolecular crowding conditions. We observed a 3 to 4 order of magnitude increase in 
the dissociation constant that cannot be explained by excluded volume alone (only a (1.2)^2 ≈ 
40% effect on protein*RNA concentration). A plausible model is that the U1A protein and SL2 
RNA adsorb on the surface of Ficoll-70, which increases the effective concentration. Thus, one 
can expect a switch in the rate constant between aqueous solution (volume) and Ficoll-70 
adsorbed (surface). Because during several processes during RNA regulation RBPs are also 
interactions with other proteins, it will be interesting to know if the excluded volume effect still 
holds during a trimolecular binding reaction involving RNA. 
 The first observation from the inside cells experiments was that the localization of SL2 
RNA inside the nucleus after microinjecting cells in the cytoplasm, and the SL2 RNA did not 
diffuse out of the nucleus after directly injecting the complex into it. Although the SL2 RNA 
localized into the nucleus, the U1A protein mostly diffused across the whole cell. In a similar 
way to the SL2 RNA, the U1A-SL2 RNA complex highly localized inside the nucleus of the 
cells. This localization is possible because the molecular weight of the U1A-SL2 RNA complex 
is less than 50 kDa allowing it to diffuse across nuclear pores. Also because the U1A-SL2 RNA 
complex is a component of the U1 snRNP spliceosomal particle (Figure 36), this complex is 
expected to localize itself into the nucleus. The interesting aspect from the observed localization 
in our experiments is the fact that the U1A protein only localized into the nucleus when it is 
complexed with the SL2 RNA. Thus, the localization of the complex could be mediated by a 
diffusion of the SL2 RNA. The small partial nuclear localization observed when the U1A 
protein was microinjected by itself could be the result of binding to the native SL2 RNA in the 
U2OS cells. Microinjection studies have been used before to understand the localization and 
transport of RNA molecules in several studies.45-48  
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Figure 36. Schematic representation of U1 snRNP particle in which it binds to the 5’ splice site of the target 
pre-mRNA inside the nucleus. U1A protein binds to the stem loop 2 of U1 snRNA. 
 
 The second observation from the inside cells studies was the reduction in binding affinity 
of the U1A-SL2 RNA complex. At 20 °C the inside cells dissociation constant is ~30 fold larger. 
This increase in the equilibrium dissociation constant relates to an increase in the association rate 
constant, which is opposite of the effect due to the excluded volume. The basic model is that in 
cells, a protein like U1A has one evolved binding partner (SL2 RNA) with strong binding 
affinity, but also many potential weak binding partners. Thus the strong interaction competes 
with many weak ‘quinary’ interactions, shifting equilibrium away from the good binding. Thus 
binding has to over-evolve, and in vitro binding looks better than is really necessary. A similar 
result has been observed before for protein folding in which the electrostatics interactions and 
stickiness in the cells are believe to overcame the macromolecular crowding effect.49 These factors 
may also play a major role in regulating protein-RNA complexes because they are highly 
charged.  
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Part II 
Protein Folding Dynamics in Living Cells 
 
Introduction 
Protein folding is an important and now fairly well understood physico-chemical process 
required for cell function.  In vitro and computational studies have been the major driver of 
protein folding science. Much has been learned with the advent of site-specific techniques like 
hydrogen exchange or Phi- and Psi-value analysis,1-3 powerful NMR methods,4,5 single molecule 
experiments,6,7 and the development of fast relaxation techniques for direct comparison with 
ever-increased sampling by computation.8-10 A quantitative statistical mechanical model has 
emerged to explain the experimental and computational observations from these studies 11,12. We 
know that unfolded states of proteins already contain significant residual structure and are biased 
for folding13,14. When there is no competition with aggregation, the protein energy landscape 
funnels small proteins towards the native state in a stochastic yet efficient quest15,16 for the lowest 
energy state encoded by the sequence.17 This process suffers some frustration due to the function 
for which proteins have evolved,18 but generally with minimal traps or off-path conformations 
sampled during folding.19,20 
A funneled energy landscape means that enthalpy and entropy of the protein and its 
solvent compensate, resulting in small free energy barriers and a very rapid folding reaction. Even 
‘slow folders’ that take minutes to react are much faster than typical small organic molecules at 
room temperature. Folding is robust, with multiple alternative low energy paths available even to 
small fold topologies.21-23 Although Boltzmann weighting is sensitive on the kBT energy scale 
(~2.5 kJ/mole at physiological temperatures),8 a predominant path usually exists for a single 
solvent condition and amino acid sequence. 
Together with its proteins, the cell has evolved into an enormously complex environment 
for metabolism, information transfer, and proof reading needed to support homeostasis (Figure 
37).24  
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Figure 37. Crowded cytosol illustrating several folding and binding processes. Red ribbon structures: The 
folding (F) – unfolding (U) equilibrium of phosphoglycerate kinase depends on macromolecular crowding. 
White ribbon structures: p53 has a disordered N terminus in aqueous solution (U), which may be shifted 
towards folding by crowding and nonspecific interactions in the cytoplasm (F) or binding to its inhibitor 
Nmd2 (purple). Blue ribbon structures: the extracellular protein VlsE folding equilibrium is shifted in the 
opposite direction from phosphoglycerate kinase in the cytoplasm; favorable contacts formed by the unfolded 
state (U) may overcome crowding effects that favor the folded state (F). (The figure was prepared by Prof. 
Taras Pogorelov with data from Prof. Adrian Elcock.) Journal of Physical Chemistry B, 2014, 118(229):8459-70 
DOI: 10.1021/jp501866v 
 
The cell depends on the function of a very diverse set of proteins to sustain these processes. Cells 
spend a considerable free energy cost transcribing and translating their genetic information to 
produce a functional proteome.25 Protein function therefore needs to be highly regulated to 
obtain the desired function. This regulation does not end with control of expression, but 
continues with post-translational modification,26-28 translocation or insertion of proteins into 
different cellular compartments or membranes,29,30 specific checkpoints during the cell cycle,31 
and programmed degradation.32 Quinary structures (weak transient macromolecular interactions 
on the order of kBT) control protein function in ways too subtle for pull-down assays or similar 
strong-binding assays to detect.33-35 These weak interactions in the cell are an important frontier 
for protein regulation and folding science.  
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 All but the most stable ordinary globular proteins unfold and refold again many times 
after translation,36 providing stochastic checkpoints for degradation. Other proteins are unfolded 
in isolation in vitro,37 yet may have more structure, or fold and bind depending on their local 
environment in the cell.38 In addition, proteins in the cellular matrix are subject to 
macromolecular crowding,39,40 electrostatic interactions41,42 and solvent-protein interactions (e.g. 
hydrophobicity) that vary among compartments43 and in time44. Many of these inter- and intra-
molecular interactions have been studied in vitro,45-48 but their relative contributions could vary 
within the cell.  
 Within this complex environment, proteins face selective pressure not just for function, 
but also for avoidance of undesirable interactions that could lead to false signaling or aggregation. 
As chaperoning mechanisms appeared, some proteins and assemblies were free to evolve to large 
size, even though their folding or assembly yields are very small in vitro without assistance.49 
Furthermore, a significant fraction of proteins with well-known function inside cells cannot be 
studied in vitro because they aggregate or lack their in-cell structure in aqueous buffer50. For 
example, a comparative study showed that the information from model-protein studies only 
represents 8.4% of E. coli soluble proteins. This difference is even larger for membrane proteins. 
50 
 Some of the effects of the cell on proteins may be incidental, they are the stochastic by-
products of a complex environment on proteins that fold and function efficiently. Because cells 
are clearly not well-stirred chemical reactors, the cell probably evolved to control protein folding 
and function in space and time. Therefore it is of interest to ask how much the cellular 
environment modulates in vitro folding mechanisms and whether such modulation could be 
critical for time- and space-selective function. Additionally, until what extent the cell has evolved 
into an optimal compromise to avoid undesirable interactions and misfolding, while promoting 
desirable control over its proteome. 
 A number of model proteins have now been studied in synthetic environments 
mimicking some aspects of the cell,51,52 and recently these studies were extended to the 
intracellular environment to deconvolute ‘intrinsic’ from ‘cellular’ effects on folding and 
function.38,43,44,53-56 The physico-chemical information obtained from in-cell protein folding 
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studies is the first step towards a comprehensive understanding on how cytoplasmic physical 
gradients and compartmentalization work at the molecular level. Therefore these studies are not 
only important for the protein-folding field, but they are also relevant for cell physiology. 
Specifically, how cells maintain homeostasis with minimal driving forces and expenditure of free 
energy.  
 With these important points in mind, the work presented in this part conveyed the 
important aspects of protein folding/unfolding. The first chapter reviews recent experimental and 
computational progress towards understanding of protein folding inside cells, and open inquiries 
for the in-cell protein-folding field. Finally, the second chapter presents how the intracellular 
environment modules the stability and kinetics of the extracellular protein VlsE.  
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Chapter 4 
Protein Folding Dynamics Studies in the Cell** 
 
4.1 Introduction 
 Protein folding is a remarkably fast unimolecular reaction, spanning microseconds to 
minutes. Thus free energy differences and activation barriers on the free energy landscape of 
proteins are rather small. This opens up the possibility of living cells modulating their protein’s 
landscapes, providing cells another way to control the function of their proteomes after 
transcriptional control, translational control and post-translational modification. In chapter, we 
discuss advances in physico-chemical studies of protein stability and folding inside living cells. 
We focus in particular on our studies using Fast Relaxation Imaging (FREI). Although the effect 
of the cell on protein free energy landscapes is only a few kT, the strong cooperativity of many 
folding and binding processes allows small modulation of the energy and entropy to produce a 
large population modulation. Lastly, we discuss some biomolecular processes that are particularly 
likely to be affected by in-cell modulation of the proteome, and thus of interest for quantitative 
physical chemistry studies. 
 
4.2 Moving towards a cell-like environment  
 
 Macromolecular crowding is one of the most important features of the in-cell 
environment. Cells are highly crowded,1,2 and depending on the organelle or sub-cellular location 
5% to 40% of the cell total volume is occupied by macromolecules.2 The mass fraction can be 
even higher with protein density about 1.4 g/cm3. 3 Crowding specifically refers to a steric effect 
(excluded volume) modeled by a short range repulsive interaction.4 Longer range interactions 
(e.g. electrostatic repulsion) or enthalpically favored sticking may also occur, but are not referred 
to as ‘crowding’.5 
 Simple excluded volume models predict that protein states of greater entropy (such as 
unfolded chains or dissociated complexes) are disfavored by the reduced volume. According to 
Hammond’s principle,6 this implies faster folding and association due to a lower reaction barrier 
when a protein is crowded. 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
** This chapter is partially reproduced from Irisbel Guzman and Martin Gruebele, Journal of Physical Chemistry 
B, 2014, 118(229):8459-70 DOI: 10.1021/jp501866v.  
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 Many in vitro experiments using sugar polymers or protein crowders have confirmed this 
picture.7-10 The cellular retinoic acid-binding protein I (CRABP1) was crowded by Ficoll-70, a 
spherical, non-perturbing and inert macromolecular crowder. The CRABP1 urea-denatured 
state is more compact in Ficoll-70 buffer than in aqueous buffer.11 Also, our studies of 
phosphoglycerate kinase (PGK) reveals higher enzymatic activity in 200 mg/ml Ficoll; the 
increase in activity is attributed to a more compact native state with proximal active sites.8 
Additionally, crowding studies of λ6-85 protein using the thermophilic protein SubL as crowder 
revealed stabilization of λ6-85 and enhanced downhill folding.7 
The situation is not always this simple even in vitro. For example, a pH-dependent 
mutant of protein Cl2 was slightly destabilized when BSA and lysozyme were use as crowders.10 
A unified model has been developed to explain the switch from stabilization to destabilization, 
which occurs at a different crossover temperature for different crowders.12 As we shall see, the 
cell can use competing effects of crowding and electrostatics to fine -tune which direction 
stability of a protein is shifted in. 
 
 Macromolecular confinement occurs when a small compartment or pore reduces the 
conformational space of a protein, as opposed to mobile macromolecules. Confinement occurs in 
many places in the cell, such as the ribosomal exit channel,13 translocon pores in membranes,14 
and the inside of chaperones such as GroEL.15 Confinement can generate repulsive or attractive 
interactions,1 and requires rather small compartments of 10 to 100 Å to be significant.16 
In vitro studies have shown how a confined environment modulates the energy landscape 
of protein folding by reducing the conformational entropy of the unfolded state. For example, 
NMR spectroscopy reveals stabilization of apomyoglobin and ubiquitin in zeolite pores.17 Also, 
the melting temperature of ribonuclease A increases by about 30 °C when it is confined in 25 Å 
pores of silica glass.18 Additionally, an unfolded mutant of protein α3W was encapsulated in 
sodium bis(2-ethylhexyl) sulfosuccinate reverse micelles, where it folded into a helix bundle.19  
 
 Longer range interactions In addition to steric effects, longer range electrostatic 
interactions as well as stickiness (hydrophobicity when water-mediated) play a role in the cell. 
These have been studied in vitro by many techniques, including small angle X-ray scattering 
(SAXS).18,20 For example, we developed a method to fit interaction potentials to concentration-
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dependent SAXS data without assuming analytical potentials.21 The potential of mean force in 
Figure 38 highlights that both repulsive interactions (e.g. long range electrostatics of charges on 
the protein surface) and attractive interactions (e.g. medium range exclusion of solvent from the 
space between proteins increases solvent entropy) can occur.  
 
Figure 38. Interaction potential between pairs of SH3 protein molecules is determined by fitting a piecewise 
potential of mean force and a continuous potential of mean force to concentration-dependent small angle X-
ray scattering data as a function of protein concentration21. This particular potential reveals both long-range 
repulsive and attractive interaction before the short-range repulsive wall (crowding) is reached. 
 
These interactions will complicate simple crowding and confinement in the cell, with its large 
variety of differently shaped and charged macromolecules and complex mix of ionic species. 
Long range interactions also occur between proteins and water molecules: on a ns time scale, 
NMR experiments show a strongly perturbed solvent layer 1-2 water molecules deep22. Terahertz 
spectroscopy reveals perturbations of the water network on a sub-ps to ps time scale up to 2 nm.23 
Although the magnitude of the perturbation per molecule drops at greater distance fro the 
protein, the number of affected solvent molecules in a shell increases as r2 with distance r from 
the protein.  
 
4.3 Methods to study protein-folding dynamics in the cell  
 
4.3.1 SUPREX  
 The stabilities of unpurified proteins from rates of H/D exchange (SUPREX) were the 
first quantitative data obtained from protein folding studies inside E.coli. This method is based 
on the fact that protons in proteins exchange with the protons from the solvent (H/D exchange). 
The H/D exchange is initiated when bacteria are transferred to a deuterated medium. SUPREX 
data showed that the monomeric λ repressor fragment, a viral protein that occurs in E. coli, has 
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the same stability inside E. coli than in vitro.24 
4.3.2 FlAsH as an in-cell protein-folding probe  
 4’,5’-bis(1,3,2-dithioarsolan-2-yl) fluorescein (FlAsH) had been used to study protein 
stability inside cells.25 Fluorescence of this dye is turned on when FlAsH is incorporated into a 
protein by binding to the genetically encoded tetracysteine motif C-C-X-X-C-C.26 To study 
protein folding using FlAsH, the tretracysteine is incorporated in the hydrophobic core of the 
protein. Thus when the protein unfolds the tetracysteine motif is exposed, FlAsH binds to it, 
and the fluorescence signal is enhanced. Using this method CRABP1 showed an apparent 
destabilization inside E. coli when urea was present.25 Also, the glutamine repeats in the exon 1 of 
huntingtin were shown to destabilize flanking proteins.27 
 
4.3.3 NMR studies in live cells  
 Except for the need for high sample concentrations, NMR is a bio-compatible technique. 
Therefore changes in protein structure inside cells can be extrapolated to changes of the protein 
folding energy landscape from in vitro to the cell. This was the approach first used by Serber et 
al. to study the structural changes of Tn501 mercuric ion reductase (MerA) inside E.coli using 
high-resolution NMR.28 Additionally, utilizing 15N-labeling to single out FlgM against the 
background of other cellular biomolecules, it was found that this disordered protein gains 
structure inside E.coli.29 Equilibrium folding studies also have been performed; for example a 
mutant of protein L was not able to fold inside E. coli cytoplasm.30 
 NMR studies inside eukaryotic cell studies were the next obvious step. Xenopus laevis 
oocytes microinjected with 15N-labeled GB1 showed that GB1 undergoes structural changes 
related to the higher viscosity and crowding inside cells.31 A cell-penetrating peptide linked to 
15N-labeled human ubiquitin (Ub-3A-CPP) was incubated with HeLa cells with a translocation 
mediator; this first study of protein folding in mammalian cells found that Ub-3A is destabilized 
inside HeLa cells.32 
 
4.3.4 In-cell TOOL studies 
  Temperature oscillation optical lock-in (TOOL) microscopy was first used to study 
DNA hybridization kinetics, but modulation techniques can also be applied to study protein 
folding inside cells.33 In this experiment reminiscent of phase-sensitive fluorescence lifetime 
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detection,34 a perturbation of variable frequency (e.g. pH or temperature modulation) is applied 
to the cell. When the frequency applied has a period greater than the reaction time τ of interest 
the reaction follows the perturbation, but when the period is smaller than τ, the reaction lags 
behind the perturbation creating a phase shift. The frequency-dependent signal amplitude and 
phase shift are used to infer t for the reaction. 
 
4.4 The fast relaxation imaging (FREI) instrument and procedure  
 FREI allows the study of fast biomolecule dynamics (currently milliseconds, potentially 
microseconds) inside cells, by first applying a sudden small temperature up- or down-jump to a 
cell, and then imaging the whole cell’s response. A FRET-labeled protein, pair of proteins, or 
other biomolecule combination such as protein/RNA is detected inside the cell as it responds to 
the perturbation.35 Thus, FREI allows us to investigate protein association, folding kinetics and 
stability inside cells by monitoring proteins in real time with spatial localization, as well as cell 
temperature and cell viability simultaneously. 
 
4.4.1 Instrument and experimental improvements  
 Our laboratory had been using laser-induced temperature jumps, based on the relaxation 
idea by Manfred Eigen,36,37 for nearly two decades to study fast protein folding in aqueous buffer. 
To bring relaxation experiments into the cell, FREI as shown in Figure 39 was developed. 
 
Figure 39. Temperature-jump fluorescence imaging microscope utilize for FREI experiments. To perform 
equilibrium experiments a resistive heated stage is used to increase the temperature, and for relaxation 
experiments the heating laser is used to initiate the temperature jump. The FRET donor is excited with a blue 
light-emitting diode (LED) and a camera is used to record fluorescence of donor and acceptor. 
FReI experiments are performed on an epifluorescent microscope where changes in 
FRET are monitored after a small mid-infrared laser creates a temperature jump. FREI is only 
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limited by the time needed to induce the relaxation kinetics, and can be used to study protein 
folding in a variety of cells with a diffraction-limited spatial resolution. A full description of the 
FREI instrument set up and data collection is given elsewhere.35 
To perform a FREI experiment, the protein or biomolecule of interest needs to be 
labeled with two fluorescent probes to monitor FRET changes. We have been using terminal 
AcGFP as donor and mCherry as acceptor because they can be conveniently expressed together 
with the target protein inside the cell. But, any other combination of FRET pairs, combined 
with cell injection, can be used. The major consideration for the FRET pair selection is that it 
should be fully functional over the 20 °C to 50 °C temperature range. It is worth noting that the 
presence of two large protein labels already “crowds” the target protein sandwiched between 
them. Therefore, we compare the same construct in vitro and in vivo; the actual crowding effect 
in-cell relative to unlabeled protein in vitro may be even larger than what we measure. 
Since our first publication on FREI35, we had added several instrument improvements 
that allow us to have more flexibility and versatility.  For example, increasing the stage 
temperature of the microscope slowly to reach the desired base temperature killed the more 
sensitive cells. Thus, we developed a fast laser stepping method to measure thermodynamic 
traces in a fraction of the time, yielding data from more viable and healthier cells.38 For this 
method, the infrared T-jump laser (2,200 nm, water extinction coefficient ca 50 cm-1) is focused 
to a 1 mm diameter spot on the slide holding the cells to provide uniform heating in our 40x 
objective field of view. The laser then steps up in power spiking briefly at each step to reach the 
desired temperature rapidly before settling into a plateau where the measurement is taken. A full 
temperature titration with less protein aggregation is observed as shown in Figure 40. 
 
Figure 40. (a) The stepping of 2,200 nm heating laser in black and mCherry temperature response in red. (b) 
Equilibrium traces of PGK-FRET in vitro unfolding using the fast temperature stepping method in green and 
the conventional resistive element method in black.  
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The stepping idea can be further extended to any programmable heating laser waveform, with a 
response time limited by the heat capacity of water and thermal conductivity of the sample. We 
also applied more general modulation waveforms to PGK-FRET to learn more about its folding 
kinetics.39  
 
4.4.2 In vitro and in cell sample preparation 
  Detailed procedures for in vitro and in-cell sample preparation are published;35,40 here we 
present a general summary. FRET-constructed proteins are usually expressed in BL21 
competent cells and pDream 2.1 is used as expression vector. After expression, the cells are lysed 
and proteins are purified using a Ni-NTA column. Characterization and purity of the proteins 
are assessed through SDS-PAGE and low-resolution electrospray ionization mass spectrometry.  
 In vitro experiments are generally performed in one of two media: (1) in aqueous buffer 
containing the FRET-constructed protein, or (2) in the same solution but with macromolecular 
crowder agents added.  Aggregates are removed from both types of in vitro solutions with a 20-
µm filter, and then the solution is added onto a glass coverslip with a 120 µm spacer. The spacer 
depth is limited by the extinction coefficient of water at the chosen heating laser wavelength. 
Subsequently, the glass coverslip is positioned on top of a microscope slide, creating a chamber 
that is ready to be imaged. For some applications, in vitro experiments are performed in 
PEGylated or quartz imaging chambers to reduce surface fouling of the protein during 
measurements. Concentration of the FRET-constructed protein varied from 1 µM to 5 µM 
depending on the desired FRET pair, and to check for concentration-dependent aggregation.  
Micrometer-sized dye beads are used in the imaging chamber to focus the objective on the 
surface of the slide by measuring at the same z position. Also with the dye beads, temperature 
variations due to heating and heat dissipation gradients can be reduced to as little as 0.1 °C from 
sample to sample. 
Our in-cell experiments usually are performed with cancer mammalian cell lines. The 
majority of the experiments so far were done in human osteosarcoma (U2-OS) cells. We have 
published a protocol that describes in detail the preparation of cells for experiments.41 Basically, 
around twenty-four hours after transfection of the cells with a plasmid expressing the FRET 
construct of interest, the microscope slide containing the cells is used to prepare an imaging 
chamber similar to the one describe above.  
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4.4.3 Data collection and analysis 
  When in vitro and in-cell protein unfolding is monitored by FREI the donor 
fluorescence intensity (D, AcGFP) increases, and the acceptor (A, mCherry) fluorescence 
intensity decreases. Therefore, upon protein unfolding there is a decrease of FRET efficiency E = 
D/(D+A) and an increase of the D/A ratio. The reverse would be observed in a protein 
association experiment. The fluorescence from the cell is split into donor and acceptor channels 
by a dichroic mirror, and the donor and acceptor channels are imaged side by side onto a CCD 
or similar camera.  Depending on the experiment, fluorescence is imaged from 24 to 100 frames 
per second. Experiments are done in a temperature range from 20 °C to 50 °C. Throughout the 
course of the experiments, the morphology of the cell is observed closely for viability.  
 Thermodynamic data is analyzed by plotting the donor over acceptor fluorescence 
intensity ratio D/A, which reduces the temperature-dependent baseline of the FRET signal 
because both donor and acceptor have a quantum yield that linearly decreases with temperature.  
A more complete cancellation of the temperature baseline can also be achieved by explicitly 
including the temperature-dependent quantum yield of the acceptor (see Figure 2C of ref.40). 
Other reaction coordinates such as FRET efficiency E=A/(D+A), or the difference D-A can also 
be plotted. As the protein unfolds and the donor and acceptor move further apart on average, the 
donor fluorescence increases and the acceptor fluorescence decreases. Therefore the D/A ratio 
increases with temperature, To fit the D/A ratio as a function of temperature, we often use a 
Taylor expansion  to describe the temperature 
dependence of the protein folding reaction free energy. In this equation, is the free 
energy, is the mid-transition point or melting temperature of the protein, and  are 
expansion parameters. Another common model is to let dH=CpdT and dS=Cp/TdT express the 
dependence of free energy on temperature.42 
 For kinetic analysis the data is plotted as D-aA because it is linearly proportional to the 
folded population. In this equation,  is the initial donor to acceptor ratio, which mostly 
eliminates the temperature dependence of quantum yield from the signal. We use a stretched 
exponential function  to fit the kinetic data. In the previous 
equation, β is a stretching factor ≤1 that reports the deviation from the single exponential decay 
€ 
ΔG(T) = CT(1)(T −Tm ) +CT(2)(T −Tm )2 + ....
€ 
ΔG(T)
€ 
Tm
€ 
CT(n )
€ 
a
€ 
D(t) − aA(t) = S(t) = Ae−( t /τ )β
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expected for a simple two-state reaction between unfolded and folded state. We also developed a 
method to extract thermodynamic parameters from kinetic data.43 This can be useful when cell 
viability does not allow the entire folding/unfolding transition to be traced out and fast 
measurement improves cell viability.  
 
 
4.5 A versatile look at the in-cell protein folding with FREI  
 
4.5.1 PGK-FRET in-cell stability and folding kinetics  
 PGK-FRET was the first protein to be studied by FREI because of two major reasons: 
we already performed extensive in vitro protein folding studies of PGK, and PGK was large 
enough to yield a large FRET signal change upon unfolding. We also thought such a large 
protein would be less perturbed by the attached labels when comparing in vitro and in-cell 
studies. Initial experiments where performed in U2-OS cells and confirmed in HeLa cells, and 
established a higher protein stability in the cytoplasm than for the same construct in vitro (DTm = 
3 ± 0.5 °C, see Figure 5). Thanks to the fluorescent bead method of aligning the imaging region 
relative temperatures can be determined to about 0.5 °C. Also, absolute readings vary by as much 
as 2 °C depending on where the measurement in the chamber is taken. The higher in-cell 
stability results from the crowded environment inside cell that favors a more compact or native-
like structure. As seen in the Introduction, and discussed later on, proteins are not always 
stabilized because crowding can be overcome by electrostatic or hydrophobic interactions (e.g. 
Figure 38). 
 
Figure 41. (a) and (b) are PGK-FRET temperature dependence inside two different cells showing the cell to 
cell kinetic variability in green versus aqueous buffer in black.  
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We subsequently measured the full temperature dependence of the equilibrium constant 
Keq=kf/ku (two-state model), observed rate coefficient kobs = kf + ku (two-state model), and thus the 
folding and unfolding rate coefficients kf and ku.38 This analysis confirmed a ~6 kJ/mole 
stabilization of PGK-FRET in the cytoplasm, and highlights cell-to cell variations of stability 
and kinetics. In Figure 5, Keq = 1 at the point where the unfolding and folding rate coefficients 
intersect (ln(kf)=ln(ku)). This point averages 3 °C higher in-cell than in vitro, but it varies from 
cell to cell. Likewise, while the folding rate in the cell is always faster than in vitro, and the 
unfolding rate is always slower, both rates vary from cell to cell (Figure 42).  
The simplest crowding model, which neglects viscosity changes, predicts that the folding 
rate should speed up as observed experimentally in Figure 41.4,44 The speed-up of refolding is 
caused by entropic destabilization of the large unfolded state in the small space between 
crowders. The same models predict that the unfolding rate should remain constant, but Figure 4 
shows that it slows down. We concluded that the unfolding rate decreases because of increased 
viscosity in the cell, in agreement with crowding models that take solvent and protein self-
friction into account45. We showed that the rate returns to the aqueous buffer value when the cell 
is immersed in hypotonic solution, so its cytoplasm swells with water due to osmotic pressure.46 
The transition state for folding is generally more compact than the unfolded state, but more 
expanded than the native state, and thus subject to destabilization by crowding, which could also 
slow down unfolding kinetics. We ruled out a large contribution of the unfolding folding barrier 
to the reduced unfolding rate inside cells as follows: If we assume that the ratio of transition state 
to native state free energy changes upon crowding is similar changes caused by mutations (phi 
value) or by denaturing solvent effects (m† value), both typically ≈ 0.3, and we combine this 
assumption with our measured spread of folding free energies within and among different cells46, 
we find that the small increase of DG†u, and the small spread of DG†u,  values cannot account for 
the reduced unfolding rate and the large spread of relaxation times we observed in cells, as shown 
in Figure 42. 
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Figure 42. Histogram of PGK-FRET relaxation times in aqueous buffer (blue) and in cells (black): the 
relaxation time variability is wider and slower inside cells.  
 
4.5.2 The intracellular environment affects protein structure 
  The radius of gyration and the N-to-C terminus distance are often used as rulers for 
protein compactness and as coordinates on protein folding energy landscape8,47 Protein 
compactness and structure are affected by several factors such as the chemical environment, 
macromolecular crowding and solvation.4,48,49 Thus, protein structure could be significantly 
different inside cells than in aqueous buffer.   
In-cell FRET studies of PGK-FRET have shown that cells modulate the compactness of 
proteins.35,50 Comparison of PGK-FRET in aqueous buffer, crowded by 200 mg/ml of Ficoll 70 
(a carbohydrate crowder) and in-cell shows that both the native and unfolded states have a 
smaller D/A ratio when crowded.8,46 Using D/A as readout of N-to-C terminus distance, we 
found PGK-FRET to be more compact in the cytoplasm than in vitro.  Folded PGK-FRET has 
a D/A ratio of about 10 in vitro, 7 in 200 mg/ml Ficoll crowder, 6.6 ± 0.3 in the cytoplasm, 5.8 ± 
0.5 in the ER and 6.1 ± 0.7 in the nucleus40. Additionally, the final D/A after unfolding is up to 
one and a half times larger in mitotic cells than in interphase cells, which implies PGK-FRET is 
more expanded upon unfolding in mitotic cells.51  
Simulations by the Cheung group propose a new “spherical” native state under such 
crowded conditions, in which the two lobes of PGK come together to form an enzymatically 
more active state.8 Thus the native and unfolded states in cells are not expected to be identical to 
their aqueous solution counterparts, but rather more compact. For example, an unfolded state in 
vivo could resemble a compact folding intermediate seen in vitro. In cells, even more so than in 
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vitro, characterizing unfolded states will be very important: Compact denatured states in the cell 
may be more prone to misfolding than in vitro unfolded states, making the evolution of 
protective mechanisms such as chaperones key to cell survival. 
As a word of caution, although the greater acceptor fluorescence in our data is consistent 
with more compact protein, the FRET labels themselves could interact differently in a crowded 
environment than in vitro, so it will be very important to verify these studies with chemically 
different labels, such as dye molecules instead of fluorescent proteins. 
 
4.5.3 Effects of sub-cellular compartments on PGK-FRET folding  
 Dhar et al. performed thermodynamic and kinetics studies in different cellular 
compartments.40 Each cellular compartment is a different micro-environment that can modulate 
the energy landscape, affecting the stability and function of interacting macromolecules. 
Localization tags were used to introduce FRET-PGK into the cell nucleus and the endoplasmic 
reticulum.  
The melting temperatures Tm in aqueous buffer for these two constructs do not differ 
significantly from the untagged PGK-FRET, and an average Tm  of 38.5 °C was observed for the 
three constructs. Figure 43 shows that PGK-FRET was more stable in the nucleus than in the 
endoplasmic reticulum (ER). In the nucleus PGK-FRET is stabilized by ~4.5 °C and in the ER 
by ~2.5 °C relative to aqueous buffer.  
The kinetics also shows differences between the two compartments. The average folding 
relaxation time was twice as fast in the nucleus. The variation of rates from cell to cell was larger 
in the ER. However, the ER kinetics in individual cells could be fitted with b ≈ 0.9 in the 
unimolecular rate law exp[-(kt)b] (the nucleus required b=0.6). Therefore the reaction has a 
smaller spread of rates in the ER than in the nucleus. PGK-FRET is not a two state folder in 
aqueous buffer (b~0.6). Thus we believe that the ER makes the folding mechanism of PGK-
FRET more two state-like: If a two state folder has kinetics with b<1 inside the cell, it could be 
due to a change in mechanism, or it could simply be that the mechanism remains two state, but 
the rate coefficient varies between different regions of the cell, yielding a non-exponential rate 
law when averaged over the whole cell. However, if a protein is not a two state folder in aqueous 
buffer (like PGK-FRET), but the rate law approaches exp[-kt] in the ER (b≈1), the simplest 
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explanation is that the mechanism has become more two-state-like, and that the folding rates are 
all similar within the ER. It is important to reiterate that the two states interconverting in the 
cell may not be structurally the same ones as in vitro. We discussed above that the intracellular 
environment affects protein structure, generally making proteins more compact. Thus the 
unfolded state inside the cell could resemble a folding intermediate in aqueous solution, for 
example.  
 
Figure 43. Representative equilibrium experiment traces show PGK-FRET stability in different subcellular 
environments.  
 
4.5.4 Modulation of PGK-FRET during the cell cycle 
 The cell cycle is a highly organized temporal regulator of macromolecules expression, 
which allows checkpoints to modulate the proteome during cell growth and division. We 
investigated the temporal variation of PGK-FRET folding as model system to study proteome 
dynamics during cell cycle.51 In particular, we compared the mitotic and interphase stages of the 
cell cycle51 to make a connection with the nucleus-cytoplasm studies discussed above. We 
hypothesized that exposure of PGK-FRET to nuclear material during mitosis would stabilize 
and speed up PGK-FRET folding, just as the nucleus had done. Indeed, PGK-FRET was 
stabilized by ~5 kJ/mole (~2.5 °C) in mitotic cells relative to interphase (Figure 44a). Relaxation 
kinetics was also a little faster in mitotic cells kobs = 0.62 ± 0.004 s-1 instead of 0.44 ± 0.01 s-1 
during interphase (Figure 44b). Phi-value analysis showed that mitotic cells have larger diffusion 
coefficients as well as larger activation barriers than interphase cells, but faster diffusion 
overcomes the increased barrier increase to speed up the rate.51 
The structural cause of the faster folding in mitotic cells is not as simple as we 
hypothesized. When we measured the folding kinetics of PGK-FRET only in the DNA-rich 
areas (located with Hoechst 33258 in mitotic cells), the rate increase was very modest over the 
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DNA-poor areas. If DNA-PGK interaction is at all responsible for the observed faster folding 
kinetics in the nucleus, some other aspect of the nuclear environment not present during mitosis 
must assist this interaction. 
 
Figure 44. (a) Sigmoidal curves of temperature titration of PGK-FRET in 9 randomly selected mitotic and 
interphase arrested cells. (b) Average kinetic traces for PGK-FRET in mitotic and interphase arrested cells.  
 
 
4.5.5 Protein folding in the presence of molecular chaperones 
 Nucleoplasmin was the first chaperone discovered to be involved in protein assembly, and 
gave birth to a new paradigm for in-cell prevention of misfolding or protein aggregation. 
Nucleoplasmin was found to be crucial for the assembly of histone proteins in the nucleus.52 The 
term chaperone was initially used to name a new class of proteins require for protein assembly.52 
Later this term was generalized to include any protein that protects the unfolded state of other 
proteins from aggregation and helps them achieve the native structure in high yield, without 
itself forming part of the final structure.53 There are several classes of chaperones, and they are 
usually classified based on their molecular weight and the stages of protein metabolism that are 
involved. PGK-FRET unfolding is not completely reversible after a temperature jump in vitro 
(e.g. Figure 4b). Since molecular chaperones are known to improve folding inside the cell, one 
might expect to see more complete refolding of PGK-FRET inside cells. Figure 45 shows that 
this is the case:35 When PGK-FRET is first unfolded in the cell by an upward temperature jump, 
and the temperature is jumped back down 15 seconds later, the native D/A ratio is recovered. 
Such recovery could be an indication of chaperones at work, but certainly shows that the 
cytoplasm is a more conducive environment for folding than the test tube after a temperature 
stress. 
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Figure 45.  Kinetic trace of PGK-FRET unfolding and refolding profile inside cells upon consecutive 
temperature upward and downward jumps separated by 15 seconds. After the heating laser is turned off the 
protein refolds, which demonstrated complete reversibility (within experimental uncertainty) in the 
intracellular environment. In vitro data such as Figure 4 do not show such reversibility. 
 
Several chaperones classes have been extensively studied. For example, hsp70 reduces 
misfolding after proteins have left the ribosome, and during translocation across the 
mitochondria as well as in proteostasis control.54 hsp70 proteins function through an ATP-
dependent reaction cycle and it is regulated by nucleotide-exchange factor and hsp40 at different 
stages.55,56  The β-sandwich subdomain in the C-terminus of hsp70 recognizes approximately 
seven hydrophobic residues of a partially unfolded substrate. This is the result of an allosteric 
process controlled by the binding and further hydrolysis of ATP to the N-terminus of HSP7053. 
Another extensively studied chaperon is the chaperonin system, which is a large complex of ~900 
kDa that encapsulated unfolded proteins inside its double ring to enhance folding.54 Each 
chaperone system has obligatory client proteins like actin and tubulin, but chaperones can also 
protect or hold other proteins during stress conditions.53  
 
4.6 The Future of in-cell protein folding studies   
 There is no question that quantitative protein folding science has evolved much since 
Anfinsen started it on a physico-chemical basis with his provoking studies on bovine pancreatic 
ribonuclease A.57-59 During the in vitro era, basic concepts such as a funneled energy landscape60 
and off-pathway intermediate61 were established. Also, fast experiments and simulations met on 
the microsecond time scale to yield a structurally resolved and experimentally verified picture of 
the folding process. The in-cell protein-folding field was unexplored because so many 
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fundamental questions had to be answered first.   
From biochemical assays to time-resolved microscopy, in-cell protein folding has rapidly 
evolved in less than a decade.  Many of the questions need to be answered quantitatively because 
small energy differences can have large effects on populations. Thus physico-chemical studies 
will be important. We have only studied the tip of the iceberg of in-cell protein folding. There is 
still a long way to go with many open questions about how quinary interactions affect the energy 
landscape of proteins and other biological macromolecules. Since the importance of in-cell 
protein folding studies to gain more information about aggregation and misfolding diseases has 
been well-documented,62 we highlight some of the other questions. How important is the 
interaction of chaperones with non-obligatory clients in controlling their folding and 
degradation? How much does the cell use compartmentalization and heterogeneity to control the 
activity and folding of proteins, and how much is it just random noise without functional 
consequences? How is protein shape and dynamics affected by crowding (entropy) and sticking 
(enthalpy) inside cells? What is the full range of measures the cell evolved to suppress undesirable 
signaling (‘short circuiting’ of signaling networks)? 
Intrinsically disordered proteins (IDPs) relate to the last two questions. Many proteins 
that are fully or partly unstructured in vitro undergo allosteric regulation and acquire structure 
when they are bound to other macromolecules.63,64 For example, the apoptotic p53 protein is a 
partial IDP that not only gains more structure upon binding, but is also regulated by other IDPs. 
p53 is inhibited by BCL-xL, and is released to bind pro-apoptotic proteins when BCL-xL binds 
to PUMA. This binding event unfolds BCL-xL, which releases p53.65,66 We do not yet fully 
understand the process by which PUMA induces BCL-xL unfolding. Additionally, the N-
terminus of p53, known as TAD, gains structure by binding to regulatory proteins.  
 Consider the ER, where newly translated proteins undergo post-translational 
modification. These modifications are capable of changing the hydrophobicity and electrostatic 
properties of proteins, which can lead to unexpected dynamics and cellular re-localization.  For 
example, a single phosphorylation in Ser193 of KSRP protein (an important protein in mRNA 
metabolism) starts its unfolding process, which then exposes a binding site that results in the re-
localization of KSRP to the nucleus.67,68 Here, partial unfolding/site exposure is coupled to 
protein transport. What is the mechanism of this phosphorylation-mediated unfolding process, 
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and how much do the stability and Ser193 exposure of KSRP change when KSRP is localized to 
the nucleus? The ER also contains an advanced machinery of chaperones such as the disulfide 
isomerases, prolyl cis-trans isomerases, and others that work in close proximity during vectorial 
and luminal protein folding.69 This machinery catalyzes chemical modifications, regulates the ER 
environment, fosters binding interactions and applies mechanical force. These physico-chemical 
processes are all linked to folding. 
As a final example, there are proteins with two distinct and functioning structures. The 
transcription factor RfaH can be transformed into a translation factor when the carboxy-terminal 
domain switches from α-helix to β-barrel.70 Also, two distinct structures have been characterized 
for lymphotacin in thermal equilibrium at two different temperatures: one is a dimeric all-β-
sheet and the other a monomeric 3-stranded β-sheet. The first structure is a regular chemokine 
and binds XCR1 agonist, and the second structure binds glycosaminoglycans.71 Such “Janus” 
proteins are candidates for structural triggering by small fluctuations in the intracellular 
environment. Thus cellular control of protein folding is not just a question of on-off, but of one 
functional state vs. another in some cases. 
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Chapter 5 
The Extracellular Protein VlsE is Destabilized Inside Cells†† 
 
5.1 Introduction 
Studies in aqueous buffer have revealed much about the folding and misfolding of 
isolated proteins,1 but the cell has also evolved many mechanisms that affect the folding process.  
For example, chaperones can bind proteins to perform a host of functions, such as storage and 
release of non-native proteins, or assistance with disassembly of aggregates.2-4 As in the test tube, 
proteins can unfold and refold many times inside the cell after their initial ribosomal synthesis. 
The interior of the cell provides a highly differentiated and crowded environment that can 
enhance refolding yield and that modulates protein stability and folding rates compared to in 
vitro.5,6 
Volume exclusion by crowding generally has a stabilizing effect on globular proteins 
because the folded state is more compact than the unfolded polypeptide chain, which is therefore 
entropically disfavored.7-9 A host of models and in vitro experiments have analyzed excluded 
volume effects: the shape and size of the proteins and crowding agents,10-12 ‘proteinaceous’ vs. 
‘synthetic’ crowding agents,13,14 and long range interactions15-17 all affect protein stability, folding 
kinetics and diffusion. Shape/size mismatch and long-range interactions can compete with the 
basic excluded volume effect.  For example, a recent combined analysis of carbohydrate and 
proteinaceous crowders showed that both produce similar stability trends in crowded proteins. 
Above a certain crossover temperature, crowding acts to stabilize proteins, while below it 
proteins are destabilized. The two classes of crowders were distinguished by their crossover 
temperature, not by their general behavior.18 
Much less is known about the crowding effect inside cells, although studies have begun to 
elucidate folding in cells during the past several years.5,6,19 Using amide hydrogen exchange 
detected by mass spectrometry, the monomeric λ repressor has about the same stability inside E. 
coli as in vitro.19 Via a FlAsH fluorescent probe, the cellular retinoic acid binding protein was 
destabilized inside E. coli in the presence of urea.6 A variant of the protein L that is ≈80% 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
†† This chapter is partially reproduced from Irisbel Guzman, Hannah Gelman, Jonathan Tai, and Martin 
Gruebele, Journal of Molecular Biology, 2014, 426(1):11-20 DOI: 10.1016/j.jmb.2013.08.024. 
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denatured in aqueous buffer was not able to refold inside the E. coli cytoplasm during NMR 
studies.20 In contrast, real-time imaging of FRET-labeled phosphoglycerate kinase (PGK-
FRET) inside cells revealed various degrees of increased stability and folding speed in different 
organelles.21 Increased intracellular FRET of this protein also indicates a more compact folded 
state inside the cell, consistent with in vitro studies.22 
In vitro folding studies have benefited greatly from a systematic comparison of the same 
protein in different environments, or different proteins in the same environment. The time has 
come for in-cell studies to do the same, either by changing the intracellular environment,21 or by 
comparing different proteins expressed in the same cell line.  Here we do the latter, using U2OS 
cells as ‘in vivo test tubes’ to compare stability and folding of two different proteins. We 
specifically ask the question: Unlike PGK, which is an intracellular protein stabilized in U2OS 
cells, could an extracellular globular protein show the opposite trend in the cell? Our ideal 
extracellular protein would preferably be a two-state folder (to simplify kinetic analysis); of 
similar size, folding rate and stability as PGK (415 residues, ~1 s-1, 39 °C). 
A truncation of Variable major protein-Like Sequence, Expressed (VlsE), whose folding 
was extensively studied by Wittung-Stafshede and coworkers,10 turns out to satisfy all of these 
requirements (Figure 46a). At 341 residues, it is the largest kinetically characterized two-state 
folder with a folding relaxation rate of 5 ± 2 s-1,23 and a stability similar to PGK in vitro when 
both proteins are FRET-labeled for in-cell detection (see below). Truncated VlsE originates 
from a highly expressed cell surface protein of the Borrelia burgdorferi spirochete and is believed 
to be important during host invasion in Lyme disease.24 Unlike PGK, which is an important 
cytoplasmic metabolic enzyme, VlsE has to be unfolded and translocated to be displayed on the 
outer membrane (Figure 46b).  Although VlsE is stabilized by simple carbohydrate crowders,11 it 
seems unlikely that it evolved to be stabilized by the cytoplasm.  Indeed, we find that VlsE is 
significantly destabilized in the U2OS cytoplasm, whereas PGK is significantly stabilized in the 
cell. 
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Figure 46. VlsE protein: (a) VlsE crystal structure. (b) Simplified scheme of VlsE protein translocation across 
the Borrelia bugdolferi double membrane. ⓐ VlsE is synthesized by the ribosome and folds in the cytoplasm. 
ⓑ The molecular chaperone SecB recognizes the signal sequence in the N-terminal region of VlsE and 
transfers VlsE to the Sec machinery that translocates it inside the periplasmic space using ATP energy. ⓒ 
Phosphatidylglycerol/ prolipoprotein diacylglyceryl transferase (Lgt), lipoprotein signal peptidase (LspA) and 
phospholipid/ apolipoprotein transacylase (Lnt) process the lipoprotein precursor into a mature form. ⓓ The 
transporter LolCDE removes the lipoprotein from the inner membrane, and forms a hydrophilic complex with 
LolA. ⓔ  The periplasmic molecular chaperone LolA removes the lipoprotein from LolCDE. ⓕ  LolA 
transfers the lipoprotein to LolB. ⓖ The lipoprotein is incorporated into the outer membrane by LolB. For 
our experiments we truncated the lipidation signal sequence and transfected a DNA plasmid containing the 
VlsE gene into U2OS cells, where it remains in the cytoplasm after translation. 
 
Besides comparing the stability and folding kinetics of two proteins for the first time in 
the same cellular environment, VlsE in-cells is also of interest for comparison with in vitro 
crowding experiments. In the presence of 100 mg/mL Ficoll, VlsE folds three times faster than 
in aqueous solution, and in the presence of 400 mg/ml it is stabilized by 6 °C.12 In contrast, our 
in-cell kinetics are slower, and the stability is lower than that found aqueous buffer. The 
stabilization found by crowding in vitro is consistent with simulations which predict an increase 
in helical content and a large change in shape (from elongated as in Figure 46a to more compact 
bean and spherical shapes) in crowded environments.12 In partial agreement with these earlier 
results, our measurements reveal evidence for multiple VlsE states and greater compactness of 
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the protein in-cell than in aqueous buffer, although these compact states may not be stabilized as 
much inside the cell as by the carbohydrate crowder Ficoll. 
 
5.2 Materials and methods 
 
5.2.1 Protein engineering and expression  
 The VlsE sequence without the N-terminal lipidation-signal was obtained from Pernilla 
Wittung-Stafshede (Umeå University) in the T7/NT-TOPO expression plasmid. We designed a 
VlsE construct fused between a Green Fluorescent Protein (AcGFP1) donor (D) and a mCherry 
acceptor (A). The construct melts at a lower temperature in vitro (and in-cell) than the unlabeled 
wild type, so folding experiments can be carried out in U2OS cells without stressing the cell 
above 45 °C. AcGFP and mCherry were bought from Clontech. A linker of just two amino acids 
was use to connect the AcGFP, VlsE and mCherry proteins. The fusion construct was cloned 
into the pDream 2.1 expression plasmid (Genscript Corp.) containing a C-terminus His-tag 
sequence (to facilitate purification) and a T7 promoter.  
BL21(DE3) pLysS (Stratagene) competent cells were transformed with the pDream 2.1 
VlsE expressing vector and grown overnight on LB plates with 100 µg/mL ampicillin at 37 °C. 
The VlsE-FRET protein could only be expressed in BL21(DE3) pLysS competent cells due to 
its toxicity. One colony was selected and grown overnight in 600 mL of LB media containing 
100 µg/mL ampicillin and 34 µg/mL of chloramphenicol at 37 °C. Subsequently, 100 mL of the 
overnight culture was transferred to 1 L of LB cultures, up to 6 L. The cultures were grown in 
LB medium, and protein expression was induced with 1 mM IPTG (Inalco) at OD600=0.60. 
After induction, the cultures were grown overnight at room temperature. The cells were pelleted, 
resuspended in 10 mL of lysis buffer per 1L of cells (50 mM NaH2PO4, 300 mM NaCl, 10 mM 
imidazole, pH 7.6) and lysed by ultrasonication.  
The lysate was centrifuged at 10,000 rpm, and the supernatant was filtered through 0.22 
µm syringe filter and loaded on a 1 mL Ni-NTA column (Qiagen). The protein was eluted with 
elution buffers (50 mM NaH2PO4, 300 mM NaCl, 100 mM imidazole, pH 7.6) after a gradient 
wash with wash buffers containing different Imidazole concentrations (50 mM NaH2PO4, 300 
mM NaCl, 20-500 mM imidazole, pH 7.6). The presence of the eluted protein in the fractions 
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was verified with SDS-PAGE. The fractions were combined and dialyzed against storage buffer 
(10 mM potassium phosphate). The protein was concentrated by Millipore centrifugal filter 
MWCO 10,000. The VlsE-FRET concentration was determined by measuring absorbance at 
475 nm and using the AcGFP1 extinction coefficient (32,500 L mol-1 cm-1) with a UV-VIS 
spectrometer (Shimadzu).  The molecular weight of the purified VlsE-FRET was confirmed by 
low-resolution electrospray ionization mass spectrometry (ESI MS) and the purity of the protein 
was assessed by SDS-PAGE.  
 
5.2.2 Cell culture, transfection and sample preparation 
 U2OS cells were cultured and grown to 50-60% confluency in DMEM supplemented 
with 1% penicillin-streptomycin (PS) and 10% fetal bovine serum (FBS). The transfection with 
the pDream 2.1 vector containing the VlsE-FRET gene and CMV promoter was performed 
with Lipofectamine (Invitrogen) following the manufacturer’s protocol. Four hours after 
transfection, cell were split and grown on coverslips overnight at 37 °C. 24 hours after 
transfection an imaging chamber was prepare between the coverslip and a standard 2.5×7.5 cm 
microscope slide, separated by a 120 µm spacer (Grace BioLabs) to form an imaging chamber 
filled with Leibovitz L-15 medium (Gibco) supplemented with 30 % FBS. For measurements in 
aqueous buffer or Ficoll buffer, the same coverslip, slides and spacers were used, but instead a 3 
µM solution of VlsE-FRET in 10 mM potassium phosphate was transferred into the imaging 
chamber. Micrometer-sized dye beads on the coverslip ensured that the objective focus was at 
the surface of the slide just as for cells, to avoid any temperature gradient across the chamber. 
 
5.2.3 Fluorescence relaxation imaging (FREI) 
  The FREI instrument is explained in detail in refs. 5,21. To collect the equilibrium data, 
donor and acceptor fluorescence were acquired for 4 s from room temperature to around 49 °C. 
For about half the cells, kinetics were measured immediately after the equilibrium data. A 4 °C 
temperature step was applied by an infrared diode laser at 2200 nm with 32 ms dead time.5 The 
red acceptor and green donor images were projected onto a CCD camera.  The initial acceptor 
intensity was scaled by a factor a so that D-aA at the beginning of the video was equal to 0 and 
then D-aA (scaled D-A) was plotted against time. Relaxation towards the new equilibrium was 
recorded for 9 s. The data in Figure 3 were corrected for a small linear bleaching baseline (which 
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was fitted to the data between 6 and 9 s) and for a fast (~0.09 s) relaxation due to GFP internal 
dynamics. Global fitting was used to fit only one baseline and GFP relaxation time for all 
measurements in a given experiment, reducing the number of fitting parameters. Experiments 
done on PGK-FRET in U2OS cells with the same protocols confirmed the result from ref. 25 
that PGK is stabilized by ca. 3 °C in-cell compared to in vitro. 
 
5.3 Results 
 
5.3.1 Protein measurement conditions 
 Protein stability and kinetics inside cells were imaged using FRET. To allow a direct 
comparison with PGK-FRET results,5 the same fluorescent probes were incorporated into VlsE. 
We cloned the green fluorescence protein (AcGFP1) as donor “D” at the N-terminus and 
mCherry as acceptor “A” at the C-terminus. The donor-acceptor ratio D/A of this construct is 
larger in the unfolded state (greater end-to-end distance, less FRET) than in the folded state. 
For in vitro experiments in aqueous buffer or Ficoll buffer, the protein solution was placed inside 
an imaging chamber as described in the Methods section. In-cell experiments were performed on 
single U2OS cells, as in our previous PGK-FRET studies, after transfection of the plasmid that 
contained the VlsE-FRET gene. For equilibrium measurements, D and A fluorescence were 
imaged for 4 s. Then a 4° C temperature jump was applied to the sample for a kinetics 
measurement. After each equilibrium/kinetic measurement, the temperature was increased by a 
resistive element mounted on the stage for the next pair of measurements. 3 minutes of 
equilibration time were allowed between measurements, a protocol identical to the one used for 
PGK studies. The equilibrium temperature was monitored with a thermocouple, and 
temperature jumps (T-jumps) were calibrated using mCherry quantum yield as the temperature 
probe (Methods).21 
 
5.3.2 VlsE-FRET is dispersed in the cytoplasm and background fluorescence is negligible  
 The representative cell imaged in Figure 47a shows that VlsE-FRET is dispersed 
throughout the cytoplasm despite its lowered stability.  No localization or other sign of 
aggregation was observed in cells at temperatures below 45 °C.  Figure 47b shows the same view 
as 47a, with the pixel RGB values multiplied up by a factor of 20 to show background auto-
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fluorescence of an adjacent unlabeled cell.  We did not observe auto-fluorescence > 2% of the 
combined GFP/mCherry signal in labeled cells with 470 nm LED excitation.  Finally, we 
confirmed that measured melting temperatures, rates, and qualitative trends in D/A ratios are 
independent of instrument alignment, and that the previously reported temperature trends in 
AcGFP1 and mCherry quantum yields (decrease with temperature) still hold.21 
 
Figure 47. (a) Representative cell demonstrating uniform VlsE-FRET dispersion inside a U2OS cell.  The 
darker area is the location of the cell nucleus, where the optical path length through the cytoplasm is shorter.  
(b) The same area with pixel values (brightness) multiplied by 20x.  The original cell is saturated, and the red 
arrows indicate the position of a non-transfected cell that shows very low autofluorescence emission 
background (≈ 2% of the transfected cell). 
 
5.3.3 VlsE-FRET is stabilized in Ficoll-70 
 The thermodynamic measurements in Ficoll buffer by Homouz et al. showed that 
unlabeled VlsE is stabilized by a simple crowder in vitro,11 just as we found previously for PGK-
FRET.22  We measured FRET-detected melting curves of our VlsE-FRET construct at 
different Ficoll concentrations ranging from 0 to 150 mg/mL (Figure 48).  The melting 
temperature of VlsE-FRET increases by about 3 °C between aqueous buffer and 150 mg/ml 
Ficoll buffer (Figure 48 inset). This data agrees with Homouz et al’s results for VlsE in Ficoll 
buffer in which they observed stabilization during urea titrations.  Thus FRET-labeled VlsE 
behaves just like VlsE and PGK-FRET in a Ficoll buffer: its stability increases. 
 
Figure 48. Melting temperature Tm of VlsE-FRET vs. Ficoll-70 concentration (0 to 150 mg/ml) fitted to a 
line. 
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5.3.4 VlsE-FRET is destabilized inside cells  
 The Donor/Acceptor (D/A) ratio of VlsE-FRET increased with temperature, yielding 
sigmoid traces for all in vitro and in-cell equilibrium unfolding experiments (Figure 49a). All 
thermal unfolding traces were fitted using a two-state free energy model whose fitting 
parameters are presented in Tables 10 and 11. The parameter Tm is the melting temperature of 
the protein, at which the free energy of the folded and unfolded states is equal.  
 
Table 10. The 4 in vitro traces were collected 3 seconds before temperature jump and the pre-jump 
temperature was achieved with the resistive heating element. 
 
 
 
 
 
 
 
Table 11. Traces from cells 1 to 9 were collected during 4 seconds of equilibrium experiments. Traces from 
cells 10 to 18 were collected 3 seconds before temperature jump. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Trial # Tm (°C) ΔG 
(kJ/mol) 
β  τ  (s) 
1 37.5 ± 0.1 3.74 ± 0.01 0.97 ± 0.01 0.42 ± 0.01 
2 37.9 ± 0.2 5.63 ± 0.01 0.94 ± 0.01 0.4 ± 0.1 
3 37.8 ± 0.2 3.94 ± 0.03 0.97 ± 0.01 0.43 ± 0.1 
4 37.9 ± 0.3 6.2 ± 0.1 0.97 ± 0.02 0.46 ± 0.01 
Cell # Tm (°C) ΔG (kJ/mol) β  τ  (s) 
1 34.7 ± 0.3 2.38 ± 0.01   
2 35.1 ± 0.6 2.08 ± 0.02   
3 34.7 ± 0.4 2.2 ± 0.2   
4 36.1 ± 0.4 2.35 ± 0.01   
5 34.9 ± 0.3 2.74 ±0.01   
6 32.9 ± 0.4 3.4 ± 0.1   
7 34.3 ± 0.2 2.83 ± 0.01   
8 34.3 ± 0.4 2.39± 0.01   
9 36 ± 1 1.726 ± 0.003   
10 34.3 ± 0.2 3.95 ± 0.01 0.87 ± 0.02 0.86 ± 0.02 
11 32.3 ± 0.4 2.9 ± 0.1 0.85 ± 0.05 3.0 ± 0.2 
12 33.4 ± 0.4 2.83 ± 0.03 0.76 ± 0.09 3.6 ± 0.8 
13 34.7 ± 0.3 2.97 ± 0.01 1.03 ± 0.02 0.80 ± 0.02 
14 35.3 ± 0.2 2.66 ± 0.01 0.92 ± 0.07 2.9 ± 0.3 
15  33.9 ± 0.2 2.081 ±0.004 0.82 ± 0.04 1.30 ± 0.05 
16 35.2 ± 0.3 2.528 ± 0.003 0.63 ± 0.05 0.81 ± 0.05 
17 35.4 ± 0.4 2.84 ± 0.02 0.79 ± 0.04 3.3 ± 0.3 
18 35.6 ± 0.4 2.74 ± 0.02 1.14 ± 0.04 0.81 ± 0.02 
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A comparison of in vitro and in-cell Tm demonstrates that the melting temperature of VlsE is on 
average 3 °C lower inside cells than in aqueous buffer (Figure 49c), and 6 °C lower than in 150 
mg/ml Ficoll buffer.  
 
Figure 49.  (a) Temperature titration traces of D/A in cells (red) and in aqueous buffer (blue). (b) Histogram 
of melting temperatures in cells (red) and in aqueous buffer (blue). (c) Averaged traces of in cell (red) and in 
buffer (blue) experiments. 
 
Even though experiments with Ficoll buffer crowders have demonstrated stabilization of VlsE 
and VlsE-FRET compared to aqueous buffer,11,23 inside the cell the crowding effect is either 
compensated by longer range interactions, or modified by new structural ensembles, or both (see 
Discussion). Measurements on PGK-FRET done in parallel with the same detection geometry 
confirmed its stabilization of 3 °C in cells relative to aqueous buffer as reported previously.5  
Thus PGK-FRET and VlsE-FRET are both stabilized by Ficoll buffer, but PGK-FRET is also 
stabilized in the cytoplasm, whereas VlSE-FRET is destabilized in the cytoplasm. 
Figure 49b shows that the range of melting temperatures is greater in U2OS cells than in 
vitro, where the range is set by measurement error. No obvious thermodynamic signature of two 
distinct protein populations inside the cells is evident in Figure 49b, although the number of cells 
studied is small, and better statistics may yet reveal a low-melting population.  No overlap 
between in-cell and aqueous buffer experiments was found.  Even the least de-stabilizing cells 
have a lower Tm than any of the in vitro measurements. 
 
5.3.5 VlsE-FRET may change shape inside cells  
 It is evident from Figure 4a that in-cell VlsE-FRET (red traces) consistently has a higher 
average D/A fluorescence intensity ratio (less FRET) than VlsE-FRET in vitro. The opposite 
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was observed for PGK-FRET, whose energy transfer between donor and acceptor was more 
efficient inside cells and crowded by Ficoll. 
Homouz et al. have proposed an alternative native state for VlsE upon crowding,11 the 
bean-shaped B state, which is somewhat more compact than the very elongated native state N 
shown in Figure 46a. Figure 50 shows their prediction for the N-C termini distance in the N 
and B states.  The B state has a larger N-C distance despite its greater compactness, which 
would result in a larger D/A ratio (less energy transfer).   
 
Figure 50. Adapted figures from Homouz et al. (2008) a) Schematic phase diagram of different VlsE structures 
induced by crowding (B, X), native or crystal (N) and unfolded (U). b) Probability density vs. N-C distance for 
the two different VlsE folded conformations (courtesy of Prof. Margaret S. Cheung). 
 
Although our measurement of in-cell D-A distance does not provide any detailed shape 
information about the protein, it is consistent with an in-cell population of a state of greater N-
C termini separation, such as the B state.  If so, the distribution's width from D/A ≈ 3 to ≈ 4.5 
indicates a range of compactness in different cells, not a completely homogeneous structural 
state.  It must be noted that their proposed in Ficoll buffer B state requires higher temperature to 
be stabilized (Figure 50a), whereas we observe a population with larger D/A ratio even in room 
temperature cells (Figure 4a).  Thus the combination of crowding and long range effects would 
have to act significantly differently in the cell than in Ficoll buffer, which is already clear from 
the opposite trends we observe for VlsE-FRET in the cell (Figure 49) and in Ficoll buffer 
(Figure 48). 
 
B A 
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5.3.6 Kinetics of VlsE-FRET slow down more than kinetics of PGK-FRET  
 To compare the kinetics of VlsE-FRET folding aqueous buffer and in 8 cells, the scaled 
difference of D-A21 (D-A) as function of time was monitored after a 4 °C temperature jump 
(Figure 51).  The starting temperature of the jumps ranged from about 25 to 45 °C.  The 
amplitude of the kinetic signal reached a maximum around Tm, where a temperature jump 
produces the largest population relaxation.26 In aqueous buffer, the maximum amplitude was 
reached at about 39.5 °C, and in U2OS cells on average at about 36.5 °C, both consistent with 
the Tm values from thermodynamics (the largest amplitude should be for a 4 °C jump from 2 °C 
below Tm to a final temperature of 2 °C above Tm). 
 
Figure 51. Sample kinetics traces. (a) in cells (red). (b) in aqueous buffer (blue).  The colored temperatures 
indicate the temperature after the temperature jump, and black arrows indicate the cycle of temperatures at 
which successive kinetic data points were collected. 
 
Our aqueous buffer result of kobs = 2.3 ± 0.4 s-1 (t = 0.4 ± 0.1 s) at Tm is in reasonable 
agreement with the value of 5 ± 2 s-1 in ref. 23. Our value was obtained by fitting the data in 
Figure 6a to a stretched exponential Aexp[-(kobst)b] to test for deviations from two-state behavior 
(Methods, Table 1).  No significant deviations were found. The average b from four aqueous 
buffer measurements 0.96 ± 0.02 is in agreement with the previous finding that VlsE is an 
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apparent two-state folder.23  Therefore kobs is the two-state total relaxation rate, equal to the sum 
of forward and backward rate coefficients. 
kobs is weakly temperature dependent inside cells (Figure 52), as was also observed for 
PGK.27 At Tm, t ranged from 0.8 to 3.6 s, with an average of 1.9 ± 1.2 s (Table 2).   
 
Figure 52. Arrhenius plot; the natural log of kobs was plotted vs. the inverse of the temperature in Kelvin, a) for 
in vitro sample kinetics, and b) for in cell sample kinetics. 
 
This average is 4.5 times slower than τ aqueous buffer (0.4 s), with a distribution that again does 
not overlap the aqueous buffer distribution at all.  In contrast, PGK-FRET was only 2 times 
slower in-cell than aqueous buffer and the fast end of the relaxation time distribution overlapped 
the in vitro value.  For PGK-FRET the factor of 2 slow-down compared to aqueous solution was 
attributed mostly to a change in local viscosity and hence diffusion coefficient Dwater/Dcell ≈ 2.28 
For VlsE we do not have the average Phi value to distinguish barrier effects from viscosity 
effects,29 so either our VlsE construct samples higher local viscosity than our PGK construct 
(Dwater/Dcell ≈ 4.5), or, if the viscosity sampled by VlsE is the same as for PGK, there is a 50% 
contribution from a slightly increased average folding barrier in cells (DDG† ≈ RTln(4.5/2) ≈ 2 
kJ/mole). 
 
5.3.7 Kinetically distinct protein populations exist inside cells  
 We observe three lines of evidence for distinct VlsE populations inside U2OS cells: 
kinetically distinct populations, non-exponential kinetic traces, and different thermodynamic 
stabilities for native states of different compactness. 
Figure 53a plots relaxation time t vs. melting temperature Tm for all 8 cells in which 
kinetics and thermodynamics were measured together. While proteins in different cells are not 
clearly distinguished by their thermodynamic stability, the cells fall into two kinetic populations, 
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both slower than the relaxation kinetics in aqueous buffer.  The order of measurement had no 
relationship with 'faster' or 'slower' cells, thus the probability of the two populations arising from 
a single-peaked probability distribution is only p≈0.03 by the Kolmogorov-Smirnov test.30 The 
populations are kinetically distinct with 97% probability. 
 
Figure 53. Distinct populations inside cells: (a) T-jump relaxation time τ vs. melting temperature Tm. (b) 
Negative correlation between D/A ratio at 25 °C vs. Tm (red dots: in cell; blue dots: in aqueous buffer). 
 
In contrast to b = 0.96 ± 0.02 in aqueous buffer, the average value of b was 0.87 ± 0.05 in 
the 8 cells for which kinetics were measured. b ranged as low as 0.6 ± 0.1 and as high as 1.1 ± 
0.1. Thus some cells’ b deviated significantly below the b =1 expected for a single exponential 
function. This result could be explained by two limiting cases. 1) Either the folding mechanism 
has become multi-state inside the cell; 2) or the proteins are still two-state folders, but exist in 2 
or more populations with different relaxation rates, so that averaging over the whole cell yields a 
non-exponential decay.  A simulation in Figure 54 shows that b = 0.87 is consistent with case 2), 
assuming in-cell variations of rates are similar to cell-to-cell variations of rates.  Cytoplasmic 
heterogeneity of two-state relaxation rates accounts quantitatively for the observed smaller value 
of b in cells, but multi-state mechanisms cannot be ruled out, especially in cells with b>1. 
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Figure 54. Distribution of β obtained by fitting simulated data to a stretched exponential τ = τmean. (a) 
Simulated data drawn from τ = τmean ± σ, and (b) simulated data drawn from τ = τmean ± ε, 
€ 
ε =
σ
N
$ 
% 
& 
' 
( 
) . 
 
As discussed earlier, the D/A ratio in-cell is on average greater than aqueous buffer 
(larger end-to-end distance in the cell).  In addition, the D/A ratio in-cell also varies more (± 0.7 
range, instead of the ± 0.1 range aqueous buffer that defines our measurement error). Plotting 
the D/A ratio at ≈25 °C against Tm yields a significant inverse correlation (R2 = 0.98 in Figure 
53b). In-cell folded VlsE populations that have the largest end-to-end distances are less stable; 
proteins with smaller end-to-end distances are more stable.  This is consistent with simple 
crowding because more compact states should be more stable than less compact states in a 
crowded matrix. 
 
5.4 Discussion 
 We can draw two main conclusions from our data.  1) The extracellular protein VlsE-
FRET is destabilized inside the cytoplasm of U2OS cells, while the cytoplasmic enzyme PGK-
FRET is stabilized.  The previously observed stabilization of PGK inside cells cannot be 
extrapolated to extracellular proteins. Extracellular proteins that are synthesized in the cytoplasm, 
but end up unfolded and translocated outside the membrane to work as receptors, adhesion 
molecules, etc. constitute approximately ~20%-30% of cellular proteins, so there could be more 
such destabilized proteins.31  2) VlsE-FRET is stabilized by the carbohydrate crowder Ficoll yet 
destabilized in the cell.  While PGK stability changes can be rationalized by simple volume 
exclusion both in a Ficoll matrix and in cells, explaining VlsE stability and folding will either 
require effects beyond crowding, or a structure-dependent volume exclusion mechanism. 
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We propose two scenarios in Figure 55 to account for the destabilization of VlsE inside 
cells and its stabilization by the synthetic crowder Ficoll: 1) Long-range interactions present in 
the cell but absent in Ficoll are able to overcome the excluded volume effect or 2) Short range 
structure-dependent excluded volume effects differ between the cell and Ficoll environments.  
More proteins with different surface charges and shapes will have to be studied to confirm 
whether the "Long range interactions" scenario or the "Shape-dependent crowding" scenario is 
more dominant. 
 
Figure 55. Simplified energy landscapes demonstrating how (a) the long-range electrostatic scenario, and (b) 
the shape-dependent crowding scenario can rationalize VlsE destabilization inside cells and VlsE stabilization 
in Ficoll, relative to aqueous buffer experiments. 
 
In the long-range interactions scenario (Figure 55, top), Ficoll and the cytoplasm act 
differently: in Ficoll buffer, the less compact unfolded U state is destabilized entropically, 
whereas the compact native state N is relatively unaffected.  As a result there is a net increase in 
the folding free energy.  In the cytoplasm, with its more complex mix of charged and uncharged 
crowders (including nucleic acids such as tRNA and charged proteins in addition to neutral 
carbohydrates), the U state could favorably interact with crowders, such as sticking to their 
surfaces.  This enthalpic effect could overcome the entropic destabilization of U, resulting in a 
net decrease of the folding free energy and in the protein stability. 
In the shape-dependent crowding scenario (Figure 55, bottom), the different shapes of 
the X and B states proposed by Homouz et al. come into play.  The B state is a more compact 
bean-shaped version of the normally elongated native state N, and the X state is a more compact 
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version of the unfolded state U.  In aqueous buffer (left), a simple two-state interconversion 
between N and U occurs.  When Ficoll is added (right), B becomes the favored ground state of 
the system replacing N, and it is stabilized so much that the usual crowding effect is seen: the 
more compact folded state is stabilized relative to the less compact unfolded state.  In the cell 
(middle), an intermediate effect is observed.  B is favored over N, just as in Ficoll, but is not 
stabilized as much, and to a varying degree from cell to cell (hatched band in Figure 55).  Thus 
the B-U folding free energy is not as favorable as N-U was in buffer, or as B-U was in Ficoll, and 
the compact protein is destabilized relative to the unfolded protein.  
The two scenarios are not mutually exclusive, and indeed, different data speak in favor or 
against either alone. Fig 53b offers evidence against the shape-dependent crowding scenario. It 
shows that B-like states with larger D/A ratios (characteristic of the B state according to Figure 
50b) result in a less stable protein; but then N-like states with smaller D/A ratio would be more 
stable in cells than B-like states.  On the other hand, Figure 49a favors the shape-dependent 
crowding scenario. The D/A ratio (end-to-end distance) in Figure 49a is larger at room 
temperature in the cells vs. aqueous buffer.  This matches the simulations by Homouz et al.11 
because the more compact B state has a larger end-to-end distance than the N state (Figure 
50b).  Sequence and structure analysis, however, do not support the scenario where long-range 
electrostatics can explain the differential destabilization of PGK and VlsE in the cell.  The 
isoelectric points of VlsE and PGK are 7.11 and 6.98, leading to negligible charge differences at 
pH ≈ 7 in the cytoplasm.  Likewise, visualization of both proteins with VMD32 shows that the 
small net charge is evenly distributed over the surface of both proteins, making it unlikely that 
the two proteins are subject to significantly different electrostatic effects.  However, electrostatics 
is not the only possible long-range interaction that could stabilize U.  Hydrophobic contacts of 
the unfolded VlsE, more likely in a complex crowding matrix than in Ficoll buffer, could 
stabilize the unfolded state when it sticks to cellular crowders. 
The kinetic and thermodynamic evidence for the presence of different structural states 
such as N or B at low temperature, and U or X at high temperature, is mixed.  As shown in 
Figure 53a, no clear populations are distinguished by Tm, but kinetically there appear to be two 
distinct populations.  If the effect is purely energetic, it would require that the activation free 
energies, but not the folding free energies are modulated differently by each cell.  This seems 
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somewhat unlikely since the average Phi value for proteins is closer to 0.3 than 0.  A simple 
explanation would be that the kinetic cell populations differ in local viscosity: such a variation 
would affect only the rate (via the prefactor), but not the stability.  We currently do not have the 
capability to measure this variation, but concurrent fluorescence anisotropy (protein rotation) 
measurements could elucidate whether viscosity variations are indeed responsible for rate 
variations while the stability remains unchanged. 
In other respects the cellular environment has similar effects on VlsE as it does on PGK. 
The folding rate of both proteins is modulated from cell to cell.28 There is some evidence of a 
change in folding mechanism, caused by ~RT~2 kJ/mole modulation of the protein energy 
landscape.  In PGK, a change from stretched (b  < 1) to single exponential behavior (b =1) was 
seen in the endoplasmic reticulum,21 an unambiguous sign that the mechanism is becoming more 
two-state-like.  In VlsE, some cells have b  > 1 (albeit barely so), which can only arise if the 
folding mechanism becomes less two-state-like (see SI).  The average change of b from ≈1 to ≈ 
0.87, on the other hand, can be explained for both proteins by rate variations within the 
cytoplasm.25 The changes are not drastic for either protein; the in-cell environment, despite all its 
chaperones and a cytoplasmic composition that makes (un)folding more reversible,5 does not 
fundamentally alter the folding stability or kinetics, but rather fine-tunes the energy landscape of 
the protein to change Tm by a few °C or rates by a factor of 2-4. 
 Comparing our data with previous in Ficoll buffer experiments utilizing synthetic 
polymers as crowding agents, we see that at this time there is no general rule to predict if a 
protein will be stabilized or destabilized inside cells, or how much of an effect short range 
(crowding) vs. long range (electrostatics or other protein-matrix interactions) will play. Either 
effect motivates further the idea that the cell can modulate the stability and folding of proteins 
differently in different situations, depending on what function and type of interactions a protein 
has. Such weak interactions, or ‘quinary structure,’33 could allow cells to control protein function 
and lifecycle beyond the level of tightly bound complexes, post-translational modification, 
ubiquitination, or other mechanisms that rely on covalent bonds or high affinity interactions to 
control proteins. In effect, such interactions would amount to 'post - post-translational' control 
of proteins within the cell. 
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Part III 
Appendix A 
Protocols Developed by Thesis Author and Used in the Text 
A.1 Designing sequencing primers and request DNA plasmid sequencing 
First: The majority of our proteins (gene of interest) are in pET or pDream plasmids, these two 
plasmids have the T7 promoter (strong promoter) that can be use as initial primer. The use of 
this primer will allow you to sequence from 700 to 900 bp of your gene. Also, in the case of pET 
plasmids, they also have a T7 terminator, that can be use as a reverse primer with the same 
capability than T7 promoter. If you use the T7 terminator the sequence that you will receive 
from the biotechnology facility is the reverse complement. So, you have to use a web program 
(http://www.bioinformatics.org/sms/rev_comp.html) to get the forward complement and do 
your further analysis. 
Second: In order to know where you need to start designing your own primers, you should send 
it for sequencing first with the T7 promoter. One you know until where in your gene the T7 
promoter can get, then you can start designing your primers.  
Designing the Primers: General Rules 
1) After you know how far the polymerase can go with the T7 promoter is better to design a 
primer around 20 to 50 bs before the T7 promoter start giving errors. You can know this by 
aligning the sequence you receive with the original (full) sequence. There are different 
programs you can use, but in general Multalin is very good and it can also align protein 
sequences (http://multalin.toulouse.inra.fr/multalin/) 
This is an example: Start designing in the around the arrow 
 
 
 
 
 
 
 
 
Start	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2) In general for sequencing primer should have the following characteristics: 
a. 16 to 20 bp 
b. GC % from 40 to 60. 
c. Melting temperature (Tm) from 55 to 65 °C 
3) Because the primers we design are not in a promoter they won’t work for a long amount of 
bp like the T7 promoter or T7 terminator. So, you will need to design a primer every 150 to 
300 bp (it will depend on your plamid and primer). You can get one that can go 300 bp, but 
other will do just 150. In general, it is save do design one around every 150 bp. 
 
This is an example: The bases on bold are primers 
 
ATG GAT TAC AAG GAT GAC GAC GAT AAG GGA TCC ATG GTG AGC AAG GGC GCC GAG CTG TTC ACC GGC ATC GTG CCC ATC 
CTG ATC GAG CTG AAT GGC GAT GTG AAT GGC CAC AAG TTC AGC GTG AGC GGC GAG GGC GAG GGC GAT GCC ACC TAC GGC 
AAG CTG ACC CTG AAG TTC ATC TGC ACC ACC GGC AAG CTG CCT GTG CCC TGG CCC ACC CTG GTG ACC ACC CTG AGC TAC 
GGC GTG CAG TGC TTC TCA CGC TAC CCC GAT CAC ATG AAG CAG CAC GAC TTC TTC AAG AGC GCC ATG CCT GAG GGC TAC 
ATC CAG GAG CGC ACC ATC TTC TTC GAG GAT GAC GGC AAC TAC AAG TCG CGC GCC GAG GTG AAG TTC GAG GGC GAT ACC 
CTG GTG AAT CGC ATC GAG CTG ACC GGC ACC GAT TTC AAG GAG GAT GGC AAC ATC CTG GGC AAT AAG ATG GAG TAC AAC 
TAC AAC GCC CAC AAT GTG TAC ATC ATG ACC GAC AAG GCC AAG AAT GGC ATC AAG GTG AAC TTC AAG ATC CGC CAC AAC 
ATC GAG GAT GGC AGC GTG CAG CTG GCC GAC CAC TAC CAG CAG AAT ACC CCC ATC GGC GAT GGC CCT GTG CTG CTG CCC 
GAT AAC CAC TAC CTG TCC ACC CAG AGC GCC CTG TCC AAG GAC CCC AAC GAG AAG CGC GAT CAC ATG ATC TAC TTC GGC 
TTC GTG ACC GCC GCC GCC ATC ACC CAC GGC ATG GAT GAG CTG TAC AAG CAT ATG AAA AGC CAA GTT GCT GAT AAG GAC 
GAC CCA ACA AAC AAA TTT TAC CAA TCT GTC ATA CAA TTA GGT AAC GGA TTT CTT GAT GTA TTC ACA TCT TTT GGT GGG TTA 
GTA GCA GAG GCT TTT GGA TTT AAA TCA GAT CCA AAA AAA TCT GAT GTA AAA ACC TAT TTT ACT ACT GTA GCT GCC AAA TTG 
GAA AAA ACA AAA ACC GAT CTT AAT AGT TTG CCT AAG GAA AAA AGC GAT ATA AGT AGT ACG ACG GGG AAA CCA GAT AGT 
ACA GGT TCT GTT GGA ACT GCC GTT GAG GGG GCT ATT AAG GAA GTT AGC GAG TTG TTG GAT AAG CTG GTA ACA GCT GTA 
AAG ACA GCT GAG GGG GCT TCA AGT GGT ACT GAT GCA ATT GGA GAA GTT GTG GAT AAT GAT GCT AAG GCT GCT GAT AAG 
GCG AGT GTG ACG GGG ATT GCT AAG GGG ATA AAG GAG ATT GTT GAA GCT GCT GGG GGG AGT GAA AAG CTG AAA GCT GTT 
GCT GCT GCT AAA GAG GGC AAT GAA AAG GCA GGG AAG TTG TTT GGG AAG GCT GGT GCT AAT GCT CAT GGG GAC AGT GAG 
GCT GCT AGC AAG GCG GCT GGT GCT GTT AGT GCT GTT AGT GGG GAA CAG ATA TTA AGT GCG ATT GTT AAG GCT GCT GAT 
GCG GCT GAG CAG GAG GGA AAG AAG CCT GAG GAG GCT AAA AAT CCG ATT GCT GCT GCT ATT GGG AAG GGT AAT GCG GAT 
GAT GGT GCG GAG TTT AAT AAG GAG GGG ATG AAG AAG GAT GAT CAG ATT GCT GCT GCT ATT GCT TTG AGG GGG ATG GCT 
AAG GAT GGA AAG TTT GCT GTG AAG GAT AAT AAT GAG AAG GGG AAG GCT GAG GGG GCT ATT AAG GGA GCT GCT GAA TCT 
GCA GTT CGC AAA GTT TTA GGG GCT ATT ACT GGG CTA ATA GGA GAC GCC GTG AGT TCC GGG CTA AGG AAA GTC GGT GAT 
TCA GTG AAG GCT GCT AGT AAA GAA ACC CCG CCG GCG CTG AAC AAA AAG CTT ATG GTG AGC AAG GGC GAG GAG GAT AAC 
ATG GCC ATC ATC AAG GAG TTC ATG CGC TTC AAG GTG CAC ATG GAG GGC TCC GTG AAC GGC CAC GAG TTC GAG ATC GAG 
GGC GAG GGC GAG GGC CGC CCC TAC GAG GGC ACC CAG ACC GCC AAG CTG AAG GTG ACC AAG GGT GGC CCC CTG CCC TTC 
GCC TGG GAC ATC CTG TCC CCT CAG TTC ATG TAC GGC TCC AAG GCC TAC GTG AAG CAC CCC GCC GAC ATC CCC GAC TAC 
TTG AAG CTG TCC TTC CCC GAG GGC TTC AAG TGG GAG CGC GTG ATG AAC TTC GAG GAC GGC GGC GTG GTG ACC GTG ACC 
CAG GAC TCC TCC CTG CAG GAC GGC GAG TTC ATC TAC AAG GTG AAG CTG CGC GGC ACC AAC TTC CCC TCC GAC GGC CCC 
GTA ATG CAG AAG AAG ACC ATG GGC TGG GAG GCC TCC TCC GAG CGG ATG TAC CCC GAG GAC GGC GCC CTG AAG GGC GAG 
ATC AAG CAG AGG CTG AAG CTG AAG GAC GGC GGC CAC TAC GAC GCT GAG GTC AAG ACC ACC TAC AAG GCC AAG AAG CCC 
GTG CAG CTG CCC GGC GCC TAC AAC GTC AAC ATC AAG TTG GAC ATC ACC TCC CAC AAC GAG GAC TAC ACC ATC GTG GAA 
CAG TAC GAA CGC GCC GAG GGC CGC CAC TCC ACC GGC GGC ATG GAC GAG CTG TAC AAG CTG GTG CCG CGC GGC AGC CAT 
CAT CAT CAT CAT CAC TAG CGG CCG C  
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4) The PrimerX program (http://www.bioinformatics.org/primerx/ ) is good to characterize 
primers for sequencing an also for mutagenesis. 
To order the primers: IDT (http://www.idtdna.com/site) 
1) Go to IDT (Integrated DNA Technologies) website → Products →DNA/RNA Synthesis 
→Custom DNA oligos; here you can choose single entry (for just one primer) or multiple 
entries. 
2) Then, in the next window you just need to give a name for your sequence and paste the 
sequence. We always order standard desalting and just 25nmole is enough for several 
reactions. 
3) Continue to checkout and click on email cart (this will email you the list of primers with the 
cost of each and the final price). 
4) Then, go to reaction (SCS Business Office) and order just (Primers) from Integrated DNA 
Technologies, with the amount of items (primers). Remember to attach the file you receive 
in your email from IDT. 
To request DNA plasmid sequencing: UIUC CORE SEQUENCING FACILITY 
1) Go to (https://unicorn.biotec.illinois.edu/) 
2) Create an account 
3) Go to Login to CoreLIMS 
4) Under Core Sequencing Services go to Sequencing Order Form 
5) In step 1 choose Sequencing 
6) In step 2 write the around of reaction for sequencing (for each primer you have to request a 
different reaction) 
7) If you are going to use the T7 promoter or T7 terminator: 
ü The miniprep concentration is usually 100 ng/µL (double check by UV) 
ü The pDream size is 7kb (you have to check for your own plasmid) 
ü Under NAME you choose the primer type 
ü The usual concentration for primer is 1 pmol/µL 
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8) For a custom primer that you design and order: 
 
9) The sequencing sometimes takes 2 to 3 days. 
 
A.2 Expression and Purification of Toxic Proteins (e.g. VlsE) 
Note: This is a modified protocol from the general protocol for protein expression written by 
Hannah Gelman. 
Encompassing mini-protocols for:  
1) E. coli transformation  
2) Protein expression  
3) Cell breaking/protein purification 
Note: Proteins like VlsE and U1A are not welcome in the E.coli cytoplasm, therefore they get 
degraded during or after translation. These are toxic proteins for E.coli.  
Mini-protocol #1:  E. coli transformation  
Materials:  
ü 50-500 ng of plasmid  
ü Bl21-plysS competent cell strain  
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ü BME (from cell kit)  
ü Ice from 5th floor CLSL-A  
ü Water Bath set to 42° C (usually the one used for CD experiments) 
ü 14 mL Falcon tubes 
ü LB agar plates with ampicillin  
ü Glass Pasteur pipette 
ü Super Optimal Broth (SOC)  
These are general instructions for cell transformation.  Consult the manufacturer’s protocol for 
the specific cells you are using.   
1) Fill an ice bucket and place Falcon tubes, BME, cells, and plasmid on ice.  Allow the Bl21-
plysS competent cells to thaw and cool for 20-30 minutes (no more than that).   
2) Aliquot 50 uL of cells into a Falcon tube.  Put the rest of the competent cells in the -80° C 
right after taking your aliquot. 
3) Add .7 uL of BME to the cells.  Mix gently.   
4) Wait for 10 minutes.  Mix gently every 2 minutes.  
5) Add 50 – 500 ng of plasmid to cells.  Mix gently.  Incubate on ice for 30 minutes.  
6) While incubating, warm up an aliquot of SOC and make sure the water bath temperature is 
set to 42° C.  
7) Heat shock the cells by holding the Falcon tubes in the water bath for 20 to 30 seconds.  
8) Set the cells on ice for 2 minutes.  
9) Add 450 uL of SOC to the Falcon tube.  Place the tube in the shaker and shake for 30 
minutes – 1 hour at 37 ° C. 
10)  While cells are shaking, remove LB plate from the fridge.  Wipe off condensation and place 
agar side down.   
11)  Remove cells from shaker.  Pipette 50 – 200 uL of cells on the LB Agar pad.   
12)  Bend a pipette by flaming and sterilize with ethanol.  Flame again until all ethanol has 
burned off.  Let the pipette cool for 15 seconds.  
13)  Spread the cells evenly on the agar.  
14)  Place the plates in the incubator, agar side up, for 12-18 hours.  Small colonies should form.   
Seal plates with parafilm and keep in the fridge until ready to use.  
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Mini-Protocol #2: Protein expression  
Materials:  
ü 2 L flasks, autoclaved with 1 L LB each  
ü 1 L flask, autoclaved with 100 mL LB  
ü 1000x Ampicillin (.1g/mL) and Chloramphenicol (25 µg/mL)  
ü 1000x IPTG (1 M)  
ü Transformed cells on plates (age < 2 weeks)  
ü LB broth stock  
ü 500 mL centrifuge tubes (remember to autoclave before start Day two) 
ü PMSF or Protease Inhibitor Cocktail 
This protocol spans over 3 days.  The specific timing of your expression may vary.   
Day One:  
1) Prepare LB by mixing 20g LB powder/950 mL dH2O (total volume 1 L).  Mix using 
magnetic stirrer and set pH = 7 after all powder is dissolved.  
** Weight LB on Scout weighing scale and wipe area afterwards – LB is very light and will 
float everywhere.  
2) Pour 1L LB into each flask.   
3) Do step 1 and 2 for 100 mL in 1L flask 
4) Autoclave flasks and let them cool in the cold room.  LB can be kept for 1 to 2 nights at 
room temperature. 
*For the small culture, you should multiply it by the amount of large culture. For example if 
you have 5 large cultures, then you want a 500 mL small culture.  
 Day Two:  
First Step: 
1) In the morning, inoculate the 100 mL culture with 1 colony of transformed cells (for every 
100 mL add an extra colony).  Add 1/1000 volume of ampicillin and chloramphenicol stock 
solution.  Let the cells grow for 3 to 5 hour at 37°C until it is very cloudy.  
Second Step: 
1) Add 1/1000 volume of ampicillin and chloramphenicol stock solution to each 1 L culture.  
2) Inoculate each flask with 100 mL of the overnight culture.  Shake at 37°C.  
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3) Baseline the UV-Vis with LB and monitor the OD600 of each flask throughout the day.   
4) When the OD600 reaches 0.6 induce the cells by adding 1 mL IPTG stock.    
• Sometimes 1 flask may grow slower than another.  If this happens, you can take the fast 
growing flask out of the shaker for 30 min – 1 hour and allow the others to catch up.  
5) Induce at 20°C, prop open the lid of the shaker and turn the temperature control down to 0. 
Induce for 16 hours. 
Day Two: (depending on induction time, this may be the evening of Day Two)  
1) Pour cells into 500 mL centrifuge bottles.  Make sure that tubes are balanced by volume.  
2) Place the F500 rotor in the centrifuge and load the bottles.  Make sure that the rotor is 
balanced.  
3) Centrifuge for 25 minutes, at 5000 rpm and 4 °C.   
4) Remove the bottles and pour off the supernatant.  If you have more flasks to spin down, you 
can pour the supernatant on to the cells that have already spun down.   
5) When all flasks have been spun down, gather cells into one container.  Bleach supernatant, 
flasks, and bottles.  Let sit 15 minutes, pour out, and wash with soap and water. 
6) Suspend cells in 10 mL lysis buffer/liter expressed + 1 mM PMSF or Protease Inhibitor 
Cocktail.  At this point cells can be frozen in dry ice and stored at -80 °C or you can continue 
with the Protein Purification protocol.  
Mini-protocol #3: Cell breaking and purification  
Materials:  
ü 500 mM Imidazole, 300 mM NaCl, 50 mM Na2PO4  (pH = 8) 
ü 300 mM NaCl, 50 mM Na2PO4  (pH = 8)  (lysis buffer)  
ü Ni-NTA His-Bind Column  
ü Sonicator, ice 
ü PMSF, DNAse  
Procedure:  
Cell breaking  
1) If your cells are frozen, thaw cells on ice in a small beaker.   
2) Add 20 uL DNAse/10 mL lysis buffer  
3) Sonicate cells  
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a. Put cell beaker in ice bucket and raise until sonicator tip is fully submerged but not 
touching the bottom.  
b. The sonicator has already a program that is used in this lab (ask someone in the lab). 
c. If you have > 100 mL of cells or more, sonicate in 2 batches to increase efficiency 
4) Centrifuge lysate in centrifuge tubes (10,000 rpm, 20 min, 4°C)  
5) Keep the supernatant, filter through 0.22 um filter (sometimes it is better to filter through 
0.45 um before). 
a. If supernatant is hard to filter – centrifuge again.  The next time, you may wish to 
sonicate for more cycles or in smaller volumes.  
Purification (for 6xHis tagged proteins, see specific protocol for other methods) 
Note: This protocol is for gravity purification; another protocol is available for FLPC 
purification in the database.  
1) Use a new or regenerated Ni-NTA column.  Equilibrate with lysis buffer.   
(choose resin height such that 1 mL resin ~ 10 mg protein expected.  May approximate ~ 
2 mL slurry/liter of cells, will depend on induction time and protein expression level)  
2) Carefully apply lysate to column using transfer pipette.  Collect the flow through.  Try not to 
disturb the column bed or allow the column to run dry.   
3) Wash with 2-3 column volumes of the following (make low concentrations of Imidazole by 
mixing with lysis buffer to keep salt concentration constant). This elution is for VlsE-FRET 
using gravity column (for the FPLC will be different). 
ü 5 CV of 20 mM Imidazole  
ü 5 CV of 40 mM Imidazole  
ü 2 CV of 50 mM Imidazole  
ü 2 CV of 200 mM Imidazole  
ü 1 CV 400 mM Imidazole   
 Collect each column volume (“fraction”) in a separate tube (you can use glass culture  
 tubes or 15 mL plastic tubes).  
4)  Run SDS-PAGE (see separate protocol) analysis for all fractions  
5) Combine fractions that have your protein and dialyze in your desired storage buffer.  
Alternatively, you can concentrate using Millipore centrifugation filters.   
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NOTES: 
*As with induction times, Imidazole concentration gradient is a guideline.  If you notice that 
your protein starts to elute with lots of other stuff, increase the number of steps at low Imidazole 
concentrations (e.g. Wash with 50 mM, 75 mM, 100 mM, 125 mM).  
**If you notice that your protein is not binding well to the column, try regenerating the column 
(see attached protocol) or using 50 mM phosphate buffer as your binding and equilibration 
buffer. 
***Add 5 mM BMe if your protein has a flanked mCherry or cysteines.   
****If you express any FRET protein you should use it ASAP or freeze it.  
 
A.3 Electromobility Shift Assay (EMSA) 
Making acrylamide gel  
1) Troughly clean 4 of 16 x 18 cm glass plates with RNAse away, MilliQ water and 70 % 
ethanol.  Add two gray spacers at each side and flush the bottom and secure with two gray 
gel clamps (not too tight though). 
2) Mix: 
ü 23.4 mL 30 % of acrylamide  
ü 8.80 mL of 2% of bis-acrylamide  
ü 8.75 mL of 10X BS  
ü 51.0 mL of MilliQ water 
ü Mix well and transfer 10 ml to a small beaker for making the plug  
a) Add 25 µl of TEMED and 50 µl of 10 % of APS to the plugging solution, mix well and 
pour immediately between plates (avoiding the formation of bubbles).   
b) Allow the gels to polymerize about 10 min. 
c) To the remaining gel solution, add 200 µl of TEMED and 400 µl of 10 % APS, mix well 
and place 15-tooth comb in each gel. 
d) Allow gels to polymerize about 20 min.  
e) Pre run the gels at (~7 ºC for CUGBP1) for about 30 min in 1X BS buffer.   
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Binding reaction  
1) Make series of 3X dilution of protein (which is 14 uL 1X Belasco Buffer with 0.5 DTT and 
7 uL protein) and incubate in the cold room for 1 hr. 
2) Remove 12 uL to a new tube. 
3) Heat up RNA at 90 ºC of 3 min, cool down on ice and make RNA diluition (5 µl of stock 5 
nM + 50 µl of 1X Belasco Buffer, add 5 µl 100 mg/ml tRNA and 190 60% glycerol water). 
4) Add 12 uL to each one. 
5) Load 10 µl onto gels. 
Running the gels 
1) Run at 350V for 45 min 
2) Dry the gels at 75 ºC for 45 min 
3) Expose the dried gel to the screen for overnight 
4) Scan the screen with storm 
 
A.4 Gel Electrophoresis (SDS-PAGE)  
Materials: 
ü Casting stand (transparent large stand) 
ü 2 casting frame (green small stands) 
ü 2 sets of glass plates: previously cleaned with water and rinsed with 70% ethanol) 
ü 2 combs: select the amount of wells you need, also cleaned and rinsed 
ü 2 small beakers (10 mL): to prepare solutions 
ü p10, p100 and p1000  
ü Running buffer  (4X) 
        57.6 g Glycine 
        12 g Tris base 
         4 g SDS 
         Water to 4 liters (no need to filter or check pH) 
ü 22.2 % Acrylamide/Bis-Acrylamide (37:1 cross-linker ratio):  
        22.2 g acrylamide,  
        0.6 g bis-acrylamide  
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        Water to 100 ml and filter with a 0.22 um filter 
ü 44.4 % Acrylamide/Bis-Acrylamide (37:1 cross-linker ratio):  
        44.4 g acrylamide,  
        1.2 g bis-acrylamide  
        Water to 100 ml and filter with a 0.22 um filter 
ü 1M Tris-HCl pH=8.8 and pH=6.8 
        157.56 g Tris-HCl (Trisma) 
         Water to 1L and adjust pH 
ü 10% SDS  
        10g Sodium Dodecyl Sulfate in 100mL water 
ü 10% APS (prepare fresh every week at least) 
         1 g Ammonium persulfate  
         10mL water 
Procedure: 
1) Have all the material and reagents ready to use 
2) Insert each set of glass plates into the casting stand (green small stand), separately, and tight 
it, as shown. 
 
 
3) Prepare the “Separate Gel Solution”: 
-­‐ Mix the following regents depending on the desire gel percent in a 10mL beaker for two 
mini gels: 
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-­‐ DON’T add the 10% APS and TEMED until you are ready to pore the Separate Gel 
Solution between the glass plates in the casting stands. The Solution will start to 
polymerize quickly. 
Reagent 12% 10% 7.5% 6% 
22.2% Acrylamide and 0.6% 
Bis-Acrylamide Mixture 
5.4 mL 4.5 mL 3.6 mL 2.7 mL 
1M Tris-HCl pH=8.8 3.8 mL 3.8 mL 3.8 mL 3.8 mL 
Distilled Water 0.7 mL 1.6 mL 2.7 mL 3.4 mL 
10% SDS 100 uL 100 100 100 
10% APS 50 uL 50 uL 50 uL 50 uL 
TEMED 5 uL 5 uL 5 uL 5 uL 
 
Reagent 24% 20% 17.5% 15% 
44.4% Acrylamide and 1.2% 
Bis-Acrylamide Mixture 
5.4 mL 4.5 mL 3.9 mL 3.4 mL 
1M Tris-HCl pH=8.8 3.8 mL  3.8 mL 3.8 mL 3.8 mL 
Distilled Water 0.69 mL 1.59 mL 2.16 mL 3.05 mL 
10% SDS 100 uL 100 uL 100 uL 100 uL 
10% APS 50 uL 50 uL 50 uL 50 uL 
TEMED 5 uL 5 uL 5 uL 5 uL 
 
4) Slowly pour the Separate Gel Solution between the glass plates using a pipette to prevent air 
bobbles until the mark (the glass plates have a mark to indicate the level for the Separate Gel 
Solution), because you need to leave space for the Stacking Gel. 
5) Add 500 to 1000 uL of distilled water to the top (a small layer) to prevent air bobbles and to 
have an even layer of the Separate Gel Solution.  
6) Wait for polymerization (30 minutes to 1 hour) 
7) Prepare the Stacking Gel Solution by mixing the following reagent for two mini gels. 
-­‐ DON’T add the 10% APS and TEMED until you are ready to pore the Stacking Gel 
Solution over the Separate Gel Solution (which is already polymerized).  
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Reagent Vol. 
22.2% Acrylamide and 0.6 % 
Bis-Acrylamide Mixture 
1.0 mL 
1M Tris-HCl pH=6.8 625 uL 
Distilled Water 3.3 mL 
10% SDS 50 uL 
10% APS 25 uL 
TEMED 2.5 uL 
 
8) Remove the layer of water and pour the Stacking Gel Solution 
9) Insert the comb slowly and wait for polymerization (30 minutes to 1 hour) 
A.5 Malemide Reaction  
Note: This is a general protocol for students trained or familiar with this reaction. 
Materials: 
ü Tris(2-carboxyethyl)phosphine (TCEP) 
ü Protein with only one cysteine 
ü Maleimide conjugate dye or molecule 
ü Buffer with NO 2-Mercaptoethanol (βMe) 
ü Nitrogen line with outlet 
ü Sonicator and vacuum line (Or high vacuum only) 
ü 5 mL or 10 mL round-bottom flask  
ü Rubber septa 
ü Needles 
ü Tubing 
ü Stirrer 
ü Paraffin 
ü Aluminum foil 
ü Centrifugal filter 
Protocol: 
Step 1: Degas buffer 
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1) Using a sonicator and house vacuum to degas your buffer for at least 1 hour. The longer the 
degasing, the better. If you use high vacuum 30 minutes is enough. 
Step 2: Removal of disulfide bonds 
1) Have your round-bottom flask ready with the stirrer in it. 
2) Add your protein first, then the TCEP and finally the buffer. 
3) Allow nitrogen to flow in and out from 5 to 10 minutes. Then, you can stop the nitrogen 
flow and put around the septa paraffin to avoid the lost of nitrogen. 
4) Let the reaction proceed for at least 2 hours. 
Step 3: Labeling (or Maleimide reaction) 
1) Remove the septa and add the Maleimide-linked molecule quickly. 
2) Allow nitrogen to flow in and out from 5 to 10 minutes. Then, you can stop the nitrogen 
flow and put paraffin around the septa to avoid the lost of nitrogen. 
3) Cover the round-bottom flask with aluminum foil.  
4) Let the reaction proceed overnight. 
Step 4: Filtration of free dye and TCEP. 
1) Select a centrifugal filter with a cutoff size adequate for your protein. 
2) Filter the solution several times until the flow throw has no color. 
Step 5: Gravity filtration 
1) Install the column vertically with column handler. Do not use inlet tubes, since it will run 
under gravity pressure. Then, opened the inlet top.  
2) Prepare the gel Sephadex G-75 (for proteins between 30,000 and 100,000 Da), for each 1 g 
swells add 12-15 mL (75% of the volume should be powder).  Mix slowly and wait for 1 hr. 
3) Pour buffer into the column until it rich 2 cm above the column bottom base. Gently swirl 
the gel, and pour the gel solution slowly to the column. You will notice that the gel is slowly 
moving down forming a packed bed.  
4) Equilibrate with 2-3 times bed volume of buffer. 
5) Wait 1 hr for the column to package. 
6) Remove buffer until have 0.5 cm above the resin 
7) Add slowly your the sample solution and start recovering as soon as possible 
8) Measure absorbance at 280nm to monitor which fraction contain the protein 
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A.6 Microinjection  
 Microinjection is a good procedure to introduce molecules inside living cells, especially 
those molecules that were modified (e.g. phosphorylated, dye labeled and glycosylated) in vitro. 
The system available in our laboratory is the Eppendorf FemtoJet microinjector and 
micromanipulator.  
Materials: 
ü Capillaries (Femtotips) 
ü Microloader tips 
ü Pipette 
ü Small Centrifuge and centrifuge tubes 
ü 22 µm Small Filter and 1 mL syringe  
Procedure: 
Note: The solution to be injected must have a concentration higher than 80 µM to be able to 
have a good signal inside cells. It is recommendable to have your sample in a simple buffer 
without high salts, chelating agents, and reducing agents.  
Step 1: Loading the Femtotip 
1) Filter solution through a 0.22 µm syringe filter (10 to 20 µL is enough). 
2) Centrifuge at ~13, 000 rpm for 5 to 10 minutes to “pellet down” heavy particles. 
3) Right after centrifugation, pipette out 3 to 4 µL from the top solution with the microloader. 
4) Remove the femtotip from it bag, and introduce the microleader into it (almost to the end). 
5) Slowly transfer the solution from the Microloader to the femtotip. 
6) Remove bubbles by gently shaking the femtotip, then remove the cap from the femtotip. You 
might need to shake more to remove all the bubbles. 
7) Screw the femtotip into the macromanipulator holder. 
Step 2: Preparing cells 
Note: This protocol is for adherent cells.  
1) Grow cells until 70 to 80 % confluency. 
2) Split cells into coverslips and let them group to a confluency of 80 to 90 % to have enough 
groups of cells 
3) Remove the growing media and wash out the cell debris with 3 to 4 mL of PBS 
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4) Add 3 mL Opti-Men reduced serum in the cover slip dish 
5) Place the dish in the center of the microscope stage.   
Step 3: Microinjection 
1) Center the femtotip with the macromanipulator in the center of the microscope stage. 
2) Bring down the femtotip into the media and then find it through the 10X objective 
3) Then, focus the cell and bring the femtotip closer to the cells with the slower speed. 
4) When you can focus both at the same level under the 10X objective, move to the 40X 
objective. At this point you need to find the first cell you want to microinject. 
5) Touch the edge of the cell with the tip and set your Z-distance, then move to the center of 
the cell and microinject. 
To learn this protocol is better to be instructed by someone first. Also, the person will need at 
least 3 days (or consecutive trials) before becoming independent.  
 
 
Picture of the microscope with microinjection system 
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Appendix B 
Protein-RNA Interactions and Protein Folding Analysis Equations 
 
Protein-RNA interactions Thermodynamics: 
 
Reaction 
 𝑃 − 𝑅 ⇌ 𝑃 + 𝑅 
 
Complex concentration 
 𝑋! = [𝑃! + 𝑅! + 𝐾!]− [𝑃! + 𝑅! + 𝐾!]! − 4𝑃!𝑅!2  
 
Dissociation constant 
 𝐾! = 𝑒(∆!!") 
 
Equilibrium free energy 
 ∆𝐺 = 𝐺1(𝑇 − 𝑇!) 
 
Signal for equilibrium traces 
 𝑆 𝑇 = 𝑆! 𝑋!(𝑇)𝑃!(𝑇) + 𝑆! 1− 𝑋!(𝑇)𝑃!(𝑇)  
 
Nonlinear van’t Hoff 
 ln 𝐾𝑑 = ln 𝐾𝑑° + ∆𝐶𝑝𝑇!𝑅 1𝑇 − 1𝑇! + ∆𝐶𝑝𝑅 ln   𝑇𝑇!  
 
 
Protein-RNA interactions Kinetics:   
 
Master kinetic equation 
 𝑑𝑃 − 𝑅𝑑𝑡 = 𝑘!""𝑃 − 𝑘!"𝑅! 
 
Signal for kinetic traces (solution with 3µM initial concentration) 
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𝑆 𝑡= 𝐴!𝑒 !!!! !!!!
+
𝐴! tanh 2𝑡𝑎𝑛ℎ!! 𝑘! + 𝑘! 𝑋!𝑘! + 𝑘! + 12𝑘!2 + 𝑡 𝑘! 𝑘! + 12𝑘! 𝑘! 𝑘! + 12𝑘! − 𝑘!
𝑘!  
 
Rate constants 
 𝑘!" = 𝑘!""𝐾!  
 
Nonlinear Eyring 
 ln 𝑘 = ln 𝑘!𝑇ℎ + ∆𝑆!𝑅 − Δ𝐻!𝑅𝑇  
 Δ𝑆! = Δ𝑆! + Δ𝐶𝑝!ln   𝑇𝑇!  
 Δ𝐻! = Δ𝐻! + Δ𝐶𝑝!(𝑇 − 𝑇!) 
 
 
Protein folding: 
 
We use a Taylor expansion to approximate the unfolding free energy: 
 
€ 
ΔG(T)T→Tm = ΔG(Tm) +
∂ΔG(T)
∂T (T −Tm) +
1
2
∂ 2ΔG(T)
∂T 2 (T −Tm)
2 + .... 
 
The 
€ 
ΔG  at the Tm is zero because the system is at equilibrium, therefore: 
 
€ 
ΔG(T)T→Tm = 0 +
∂ΔG(T)
∂T (T −Tm) +
1
2
∂ 2ΔG(T)
∂T 2 (T −Tm)
2 
 
The differentiable parts are define as constants
€ 
CT(1) =
∂ΔG(T)
∂T  and 
€ 
CT(2) =
1
2
∂ 2ΔG(T)
∂T 2  
€ 
ΔG(T)T→Tm = CT(1)(T −Tm) +CT(2)(T −Tm)2  
 
The first part of the equation,
€ 
ΔG(T)T→Tm = CT(1)(T −Tm) , is comparable to the free energy 
equation,
€ 
ΔG = ΔH −TΔS , in the following way: 
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€ 
ΔG(T)T→Tm = CT(1)(T) −CT(1)(Tm)  
 
€ 
ΔG(T)T→Tm = −CT(1)(Tm) +CT(1)(T)  
 
€ 
ΔH = −CT(1)(Tm)  
 
€ 
−TΔS = CT(1)(T)  
 
€ 
ΔS = −CT(1)  
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Appendix C 
DNA Plasmids Sequences 
U1A protein 
CAT CAT CAT CAT CAT CAC AGC AGC GGC CTG GTG CCG CGC GGC AGC CAT 
ATG GCA GTT CCC GAG ACC CGC CCT AAC CAC ACT ATT TAT ATC AAC AAC CTC 
AAT GAG AAG ATC AAG AAG GAT GAG CTA AAA AAG TCC CTG TAC GCC ATC TTC 
TCC CAG TTT GGC CAG ATC CTG GAT ATC CTG GTA TCA CGG AGC CTG AAG ATG 
AGG GGC CAG GCC TTT GTC ATC TTC AAG GAG GTC AGC AGC GCC ACC AAC 
GCC CTG CGC TCC ATG CAG GGT TTC CCT TTC TAT GAC AAA CCT ATG CGT ATC 
CAG TAT GCC AAG ACC GAC TCA GAT ATC ATT GCC AAG ATG AAA GGC ACC TTC 
GTG 
 
Yellow – His Tag 
 
VlsE-FRET protein 
ATG GAT TAC AAG GAT GAC GAC GAT AAG GGA TCC ATG GTG AGC AAG GGC 
GCC GAG CTG TTC ACC GGC ATC GTG CCC ATC CTG ATC GAG CTG AAT GGC 
GAT GTG AAT GGC CAC AAG TTC AGC GTG AGC GGC GAG GGC GAG GGC GAT 
GCC ACC TAC GGC AAG CTG ACC CTG AAG TTC ATC TGC ACC ACC GGC AAG 
CTG CCT GTG CCC TGG CCC ACC CTG GTG ACC ACC CTG AGC TAC GGC GTG 
CAG TGC TTC TCA CGC TAC CCC GAT CAC ATG AAG CAG CAC GAC TTC TTC AAG 
AGC GCC ATG CCT GAG GGC TAC ATC CAG GAG CGC ACC ATC TTC TTC GAG 
GAT GAC GGC AAC TAC AAG TCG CGC GCC GAG GTG AAG TTC GAG GGC GAT 
ACC CTG GTG AAT CGC ATC GAG CTG ACC GGC ACC GAT TTC AAG GAG GAT 
GGC AAC ATC CTG GGC AAT AAG ATG GAG TAC AAC TAC AAC GCC CAC AAT 
GTG TAC ATC ATG ACC GAC AAG GCC AAG AAT GGC ATC AAG GTG AAC TTC 
AAG ATC CGC CAC AAC ATC GAG GAT GGC AGC GTG CAG CTG GCC GAC CAC 
TAC CAG CAG AAT ACC CCC ATC GGC GAT GGC CCT GTG CTG CTG CCC GAT AAC 
CAC TAC CTG TCC ACC CAG AGC GCC CTG TCC AAG GAC CCC AAC GAG AAG 
CGC GAT CAC ATG ATC TAC TTC GGC TTC GTG ACC GCC GCC GCC ATC ACC CAC 
GGC ATG GAT GAG CTG TAC AAG CAT ATG AAA AGC CAA GTT GCT GAT AAG 
GAC GAC CCA ACA AAC AAA TTT TAC CAA TCT GTC ATA CAA TTA GGT AAC GGA 
TTT CTT GAT GTA TTC ACA TCT TTT GGT GGG TTA GTA GCA GAG GCT TTT GGA 
TTT AAA TCA GAT CCA AAA AAA TCT GAT GTA AAA ACC TAT TTT ACT ACT GTA 
GCT GCC AAA TTG GAA AAA ACA AAA ACC GAT CTT AAT AGT TTG CCT AAG GAA 
AAA AGC GAT ATA AGT AGT ACG ACG GGG AAA CCA GAT AGT ACA GGT TCT 
GTT GGA ACT GCC GTT GAG GGG GCT ATT AAG GAA GTT AGC GAG TTG TTG 
GAT AAG CTG GTA ACA GCT GTA AAG ACA GCT GAG GGG GCT TCA AGT GGT 
ACT GAT GCA ATT GGA GAA GTT GTG GAT AAT GAT GCT AAG GCT GCT GAT 
AAG GCG AGT GTG ACG GGG ATT GCT AAG GGG ATA AAG GAG ATT GTT GAA 
GCT GCT GGG GGG AGT GAA AAG CTG AAA GCT GTT GCT GCT GCT AAA GAG 
GGC AAT GAA AAG GCA GGG AAG TTG TTT GGG AAG GCT GGT GCT AAT GCT 
CAT GGG GAC AGT GAG GCT GCT AGC AAG GCG GCT GGT GCT GTT AGT GCT 
GTT AGT GGG GAA CAG ATA TTA AGT GCG ATT GTT AAG GCT GCT GAT GCG 
GCT GAG CAG GAG GGA AAG AAG CCT GAG GAG GCT AAA AAT CCG ATT GCT 
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GCT GCT ATT GGG AAG GGT AAT GCG GAT GAT GGT GCG GAG TTT AAT AAG 
GAG GGG ATG AAG AAG GAT GAT CAG ATT GCT GCT GCT ATT GCT TTG AGG 
GGG ATG GCT AAG GAT GGA AAG TTT GCT GTG AAG GAT AAT AAT GAG AAG 
GGG AAG GCT GAG GGG GCT ATT AAG GGA GCT GCT GAA TCT GCA GTT CGC 
AAA GTT TTA GGG GCT ATT ACT GGG CTA ATA GGA GAC GCC GTG AGT TCC 
GGG CTA AGG AAA GTC GGT GAT TCA GTG AAG GCT GCT AGT AAA GAA ACC 
CCG CCG GCG CTG AAC AAA AAG CTT ATG GTG AGC AAG GGC GAG GAG GAT 
AAC ATG GCC ATC ATC AAG GAG TTC ATG CGC TTC AAG GTG CAC ATG GAG 
GGC TCC GTG AAC GGC CAC GAG TTC GAG ATC GAG GGC GAG GGC GAG GGC 
CGC CCC TAC GAG GGC ACC CAG ACC GCC AAG CTG AAG GTG ACC AAG GGT 
GGC CCC CTG CCC TTC GCC TGG GAC ATC CTG TCC CCT CAG TTC ATG TAC GGC 
TCC AAG GCC TAC GTG AAG CAC CCC GCC GAC ATC CCC GAC TAC TTG AAG CTG 
TCC TTC CCC GAG GGC TTC AAG TGG GAG CGC GTG ATG AAC TTC GAG GAC 
GGC GGC GTG GTG ACC GTG ACC CAG GAC TCC TCC CTG CAG GAC GGC GAG 
TTC ATC TAC AAG GTG AAG CTG CGC GGC ACC AAC TTC CCC TCC GAC GGC CCC 
GTA ATG CAG AAG AAG ACC ATG GGC TGG GAG GCC TCC TCC GAG CGG ATG 
TAC CCC GAG GAC GGC GCC CTG AAG GGC GAG ATC AAG CAG AGG CTG AAG 
CTG AAG GAC GGC GGC CAC TAC GAC GCT GAG GTC AAG ACC ACC TAC AAG 
GCC AAG AAG CCC GTG CAG CTG CCC GGC GCC TAC AAC GTC AAC ATC AAG 
TTG GAC ATC ACC TCC CAC AAC GAG GAC TAC ACC ATC GTG GAA CAG TAC GAA 
CGC GCC GAG GGC CGC CAC TCC ACC GGC GGC ATG GAC GAG CTG TAC AAG 
CTG GTG CCG CGC GGC AGC CAT CAT CAT CAT CAT CAC TAG CGG CCG C  
 
Yellow – Flag tag 
Green – GFP 
Grey – VlsE sequence 
Magenta – Restriction sites 
Red - mCherry 
Light blue - Histag  
 
 
 
 
 
 
 
 
 
